Skip to main content
The Cochrane Database of Systematic Reviews logoLink to The Cochrane Database of Systematic Reviews
. 2021 Nov 8;2021(11):CD013385. doi: 10.1002/14651858.CD013385.pub2

Decision coaching for people making healthcare decisions

Janet Jull 1,, Sascha Köpke 2, Maureen Smith 3, Meg Carley 4, Jeanette Finderup 5,6,7, Anne C Rahn 8, Laura Boland 9,10, Sandra Dunn 11, Andrew A Dwyer 12,13, Jürgen Kasper 14, Simone Maria Kienlin 15,16, France Légaré 17, Krystina B Lewis 18,19, Anne Lyddiatt 20, Claudia Rutherford 21,22, Junqiang Zhao 18, Tamara Rader 23, Ian D Graham 4,24, Dawn Stacey 18
Editor: Cochrane Consumers and Communication Group
PMCID: PMC8575556  PMID: 34749427

Abstract

Background

Decision coaching is non‐directive support delivered by a healthcare provider to help patients prepare to actively participate in making a health decision. ‘Healthcare providers’ are considered to be all people who are engaged in actions whose primary intent is to protect and improve health (e.g. nurses, doctors, pharmacists, social workers, health support workers such as peer health workers).

Little is known about the effectiveness of decision coaching.

Objectives

To determine the effects of decision coaching (I) for people facing healthcare decisions for themselves or a family member (P) compared to (C) usual care or evidence‐based intervention only, on outcomes (O) related to preparation for decision making, decisional needs and potential adverse effects.

Search methods

We searched the Cochrane Library (Wiley), Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (Ovid), Embase (Ovid), PsycINFO (Ovid), CINAHL (Ebsco), Nursing and Allied Health Source (ProQuest), and Web of Science from database inception to June 2021.

Selection criteria

We included randomised controlled trials (RCTs) where the intervention was provided to adults or children preparing to make a treatment or screening healthcare decision for themselves or a family member. Decision coaching was defined as: a) delivered individually by a healthcare provider who is trained or using a protocol; and b) providing non‐directive support and preparing an adult or child to participate in a healthcare decision. Comparisons included usual care or an alternate intervention. There were no language restrictions.

Data collection and analysis

Two authors independently screened citations, assessed risk of bias, and extracted data on characteristics of the intervention(s) and outcomes. Any disagreements were resolved by discussion to reach consensus. We used the standardised mean difference (SMD) with 95% confidence intervals (CI) as the measures of treatment effect and, where possible, synthesised results using a random‐effects model. If more than one study measured the same outcome using different tools, we used a random‐effects model to calculate the standardised mean difference (SMD) and 95% CI. We presented outcomes in summary of findings tables and applied GRADE methods to rate the certainty of the evidence.

Main results

Out of 12,984 citations screened, we included 28 studies of decision coaching interventions alone or in combination with evidence‐based information, involving 5509 adult participants (aged 18 to 85 years; 64% female, 52% white, 33% African‐American/Black; 68% post‐secondary education). The studies evaluated decision coaching used for a range of healthcare decisions (e.g. treatment decisions for cancer, menopause, mental illness, advancing kidney disease; screening decisions for cancer, genetic testing). Four of the 28 studies included three comparator arms. 

For decision coaching compared with usual care (n = 4 studies), we are uncertain if decision coaching compared with usual care improves any outcomes (i.e. preparation for decision making, decision self‐confidence, knowledge, decision regret, anxiety) as the certainty of the evidence was very low. 

For decision coaching compared with evidence‐based information only (n = 4 studies), there is low certainty‐evidence that participants exposed to decision coaching may have little or no change in knowledge (SMD ‐0.23, 95% CI: ‐0.50 to 0.04; 3 studies, 406 participants). There is low certainty‐evidence that participants exposed to decision coaching may have little or no change in anxiety, compared with evidence‐based information. We are uncertain if decision coaching compared with evidence‐based information improves other outcomes (i.e. decision self‐confidence, feeling uninformed) as the certainty of the evidence was very low.

For decision coaching plus evidence‐based information compared with usual care (n = 17 studies), there is low certainty‐evidence that participants may have improved knowledge (SMD 9.3, 95% CI: 6.6 to 12.1; 5 studies, 1073 participants). We are uncertain if decision coaching plus evidence‐based information compared with usual care improves other outcomes (i.e. preparation for decision making, decision self‐confidence, feeling uninformed, unclear values, feeling unsupported, decision regret, anxiety) as the certainty of the evidence was very low.

For decision coaching plus evidence‐based information compared with evidence‐based information only (n = 7 studies), we are uncertain if decision coaching plus evidence‐based information compared with evidence‐based information only improves any outcomes (i.e. feeling uninformed, unclear values, feeling unsupported, knowledge, anxiety) as the certainty of the evidence was very low.

Authors' conclusions

Decision coaching may improve participants’ knowledge when used with evidence‐based information. Our findings do not indicate any significant adverse effects (e.g. decision regret, anxiety) with the use of decision coaching. It is not possible to establish strong conclusions for other outcomes. It is unclear if decision coaching always needs to be paired with evidence‐informed information. Further research is needed to establish the effectiveness of decision coaching for a broader range of outcomes.

Plain language summary

Decision coaching for people making healthcare decisions

Background

There is a need to better involve people who are making healthcare decisions about treatments (e.g. surgery) or screening (e.g. tests to tell if there is a health problem). Quality decisions are made when people know the best available evidence on options and can share what matters with their healthcare provider(s).

Decision coaching supports people to prepare for making a health decision. It is provided by healthcare providers who are trained or use a protocol for decision coaching (e.g. nurses, doctors, pharmacists, social workers, health support workers such as peer health workers). 

We wanted to find out if decision coaching helps people to prepare for making healthcare decisions.

 

What did we do?

We are a team of patient partners, healthcare providers, teachers and researchers from seven countries.

We looked for studies that tested decision coaching with people (adults and children) to prepare them for making a healthcare decision about treatment or screening for themselves or a family member.

We included studies if people who received decision coaching were randomly put into study groups (e.g. using a computer to decide who goes in which group). Studies where people are randomly put into groups are the best way to compare findings between groups and give results we can rely on when we look at the effects of an intervention like decision coaching. 

 

Search strategy 

To find studies, we searched eight online data banks. We asked experts and authors of studies about decision coaching. We included studies published up to June 2021. 

 

What we found 

We found 28 studies about decision coaching used alone or with high‐quality patient information based on research (called ‘evidence‐based information’). There was a total of 5509 adults in the 28 studies. None of the studies included children, and only one study included people (parents) making decisions for someone else. The studies tested decision coaching with a range of healthcare decisions such as treatment decisions related to cancer, menopause, or mental illness; cancer screening decisions, and genetic testing. 

Some of the studies looked at decision coaching with, or compared to, disease‐specific information or evidence‐based information such as patient decision aids (booklets, videos, online tools that: make the decision clear, provide options and the pros and cons, and help people be clear on what matters to them).

 

What does the evidence show?

People who received decision coaching compared with evidence‐based information only: 

‐ may have little or no change in knowledge (406 patients, 3 studies);

‐ may have little of no change in anxiety (242 patients, 1 study).

 

People who received decision coaching plus evidence‐based information compared with usual care: 

‐may have improved knowledge (1073 patients, 5 studies)

 

Our confidence in the results

We have low confidence that decision coaching plus evidence‐based information improves people’s knowledge compared to usual care. We have low confidence that decision coaching may have little or no effect on knowledge and anxiety compared to evidence‐based information. We are less confident about our other findings, as the certainty of the evidence is very low and there were important outcomes that were not reported by the included studies. Many studies had a small number of people taking part and this means that the results of this review might change with more studies.  

 

What this means

Decision coaching may improve peoples’ knowledge to help them prepare to make healthcare decisions when used with evidence‐based information. The review did not detect any adverse effects with the use of decision coaching. 

Summary of findings

Background

Description of the condition

Healthcare systems around the world call for improved patient engagement and increased efforts to support those making healthcare decisions (see ACSQHC 2021Chow 2009Frosch 2011Härter 2011NICE 2021Oslo University Hospital 2021). Shared decision making (SDM) is a process by which people who are personally experiencing a health issue ('patients') (SCPOR 2019), and their clinician(s) work together to make decisions about screening, treatments, or management of chronic conditions. Family members or significant others, or both, may also participate in SDM. SDM is based on the best available evidence on healthcare options and the patients' informed preferences (Coulter 2011Makoul 2006). SDM has been shown to improve patient outcomes and experience, improve the experiences and effectiveness of health professionals in their communication with patients, and may optimise costs in healthcare (Légaré 2012Légaré 2014Légaré 2018). Despite the benefits and effectiveness of SDM, there have been low levels of uptake in clinical practice (Couet 2013Coulter 2018). 

To facilitate patient involvement in decision making, healthcare providers trained or using a protocol in decision coaching may use different interventions with patients including decision coaching, patient decision aids, and question prompts (Stacey 2017a). 'Healthcare providers' refers to both healthcare professionals (e.g. audiology, speech language pathology, dentistry, medicine, nursing, midwifery, occupational, physiotherapy) and health support workers (e.g. peer support worker, lay health worker) (Jull 2019WHO 2010). We consider healthcare providers to be all people who are engaged in actions whose primary intent is to protect and improve health (WHO 2007). Interventions for patients only have the potential to be effective at facilitating patient involvement in decision making (e.g. patient decision aids); however, interventions targeting patients and healthcare providers (e.g. training) have the greatest potential for facilitating SDM (Légaré 2018). 

Description of the intervention

Decision coaching is non‐directive support delivered by a healthcare provider to help patients prepare to actively participate in making a health decision (Jull 2019Rahn 2021Stacey 2012). The goal is to improve the decision‐making process and to ultimately achieve informed, values‐congruent decisions. Decision coaches support patients to: a) identify their decision‐making needs; b) help them understand information that is evidence‐based on options (including watchful waiting), benefits and harms; c) help them clarify their values for outcomes of options (what matters to them); and d) encourage them to communicate their preferences to others (e.g. family, clinicians). Decision coaches may also provide patients with other evidence‐based information such as patient decision aids that are paper‐based or online tools that may be used alone or in a consultation with a healthcare provider (Jull 2019Rahn 2021Stacey 2017b). 

 

Decision coaching is provided by interacting with patients using face‐to‐face, telephone or other communication media (i.e. not automated electronically) (Jull 2019Stacey 2012). Decision coaching aligns well with the competencies of most healthcare providers who are expected to provide information that is evidence‐based and to support patient’s chosen level of participation (Joseph‐Williams 2014Politi 2013). Decision coaching is not routinely taught in training programmes preparing healthcare professionals for licensure; healthcare providers require additional specific training focussed on the knowledge and skills for providing decision coaching or a specific protocol (Stacey 2006Stacey 2009). 

How the intervention might work

Decision coaching aims to support adults and children to participate in the process of decision making to improve the quality of the decision‐making process and, consequently, the quality of the decision. This is consistent with decision coaching and other interventions described by the Ottawa Decision Support Framework (O'Connor 1998Stacey 2020). According to this Framework, decision making can be adversely affected by unmet decisional needs: decisional conflict (e.g. uncertainty about the best course of action); inadequate knowledge; unrealistic expectations; unclear values for outcomes of options; inadequate support or resources; complex decision type; urgent timing; unreceptive stage of decision making; polarised leaning towards an option; and participants' characteristics (Stacey 2020). The main assumption of the Framework is decision‐support interventions (e.g. counselling, patient decision aids, decision coaching) that address patients’ decisional needs to improve the quality of the decision and the decision‐making process, which may favourably affect implementation of the chosen option and appropriate use of health services. However, decision uncertainty is typically addressed after consultation with the clinician. 

Why it is important to do this review

The Cochrane Review of interventions to improve the use of SDM reported low certainty of evidence (Légaré 2018). When interventions to improve the use of SDM included decision coaching, it was delivered as part of a multi‐faceted intervention which makes it difficult to determine the effect of decision coaching and the effect on outcomes beyond SDM is unclear. Another review, focussed on the broader concept of coaching, showed that 17 studies of various designs indicated limited evidence suggesting improved patient‐physician communication in specialists’ consultations (Alders 2017). Other reviews have captured aspects of decision coaching when conducted within randomised controlled trials evaluating patient decision aids, yet none have specifically focussed on decision coaching as an intervention (Rahn 2021Stacey 2012Stacey 2017b). For example, the Cochrane Review of patient decision aids reported moderate certainty of evidence for the effects of patient decision aids on patient participation in decision making and multiple other outcomes (e.g. decision quality, decision‐making process) (Stacey 2017b). Some patient decision‐aid studies included decision coaching. A recent scoping review of decision coaching provided alongside a patient decision aid compared to usual care indicated that decision coaching with a patient decision aid improves knowledge and there were mixed results for other outcomes with no harms reported (Rahn 2021). A recent study about implementing SDM in clinical practice by healthcare providers indicated the need to focus on the use of behaviour change approaches with healthcare providers and with patients, for more effective SDM implementation (Agbadjé 2020). 

In summary, we convened an interdisciplinary, international team who are active in decision coaching. There have been no previous reviews conducted to explicitly measure the effectiveness of decision coaching as an intervention to facilitate patient participation in decision making. Given the human resource requirements to provide decision coaching, our team viewed it as important to determine the unique contribution of decision coaching as a healthcare intervention.

Objectives

To determine the effects of decision coaching (I) for people facing healthcare decisions for themselves or a family member (P) compared to (C) usual care or evidence‐based intervention only, on outcomes (O) related to preparation for decision making, decisional needs and potential adverse effects.

Methods

Criteria for considering studies for this review

Types of studies

We included randomised controlled trials (RCTs) with any kind of allocation method, e.g. individual, cluster, or stepped‐wedge. We excluded all other study designs and commentaries. There were no language restrictions.

Types of participants

We included studies conducted with adults and children preparing to make a healthcare decision regarding treatment or screening for themselves or a family member (substitute decision maker). Adults were defined as 18 years of age and older. Children were defined as under 18 years of age. We excluded any studies with someone who was making a lifestyle decision only, a decision about participation in research, or advanced care planning. We excluded studies with simulated patients and/or with patients making hypothetical decisions.

Types of interventions

We considered studies evaluating the decision‐coaching intervention that met the following minimal criteria:

  • delivered by a healthcare provider trained or using a protocol in decision coaching;

  • aimed to prepare the people to participate in making a healthcare decision;

  • delivered non‐directive support to people in the process of decision making; and

  • delivered individually, person‐to‐person, by telephone, or via the internet.

Different terms may be used in place of 'decision coaching', such as 'health counselling', 'support', and 'navigation' (Stacey 2013). We also included decision‐coaching interventions paired with evidence‐based information (e.g. patient decision aid) (Stacey 2012).

We excluded studies that described healthcare providers who were: a) making the decision with, or on behalf of, the person; b) not prepared for decision coaching with training or a protocol; c) recommending or being directive about a specific option; d) not described as having direct interests in providing decision coaching; e) providing decision coaching to groups; or f) automated decision coaching.

We included any comparison (e.g. usual care or other) except those where decision coaching was provided to both groups in the study:

  • decision coaching compared with usual care;

  • decision coaching compared with evidence‐based information only;*

  • decision coaching plus evidence‐based information* compared with usual care; and,

  • decision coaching plus evidence‐based information* compared with evidence‐based information only*.

*evidence‐based information includes patient decision aids.

Types of outcome measures

We took the following steps before including outcomes in the Results and Summary of findings tables.

If the outcomes of interest were reported in the article with only one measure (e.g. Decisional Conflict subscales), then no further action was needed. If reported with more than one measure (e.g. knowledge), we had planned that the outcome measures for each article would be listed and two review authors would independently make decisions about what is most relevant to patients; any differences were resolved by the involvement of a third author. For outcomes with more than one measure (e.g. knowledge) that could not be included in meta‐analysis, we reported results descriptively.

Outcomes of interest to the knowledge users and researchers on the team included active preparation for health decision making, decision‐making process outcomes and decision quality (e.g. informed, values‐congruent chosen option). As the main aim of decision coaching is to prepare people to participate in decision making, we identified primary outcomes that include preparation for active participation in making a health decision, resolution of modifiable decisional needs of relevance to decision coaching and adverse effects. 

We included data for all outcomes reported in each study that mapped to the primary and secondary outcomes of this review.

Primary outcomes
  • Preparation for active participation in making a health decision (patient‐reported). Outcomes were reported as per the Preparation for Health Decision Making scale (Bennett 2010). Preparation for active decision making includes: recognise that a decision needs to be made, feels prepared to make a decision, is helped to consider advantages and disadvantages of the decision, considers which advantages and disadvantages matter the most to the patient, organise thoughts about the decision, think about how involved they want to be in the decision, prepare to talk with a healthcare provider about the decision, and identify questions to ask. Other indicators of preparation for active participation in making a health decision include decisional self‐confidence and patient involvement in decision making (patient, observer‐reported) including perceived involvement, preferred level of involvement, participated at preferred level of involvement.

  • Resolution of modifiable decisional needs relevant to decision coaching (patient‐reported). Example outcomes, according to the Ottawa Decision Support Framework (Hoefel 2020Stacey 2020), include: uninformed, unrealistic expectations; unclear values; and inadequate support.

  • Any reports of adverse effects on patient or decision coach (patient, observer‐reported), that includes worsening effects such as increased decision regret and anxiety (meaning lower remorse or distress over a decision (Brehaut 2003)).

Secondary outcomes
  • Satisfaction with decision coaching (patient‐reported)

  • Decision quality (e.g. informed choice, values‐congruent chosen option)

  • Health systems resources (e.g. length of time, cost)

  • Quality of life (patient‐reported)

  • Quality of decision coaching (measured by an observer)

Search methods for identification of studies

Electronic searches

We developed and executed a comprehensive search strategy with an information specialist (AP), that was peer reviewed by a second information specialist (TR), according to the Peer Reviewed Electronic Search Strategy (PRESS) guidelines (McGowan 2016). After screening for included studies, we identified one additional study that should have been included. We worked with the information specialist (AP) to update our search strategy and conducted a new search in May 2020 with the additional key words (knowledg* or power* or empower*).

We searched from database inception to June 2021 in the following databases: the Cochrane Library (Wiley), Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (Ovid), Embase (Ovid), PsycINFO (Ovid), CINAHL (Ebsco), Nursing and Allied Health Source (ProQuest), and Web of Science. We conducted the original search strategy for MEDLINE (Ovid) and tailored it to other databases (Appendix 1Appendix 2Appendix 3Appendix 4Appendix 5Appendix 6Appendix 7). The search strategy had the Cochrane RCT classifier added to limit to RCTs only. Conference abstracts and theses were excluded. We did not restrict the search by language. 

Searching other resources

We searched the following grey literature sources:

  • Forward and backwards citation searching of included studies were used. Google Scholar was used to identify articles that have cited each of the included studies (forwards searching) and reference lists of included studies were screened for other relevant articles (backwards searching).

  • Google Scholar using advanced search (with key words combined scanning the most recent 50 citations, as per guidance from the information specialist (AP))

  • Contacting experts on shared decision making and decision coaching through the International Shared Decision Making Facebook group and authors of included studies to identify other relevant studies.

Data collection and analysis

According to the Canadian Institutes of Health Research (CIHR), integrated knowledge translation (KT) is a research approach that involves knowledge users as research team members who are active throughout the entire research process, from defining the research question to applying the findings (CIHR 2015). Our team consisted of a study executive including a patient partner (JJ, DS, SKo, MS) and international collaborative research group, that has been engaged in the entire systematic review process so that the outputs of the research are more likely to be applied in practice and policy (Bowen 2013Van de Ven 2006). For each step of the systematic review methods, we invited team members to actively participate. We also used formal and informal group consensus methods to make decisions about the conduct of the review (Pollock 2019).

Selection of studies

We applied the Cochrane RCT Classifier to the database search results. The Classifier assigned a probability (from 0 to 100) of being a randomised trial to each citation retrieved. Those citations with Classifier scores of nine or less were excluded from dual reviewer screening but were screened by a single reviewer (titles and abstracts) to ensure that no studies were misclassified and wrongly excluded from the search outputs.

For other studies assigned a probability of > 9 of being an RCT, two members of the author team (DS, JF, KL, LB, AD, SKi, SKo, JJ, AR, JK) randomly allocated and independently screened titles and abstracts against inclusion and exclusion criteria using the online systematic review software Covidence 2021. After resolving discrepancies, we retrieved the full text of any studies identified as potentially relevant. Two members of the review author team (DS, JF, JJ, AR, SKi, KL, LB, AD, SKo, JK) were randomly allocated to screen full‐text studies. Discrepancies were resolved by discussion with a third review author who did not participate in the screening to reach consensus. Finally, two reviewers confirmed the eligibility of the decision‐coaching intervention in all included studies and a third reviewer helped reach consensus on discrepancies (JJ, DS, JF).  Findings were reported in a PRISMA diagram (Liberati 2009).

All excluded full‐text studies were listed with reason(s) (see Characteristics of excluded studies). When there were multiple publications on the same study, reports were collated such that each study (rather than each report) was the unit of analysis. Concurrently, one of two members of the author team (JZ, DS) reviewed all citations excluded when the RCT classifier was added to screen for any RCTs that may have accidently been removed, as per guidance from the information specialist (AP).

Data extraction and management

We used the Cochrane Consumers and Communication Review Group Data Extraction Template (available at: cccrg.cochrane.org/author‐resources) and included criteria from PRISMA Equity (Welch 2015), the Template for Intervention Description and Replication (TIDieR) (Hoffmann 2014), and Guidance for Reporting Involvement of Patients and Public (GRIPP2) (Staniszewska 2017), to extract information on the general study information, and methods. In addition to TIDieR, data were extracted on the decision‐coaching intervention for eight elements: training/protocol; facilitates progress in decision making; focus on specific decision; decision‐making needs assessment/discussion; provides information/discusses options; clarifies values; encourages communication; and screens for implementation. Data on characteristics of participants were extracted using ‘PROGRESS‐Plus’ (place of residence, race/ethnicity/culture/language, occupation, gender/sex, religion, education, socioeconomic status, social capital) and Plus refers to additional categories such as age, sexual orientation and disability which may influence opportunities for health of individuals and populations (Evans 2003O'Neill 2013Oliver 2008Oliver 2012). 

To determine patient and public involvement as partners on the research teams, we used the Guidance for Reporting Involvement of Patients and Public (GRIPP2) (Staniszewska 2017). While not specific to systematic reviews, many of the recommended items have been identified by Cochrane as applicable to systematic reviews (Cochrane Training 2021).

Four members of the review team (JJ, AR, DS, JZ) pilot tested the standardised data extraction form in MS Excel with three studies. Any discrepancies were resolved by discussion that included other team members (SKo, MS, MC) until consensus was reached.

Two members of the review author team (JZ, DS, AR, JF, JJ, SKo) independently extracted data from included studies using the pilot‐tested data extraction form. One review author (JZ) extracted 100% of the data and a second author extracted data on the characteristics of the intervention(s) and outcomes. Any discrepancies were resolved by discussion until consensus was reached, or through consultation with a third review author who did not conduct the data extraction. Review authors did not extract data from their own studies (AR, SKo, JK). 

All extracted data in the standardised data extraction form were transferred into Review Manager (RevMan Web) or Excel tables by one author (DS), and independently checked for accuracy against the data extraction sheets by a second review author (MC).

Assessment of risk of bias in included studies

Two members of the review author team (DS, MC, JF, JJ, SKo, AR, JZ) independently assessed the methodological risk of bias of included studies, in accordance with the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011), and the Cochrane Consumers and Communication guidelines (Ryan 2013). These guidelines recommend the explicit reporting of the following individual elements for RCTs: random sequence generation; allocation sequence concealment; blinding (participants, personnel, and outcome assessment); completeness of outcome data, selective outcome reporting; and other sources of bias (such as whether the same healthcare provider delivered the decision‐coaching intervention and the comparator, whether clustering was accounted for in the analysis, and other potential sources of bias reported by the study authors).  We judged each item as being at low, unclear, or high risk of bias, as set out in the criteria provided in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011). We provided a quote from the study report and a justification for our judgement for each item in the risk of bias table.

We considered studies to be at high risk of bias if they were judged as having high or unclear risk of bias regarding sequence generation or allocation concealment, based on these factors being particularly important potential sources of bias (Higgins 2011). We considered blinding separately for different outcomes, where appropriate. For example, studies using subjective outcome measures were judged as having high risk of bias when no blinding was used and those using objective outcome measures were judged as having low or unclear risk of bias. Completeness of outcome data (avoidance of attrition bias) was considered separately for different lengths of follow‐up (shorter and longer follow‐up). We considered the outcomes in terms of timing of assessment to determine what data could be analysed together in meta‐analysis. If multiple time points were reported, then we considered data in relation to time points (e.g. knowledge should be measured soon after exposure to the intervention versus knowledge measured at one year).

For cluster‐RCTs, we assessed and reported the risk of bias associated with an additional domain: 'Selective recruitment of cluster participants.' 

In all cases, two review authors independently assessed the risk of bias of included studies, with any disagreements resolved by discussion with a third author to reach consensus.

Measures of treatment effect

For continuous measures, we analysed data using a random‐effects model to calculate the mean difference (MD) and 95% CI. If more than one study measured the same outcome using different tools, we verified that the data could be merged, standardised the findings and used a random‐effects model to calculate the standardised mean difference (SMD) and 95% CI. When data could not be pooled, we reported outcomes and strength of findings according to the original study.

Unit of analysis issues

For cluster‐RCTs or studies with multiple treatment groups, we applied the methods recommended in the Cochrane Handbook for Systematic Reviews of Interventions (Deeks 2017). If cluster‐RCTs or studies with multiple treatment groups were included, we checked for unit of analysis errors. Where errors were found and sufficient information was available, we planned to re‐analyse the data using the appropriate unit of analysis, by taking account of the intra‐cluster correlation coefficient (ICC). We also planned to obtain estimates of the ICC by contacting authors of included studies, or to impute them using estimates from external sources. If it was not possible to obtain sufficient information to re‐analyse the data, then we would not include studies in meta‐analysis. In case of a narrative summary, we planned to annotate the unit of analysis error. Of the two cluster‐RCTs, Hamann 2006 did not account for clustering in the analysis of data and Berger‐Höger 2019 accounted for clustering in the analysis of data.

No studies were included in meta‐analysis that compared more than one intervention group to one control group.

Dealing with missing data

For participant data, where possible, we planned to conduct analysis on an intention‐to‐treat basis; otherwise data were analysed as reported. We attempted to contact study authors when there were missing data. We reported on the levels of loss to follow‐up data as attrition bias.

Assessment of heterogeneity

For meta‐analysis findings, we assessed the degree of heterogeneity by visual inspection of forest plots and by examining the Chi² test and the I² statistic for heterogeneity for each outcome (Gentles 2013Hatala 2005). An I² value of 50% or more was considered to represent substantial heterogeneity. The I² value was interpreted in relation to the size and direction of effects as well as the strength of the evidence for heterogeneity, based on the Chi² test (Deeks 2017). 

Assessment of reporting biases

To minimise the risk of publication bias, we performed comprehensive searches in multiple databases, including searching for unpublished studies in progress. Due to the small number of studies included for each endpoint, we did not use a funnel plot to investigate the likelihood of overt publication bias.

We assessed reporting bias qualitatively, based on the characteristics of the included studies (e.g. if only small studies that indicated positive findings were identified for inclusion) and if information obtained by contacting experts and study authors indicated there were relevant unpublished studies. We considered publication of registered protocols to be an indicator that studies were reported as originally planned. 

Data synthesis

Where studies were considered similar enough (based on consideration of populations, interventions, outcomes), we conducted meta‐analysis of primary and secondary outcomes, using RevMan Web (RevMan Web 2021). When possible, meta‐analysis of outcomes was conducted based on whether the intervention(s) in the included studies were similar (in terms of participants, settings, intervention, comparison and outcome measures) and provided meaningful conclusions from the statistically pooled results.

For the synthesis, the time points post‐coaching ('post‐intervention') were compared between studies. We used the post‐intervention results in meta‐analysis or descriptively. We were able to apply this approach to all the studies, except one study that provided two post‐intervention measures (Brown 2019) where no data were reported and the authors indicated that the measures (e.g. decision regret) were likely used too soon after the intervention to detect differences. 

Due to the variability in the populations, interventions, and different instruments to measure the outcomes (i.e. knowledge) we used a random‐effects model for meta‐analysis. Otherwise, findings were synthesised without meta‐analysis.

Subgroup analysis and investigation of heterogeneity

Where heterogeneity was present in pooled effect estimates, we had planned to explore possible reasons for variability by conducting subgroup analysis. We had proposed subgroup analyses based on the Ottawa Decision Support Framework theory (O'Connor 1998Stacey 2020), and the expertise of members of the author team who are active in the development, implementation, and evaluation of decision coaching: types of decisions (treatment, screening, diagnostic); method of intervention delivery (in person, by telephone, internet‐based); and characteristics of participants who are recipients of the intervention and who delivered the intervention, i.e. sex and/or gender, education, socioeconomic status, occupation of decision coaches (healthcare providers who are health support workers versus healthcare professionals). We did not conduct any subgroup analyses or investigate heterogeneity due to small numbers of included studies in each of the review's comparisons.

Sensitivity analysis

Sensitivity analyses was planned to assess the robustness of the results, to examine the effect of including compared to excluding studies at high risk of bias. For example, if different decisions are made about the analysis, how much does this affect the results? Sensitivity analyses were also planned to assess the effects of any imputed data on pooled effect estimates. We did not conduct sensitivity analyses due to the small numbers of included studies within comparisons.

Summary of findings and assessment of the certainty of the evidence

We prepared a summary of findings table to present the results of meta‐analyses syntheses and/or narrative synthesis for each primary outcome (e.g. preparation in health decision making), including potential harms, outlined in Types of outcome measures (Ryan 2016). Two reviewers independently used the GRADE criteria to rate the strength of the evidence for each major outcome. We provided a source and rationale for each assumed risk cited in the tables, and used the GRADE criteria to rank the certainty of evidence based on the methods described in chapter 11 of the Cochrane Handbook for Systematic Reviews of Interventions (Schünemann 2011), using GRADEpro GDT software (GRADEpro GDT 2021Schünemann 2013). 

Results

Description of studies

Results of the search

The search strategy yielded 12,984 citations (Figure 1), 12,702 were excluded after title and abstract screening, and 234 excluded after full‐text screening (see Characteristics of excluded studies). We included 28 studies, identified 16 ongoing studies (see references to Ongoing studies and Characteristics of ongoing studies) and four studies are awaiting classification (see Characteristics of studies awaiting classification).

1.

1

Included studies

We included 28 studies with a total of 5509 participants (see Characteristics of included studies). Of the 28 included studies, 26 were RCTs with individuals randomised and two were RCTs with cluster‐randomisation (Berger‐Höger 2019Hamann 2006) (Table 5). The studies were conducted in the USA (n = 13), Canada (n = 4), Germany (n = 4), UK (n = 4), Australia (n = 1), Japan (n = 1), and the Netherlands (n = 1). The studies focussed on the use of decision coaching to support healthcare decisions about treatment (n = 18) or screening (n = 10). Treatment decisions were about cancer (n = 6), menopause (n = 2), mental illness (n = 2), advanced kidney disease (n = 1), lumbar stenosis (n = 1), birth control (n = 1), menorrhagia (n = 1), diabetic foot (n = 1), multiple sclerosis (n = 1), osteoarthritis (n = 1), and embryo transfer (n = 1). Other healthcare decisions were about cancer screening (n = 4) and genetic testing (n = 6) (Table 5). We reported on funding for each study (see Table 6).

1. Characteristics of included studies (N = 28).
First Author
Year
Country Study purpose Decision Setting Length of follow‐up Participants randomised
 
Adam 2019
  Canada
  To compare effectiveness and acceptability of DECIDE to conventional genetic counselling, using a non‐inferiority model, in families considering genomic testing for their child with early‐onset epilepsy Genetic testing for epilepsy
  1 epilepsy clinic
  2 weeks
 
  54 (coaching) versus 52 (PtDA)
 
 
Aoki 2019 Japan To evaluate the effects of a 7‐day SDM program for outpatients with a first episode of mood disorders among university students
  Treatment of mood disorders (depression, bipolar) 
  1 mental health outpatient centre
  6 months 35 (coaching + PtDA) versus 53 (usual care)
Berger‐Höger 2019* Germany
  To investigate whether an informed SDM intervention for women with ductal carcinoma in situ comprising an evidence‐based PtDA with nurse‐led decision coaching enhances the extent of mutual SDM behaviour of patients and professionals about treatment options Treatment of ductal carcinoma in situ 16 certified breast care centres 2 months
  37 (coaching + PtDA) versus 30 (usual care)
Bozic 2013
  USA To evaluate the impact of decision and communication aids on patient knowledge, efficiency of decision making, treatment choice Treatment of hip/knee osteoarthritis 2 academic medical centres 6 weeks after surgeon consult
 
  95 (coaching + PtDA) versus 103 (usual care)
 
 
Brown 2019
  Australia To evaluate the effectiveness of a decision support intervention in facilitating the older person with advanced kidney disease to make a treatment choice
  Treatment of advanced kidney disease
  4 public hospital renal programmes 12 weeks 
  19 (coaching + PtDA) versus 22 (usual care) 
Col 2007
  USA
  To compare effectiveness of individualised evidence‐based information with standard educational materials on decisions about menopausal treatments
  Treatment of menopausal symptoms 2 internal medicine practices and 1 OB/GYN
  2 weeks 50 (coaching + EBinfo) versus 45 (EBinfo) versus 50 (usual care)
Davison 1997
  Canada To explore the hypothesis that assisting men with prostate cancer to obtain information would enable them to assume a more active role in treatment decision making and decrease their levels of anxiety and depression
  Treatment of prostate cancer
  1 community urology clinic 6 weeks
  30 (coaching + PtDA) versus 30 (usual care)
 
 
Deschamps 2004
   Canada
  To compare the effects of pharmacist consultation versus a PtDA on women's decisional conflict regarding use of hormone replacement therapy and subsequent satisfaction with the decision‐making process
  Treatment of menopausal symptoms
  1 family medicine clinic
 
  12 months
  67 (coaching) versus 61 (PtDA) 
 
 
Green 2001
  USA To compare face‐to‐face education and counselling by a genetic counselor with education by an interactive computer program, assessing the effects of each on knowledge of breast cancer genetics and intent to undergo genetic testing
  Genetic testing for breast cancer
  1 community clinic, recruited through newspapers
  post‐intervention 29 (coaching) versus 29 (PtDA) versus 14 (usual care)
 
 
Hacking 2013
  Scotland
  To evaluate the efficacy of the decision navigation intervention on patients’ confidence in making decisions, certainty in decisions made during consultations, and impact on mood and adjustment
  Treatment decisions for early stage‐prostate cancer
  1 hospital diagnostic clinic
  pre‐consultation and 6 months
  63 (coaching) versus 60 (usual care)
 
Hamann 2006* Germany To assess an intervention designed to facilitate SDM among acutely ill inpatients with schizophrenia Treatment for schizophrenia
  12 acute psychiatric wards of 2 state hospitals 18 months
  54 (coaching + PtDA) versus 59 (usual care)
 
Hunter 2005
  Canada To determine whether alternative approaches to genetic counselling, (a) individual counselling (b) group counselling, and (c) use of a PtDA with the opportunity to speak with a genetic counsellor, are equally effective in prenatal diagnostic testing counselling in advanced maternal age women/partners Prenatal diagnostic testing
  1 regional genetics clinic
  at 24 weeks gestation
  126 (coaching) versus 116 (PtDA)
Kearing 2016 USA To assess the impact of telephone health coaching in addition to a video PtDA compared to a PtDA alone for patients with spinal stenosis Treatment of lumbar spinal stenosis 1 orthopaedic surgeon or non‐surgical spine clinic
  6 months 98 (coaching + PtDA) versus 101 (PtDA)
 
Kennedy 2002
  UK To evaluate the effects of information with and without a structured preference elicitation interview, on treatment choices, health outcomes, and costs  Treatment of uncomplicated menorrhagia Specialist clinic at 6 hospitals
  2 years
  300 (coaching + PtDA) versus 296 (PtDA) versus 298 (usual care)
 
Langston 2010
  USA To evaluate the addition of structured contraceptive counselling to usual care on choice, initiation, and continuation of very effective contraception after uterine aspiration Treatment to avoid pregnancy
  1 family planning referral clinic to be seen at 1 private practice
  3 months
  114 (coaching + PtDA) versus 108 (usual care)
 
Lepore 2012
  USA
  To evaluate the efficacy of a decision‐support intervention focussed on prostate cancer testing in a sample of predominantly immigrant black men
  Screening for prostate cancer Insurance beneficiaries of large healthcare workers union, study conducted via telephone 2 years
  244 (coaching + PtDA) versus 246 (usual care)
Lerman 1997
  USA To evaluate the impact of alternate strategies for pretest education and counselling on decision making regarding BRCA1 testing among women at low‐to‐moderate risk who have a family history of breast and/or ovarian cancer
  Genetic testing for breast and/or ovarian cancer 2 cancer centres in Washington DC 1 month
  122 (coaching + PtDA) versus 114 (PtDA) versus 164 (waiting‐list control)
Matloff 2006
 
USA To examine if a personalised risk assessment and genetic counselling intervention developed for this pilot study would affect knowledge, risks perception, and decision making in a group of women who had one first‐degree relative with breast cancer, as compared with a control group
  Genetic testing Setting not reported
  6 months 32 (coaching) versus 32 (usual care)
 
McBride 2016 UK To explore whether the use of an intervention to increase SDM increased decision self‐efficacy and foot‐treatment adherence in patients with a diabetic foot ulcer Treatment of diabetic foot ulcer 1 diabetes foot clinic
  12 weeks 30 (coaching + PtDA) versus 26 (usual care)
 
Miller 2005a  USA To develop and evaluate a theory‐based educational intervention designed to increase callers’ understanding of inherited risk, their family history of cancer, and benefits/limitations of genetic testing
  Genetic testing
  National Cancer Institute’s Cancer Information Service 6 months
  279 women randomised to coaching plus PtDA versus usual care (numbers per group not reported)
Mishel 2009
  USA
  To examine the effects of a theory‐based decision‐making uncertainty management intervention providing newly diagnosed prostate cancer patients with information, communication skills and personally designed prompts
  Treatment of prostate cancer
  2 cancer centres, 3 community hospitals, 1 Veterans' Administration medical centre
   3 months 93 (coaching + written information + video) versus 74 (usual care)
Myers 2005
  USA To test the impact of an informed decision‐making intervention on prostate cancer screening use
  Screening for prostate cancer 
  3 primary care practices
 
  11 months 121 (coaching plus PtDA) versus 121 (PtDA) 
 
Myers 2011
  USA
  To assess the impact of a mediated decision support intervention on primary care patient prostate cancer screening knowledge, decisional conflict, informed decision making, and screening
  Screening for prostate cancer  2 primary care practices 120 days
 
  156 (coaching plus PtDA) versus 157 (PtDA)
 
Rahn 2018
  Germany To test the feasibility of a decision‐coaching programme and recruitment strategies to inform the main trial
  Immunotherapy decisions for multiple sclerosis
  2 multiple sclerosis centres 6 months
  38 (coaching plus EBinfo) versus 35 (EBinfo)
 
Shepherd 2019
  Scotland
   
To evaluate the effectiveness of Consultation Planning, Recording and
Summarising on self‐reported decision self‐efficacy, conflict, and regret, anxiety and depression, in patients with colorectal cancer  for up to 3 care planning consultations and 3 months follow‐up, compared with the usual care experience
Treatment of colorectal cancer
 
  1 clinic in a  cancer centre
 
  3 months after discharge from the clinic
 
  68 (coaching) versus 69 (usual care)
 
 
Sheridan 2012
  USA
  To examine the effects of a prostate cancer screening intervention to promote SDM and determine whether framing prostate information in the context of other clearly beneficial men's health services affects decisions Prostate cancer screening
  2 primary care practices (1 academic, 1 community
practice)
 
9 months
  60 (coaching + video + information) versus 70 (video on seat belt safety)
Van Peperstraten 2010
  Netherlands
  To evaluate the effects of a multifaceted empowerment strategy on the actual use of single embryo transfer after in vitro fertilisation Treatment embryo transfer 
  5 in vitro fertilisation clinics (2 hospitals, 3 clinics)
  5 weeks 152 (coaching + PtDA) versus 156 (usual care)
 
Vodermaier 2009
  Germany To examine the impact of a PtDA intervention in breast cancer inpatients in Germany
  Treatment for breast cancer
  1 gynaecology 
department at university hospital
 
1 week
  74 (coaching + PtDA) versus 78 (usual care)
 

Abbreviations: 
BRCA1=Breast cancer type 1 susceptibility protein EBinfo=evidence‐based informationPtDA=patient decision aidSDM=Shared Decision Making

* Cluster RCT

 Excluded one comparator arm because of group coaching

Excluded one comparator arm because the intervention measured family support

2. Study funding sources (N = 28 studies).
First Author
Year
Source of funding
Adam 2019 This research was performed as part of the study “Paediatric Epilepsy: Using Genomics to Improve Patient Care and Outcomes,” that was supported by the Canada Excellence Research Chair (MF) and the Alva Foundation (MC). The DECIDE research was funded by a Canadian Institutes of Health Research grant to JMF and a Canadian Institutes of Health Research New Investigator award to NB.
Aoki 2019 This research did not receive any specific grant from funding agencies in the public, commercial, or not‐for‐profit sectors
Berger‐Höger 2019 The German Federal Ministry of Health funded the study within the National Cancer Action Plan (Grant No. NKP – 332 – 054).
Bozic 2013 This work was supported by a grant from the RobertWood Johnson Foundation (RWJF).
Brown 2019 National Health and Medical Research Council; Australian Centre for Health Service Innovation (AusHSI); Queensland Health Nursing and Midwifery Research
Fellowship; Chronic Kidney Disease Centre of Research Excellence; Sunshine Coast Hospital and Health Service; Wide Bay Hospital and Health Service
Col 2007 This work was supported by grants from the Robert Wood Johnson Foundation (RWJ # 46461) and AHRQ R01 HS013329‐01.
Davison 1997 Supported by a studentship from the National Cancer Institute of Canada with funds provided by the Canadian Cancer Society to the first author, and by an investigator award from the Medical Research Council of Canada and the National Health Research and Development Program to the second author.
Deschamps 2004 Financial support for this study was provided in part by an unrestricted research grant from Eli Lilly Canada Inc. The funding agreement ensured the authors’
independence in designing the study, interpreting the data, and writing and publishing the report.
Green 2001 This publication was supported by grant number 1R03 CA 70638 from the National Cancer Institute (NCI), and grant number 1 R01 CA84770 from NCI and the National Human Genome Research Institute (NHGRI). 
Hacking 2013 Macmillan Cancer Support funded this study in its entirety.
Hamann 2006 The trial was funded by the German Ministry of Health and Social Security (217‐43794‐5/9) within the funding project ‘Der Patient als Partner im medizinischen Entscheidungsprozess’.
Hunter 2005 Not reported
Kearing 2016 The Informed Medical Decisions Foundation, Boston MA and the National Institute for Arthritis, Musculoskeletal, and Skin Diseases #P60AR062799 grant funds were received in support of this work.
Kennedy 2002 Our research was supported by a grant from the UK NHS research and development health technology assessment programme. The health economics research group receives funding from the UK Department of Health. Dr Sculpher received a career scientist award in public health funded by the NHS research and development programme.
Langston 2010 Financial support provided by a grant from an anonymous foundation
Lepore 2012 This research was supported by grant R01 CA104223 from the National Cancer Institute of the National Institutes of Health
Lerman 1997 Supported by Public Health Service grants (RO1MH/HG54435) from the National Institutes of Mental Health and the National Center for Human Genome Research, National Institutes of Health Department of Health and Human Services
Matloff 2006 This study was funded by a grant from the Susan G. Komen Foundation.
McBride 2016 This work was supported by NHS Lothian and NHS Education for Scotland.
Miller 2005a This research was supported in part by the Department of Defense DAMD17‐98‐1‐8306, DAMD17‐01‐1‐0238, and DAMD17‐02‐1‐0382 grants, the Fox Chase Cancer Center’s Behavioral Research Core Facility (P30CA06927), and NIH grant R01HG01766.
Mishel 2009 The work submitted here was funded by NIH, NINR (5RO1NR08144) and was entitled Decision Making under Uncertainty in Prostate Cancer, Merle Mishel, PI.
Myers 2005 The work reported in this paper was supported by a grant from the Quality Care Research Fund, Aetna Foundation.
Myers 2011 The Decision Counseling Trial was conducted under AAMC/CDC cooperative agreement grant MM‐0554‐03.
Rahn 2018 This study was funded by the German Ministry of Education and Research within the KKNMS (01GI1206).
Shepherd 2019 Coventry University, Grant/Award Number: PhD studentship; Macmillan Cancer Care; NHS Lothian
Sheridan 2012 This research was supported by the Centers for Disease Control and Prevention (CDC, #TS0845).
Van Peperstraten 2010 This study was funded by the Netherlands Organisation for Health Research and Development (grant No 945‐16‐105). All researchers are independent from this source of funding. The study sponsor had no role in the study design, collection, analysis, and interpretation of data, the writing of the article, and the decision to submit it for publication.
Vodermaier 2009 This work was supported by the German Ministry of Health as a pre‐operating study in the focus programme ‘The Patient as a Partner in the Medical Decision Making Process’ under Grant no. 217‐43794‐5/2 (Professor Dr Michael Untch, PI) and by a stipend from the Dr‐Werner‐Jackstaedt‐Stiftung in the Founder Association of the German Sciences under Grant no. S134‐10.021 (Dr Andrea Vodermaier).

Characteristics of participants

Participants’ mean age was 48.1 years (n = 25 studies; 4728 participants) ranging from 18 to 85 years (n = 7 studies; 774 participants) (see Table 7, Characteristics of participants). Participants were 64.1% female and 35.9% male (n = 28 studies; 5373 participants). Reported race and ethnicity included: white (52.1%), African‐American/black (33.4%), Hispanic (6.7%) or other/unknown (7.7%) (n = 16 studies; 3080 participants). Participant education levels were reported as post‐secondary (67.6%) or secondary school diploma or less (32.4%) (n = 21 studies; 3458 participants).

3. Characteristics of participants (N = 28 studies).
Author (year) Age (mean)* Male:female (per cent) Ethnicity Education
<= HS:> HS
Income Employment Civil status
 
Adam 2019
  n/r 14:86 n/r 25 (23.8%):
80 (76.2%)
n/r n/r n/r
Aoki 2019 22.0 55:45 n/r 0 (0.0%):
88 (100.0%)
n/r All students n/r
Berger‐Höger 2019 58.1 0:100 n/r 45 (72.6%):
17 (27.4%)
n/r n/r Married 45 (72.6%)
Partnership 3 (4.8%)
Divorced 7 (11.3%)
Widowed 5 (8.1%)
Single 2 (3.2%)
Bozic 2013
  63.1 46:54 Non‐Hispanic 41 (73.2%)
Hispanic 9 (7.3%)
Unknown 24 (19.5%)
15 (12.2%):
108 (87.8%)
< $50K 36 (29.3%)
≥ $50 ‐ 100K 37 (30.1%)
> $100K 45 (36.6%)
Missing 5 (4.1%)
Yes 56 (45.5%)
No 9 (7.3%)
Retired 44 (35.8%)
Disabled 10 (8.1%)
Missing 4 (3.3%)
n/r
Brown 2019
  77.9 0:100 n/r n/r n/r Work 3 (7.3%)
Pension 30 (73.2%)
Self‐funded retiree 8 (19.5%)
n/r
Col 2007
  52.3 0:100 White 93 (97.9%)
Not reported 2 (2.1%)
67 (46.2%):
78 (53.8%)
n/r n/r Married or partnered 108 (74.5%)
Davison 1997
  67.9 100:0 n/r 35 (58.3%):
25 (41.7%)
n/r Full time 12 (20.0%)
Part time 5 (8.3%)
Retired 43 (71.7%)
Married or partnered 52 (86.7%)
Deschamps 2004
  n/r 0:100 White 104 (99.0%)
Not reported 1 (1.0%)
20 (19.0%):
85 (81.0%)
n/r Technical 37 (35.2%)
Professional 37 (35.2%)
Not reported 31 (29.6)
Married or partnered 90 (85.7%)
Green 2001
  43.8 0:100 White 70 (97.2%)
African‐American 2 (2.8%)
3 (4.2%):
69 (95.8%)
< $35K 7 (9.7%)
≥ $35‐55K 12 (16.7%)
> $55K 53 (73.6%)
Work outside the home 56 (77.8%)
Do not work outside the home 16 (22.2%)
n/r
Hacking 2013
  66.3 100:0 Caucasian 115 (100%) Reported as education ≥ 16 years n/r Employed (27%)
Unemployed/retired (73%)
Living with partner 91 (79.1%)
Hamann 2006 37.7 55:45 n/r Reported as education ≥ 10 years n/r n/r n/r
Hunter 2005
  36.8 0:100 British/European (83.9%)
Asian, Aboriginal, Black, Middle Eastern, Ashkenazi Jewish (5.1%)
Unknown (11%)
Reported as means using 8‐point scale Reported as means using 11‐point scale Yes 211 (87.2%)
Not reported 31 (12.8%)
n/r
Kearing 2016 66.7 52:48 White 164 (97.6%)
Not reported 4 (2.4%)
54 (32.1%):
114 (67.9%)
n/r Retired 83 (49.4%)
Not reported 85 (50.6%)
Married 118 (70.2%)
Kennedy 2002
  40.3 0:100 n/r Reported as age leaving full‐time education n/r n/r n/r
Langston 2010
  26.2 0:100 Hispanic 195 (88.2%)
Not reported 26 (11.8%)
71 (32.0%):
151 (68.0%)
n/r n/r Stable relationship 155 (69.8%)
Lepore 2012
  55.0 100:0 Black 490 (100%) 309 (63.1%):
181 (36.9%)
n/r n/r Married 410 (83.7%)
Lerman 1997
  n/r 0:100 White 283 (70.9%)
African‐American 106 (26.6%)
Other 10 (2.5%)
40 (10.0%):
359 (90.0%)
≤ $35K 79 (20.3%)
≥ $35K‐$50K 67 (17.2%)
≥ $50K 243 (62.5%)
n/r Married 250 (62.5%)
Unmarried 150 (37.5%)
Matloff 2006
  49.0 0:100 European (54%)
Ashkenazi Jewish (21%)
Both Ashkenazi Jewish and European non‐Ashkenazi Jewish (8%)
Latin American/Caribbean (2%)
Other (4%)
Unknown (10%)
11 (17.2%):
53 (82.8%)
≥ $75,000 (58%) n/r Married (71%)
McBride 2016
  61.1 73:27 White 56 (100%) 26 (46.4%):
30 (53.6%)
n/r Full‐time 11 (19.6%)
Part‐time 4 (7.1%)
Retired 31 (55.4%)
No 6 (10.7%)
Student 1 (1.8%)
Other 3 (5.4%)
Married 32 (57.1%)
Partner 4 (7.1%)
Divorced 4 (7.1%)
Separated 3 (5.4%)
Widowed 3 (5.4%)
Single 10 (17.9%)
Mishel 2009 62.5 100:0 Caucasian 119 (71.3)
Black 48 (28.7)
Reported as mean years of education < $6K 4 (2.6%)
≥ $6K–12K 11 (7.1%)
≥ $12K–24K 21(13.6%)
≥ $24K–48K 45 (29.0%)
> $48K 74 (47.7%)   
Yes 97 (58.1%)
Not reported 70 (41.9%)
Married or partnered 132 (79.0%)
Miller 2005a 46.2 0:100 Caucasian 227 (88.7%)
African American 14 (5.5%)
Native American 4 (1.6%)
Hispanic 3 (1.2%)
Asian 2 (0.7%)
Other 6 (2.3%)
75 (29.4%):
180 (70.6%)
n/r n/r n/r
Myers 2005 52.0 100:0 African‐American 242 (100%) Reported as < or > 12 years of education n/r n/r Married 152 (62.8%)
Not married 90 (37.2%)
Myers 2011
  56.5 100:0 White 176 (56.4%)
African‐American 128 (41.0%)
Other 8 (2.6%)
101 (32.6%):
209 (67.4%)
n/r n/r Married 197 (62.9%)
Not married 116 (37.1%)
Rahn 2018
  37.3 26:74 n/r 26 (40.6%):
38 (59.4%)
n/r At least part‐time 50 (78.1%)
Not reported 14 (21.9%)
n/r
Shepherd 2019
  62.1 59:41 White 129 (97.7%)
Chinese 1 (0.76%)
Mixed 1 (0.76%)
Other 1 (0.76%)
65 (49.6%):
66 (50.4%)
n/r Full time 39 (29.6%)
Part time 16 (12.1%)
Not reported 77 (58.3%)
Married 92 (69.7%)
Divorced 18 (13.6%)
Separated 3 (2.3%)
Widowed 6 (4.6%)
Single 13 (9.8%)
Sheridan 2012
  57.6 100:0 White 70 (54.7)
Not reported 58 (45.3)
41 (32.0%):
87 (68.0%)
n/r n/r Married 78 (60.9%)
Van Peperstraten 2010
  31.9 0:100 n/r 7 (2.3%):
297 (97.7%)
€13200 ‐ 21120 6 (2.0%)
≥ €21120 ‐ 33000 37 (12.1%)
> €33000 212 (69.5%)
Did not want to tell 40 (13.1%)
n/r n/r
Vodermaier 2009
  55.2 0:100 n/r 85 (79.4%):
22 (20.6%)
n/r Yes 52 (47.3%)
No 58 (52.7%)
Married/cohabiting 81 (73.0%)

HS=High School

*Mean age of the sample was calculated using the group means for 16/24 studies

Cluster‐RCT

 

Description of the intervention 

In the 28 studies, there were four comparisons:

  • decision coaching compared with usual care (n = 4 studies);

  • decision coaching compared with evidence‐based information only (n = 4 studies);*

  • decision coaching plus evidence‐based information* compared with usual care (n = 17 studies); and,

  • decision coaching plus evidence‐based information* compared with evidence‐based information only (n = 7 studies).

*evidence‐based information includes patient decision aids.

Four of the 28 studies included 3 comparator arms (Col 2007Green 2001Kennedy 2002Lerman 1997). The evidence‐based information was typically a patient decision aid (21 studies) or more general evidence‐based information (4 studies).

 

Characteristics of decision coaching

Decision coaching was provided by nurses (n = 10), genetic counsellors (n = 4), psychologists (n = 3), a pharmacist (n = 1), a mix of healthcare professionals (n = 2), or others trained in decision coaching (n = 8). Most studies reported coaching occurred in‐person (n = 16) and/or by telephone (n = 12) (see Table 8). 

4. TIDieR Intervention Summary (N = 28 studies).
Author (year) Brief name and why What was DC intervention Who provided DC How, where, when, how much Tailoring or modifying DC Strategies for intervention fidelity
Adam 2019 Genetic counselling for families about genomic testing DC used checklist with pros and cons of testing (same as PtDA), discussed talking to family and friends genetic counsellor Once for 1 hour DC in person at an epilepsy clinic or on telephone
once for 1 hour
n/r checklist and factual content same as the PtDA
Aoki 2019 DC using 7‐day SDM program to increase patient‐perceived involvement in decision making Prior to DC, clinician gave options and patient reviewed PtDA. DC discussed options, answered questions, asked patient to give their preference   nurse After PtDA, one 20‐30 minute DC in person at a mental health outpatient centre or on the telephone between clinician consults n/r extent of intervention fidelity was monitored
Berger‐Höger 2019* DC using 6‐step SDM program to support women with breast cancer DC defined problem requiring a decision; described SDM, gave PtDA, clarified patients' values, gave option to postpone decision, offered prompt cards specialised nurses Once for 47.5 minutes DC in person at 16 certified breast care centres on average 4.3 days before MD consult n/r Video‐taped DC and MD consults, prompt cards for nurses, summary information on 4 treatment options included in PtDA
Bozic 2013 SCOPED with DC and PtDA to evaluate impact of these SDM tools After PtDA, DC helped patient write list of  questions for surgeon. After MD consult, sent patient‐ recorded consult and surgeon's dictated note health coach After PtDA, one telephone call (length of time n/r) and DC attended 54 minutes consult at an academic medical centre for which 21 minutes was with the surgeon n/r n/r
Brown 2019 Decision‐support intervention using OPTIONS (PtDA) PtDA then DC used the PtDA to support patient in active, autonomous role in decision making renal nurse After PtDA, 1 or 2 sessions in person for 45 minutes at a public hospital renal programme n/r format was per training in Ottawa Decision Support tutorial
Col 2007 DC plus EBinfo with personal risk estimates DC reviewed EBinfo to discuss personal risk estimates and the worksheet, prioritise questions and rehearse question asking coach with Masters in Public Health Once for 10‐20 minutes DC in person just before MD consult
 
n/r protocol, training, EBinfo, document for goals
Davison 1997 Empowerment intervention to help men assert control over the factors that affect their health DC asked men what information they need for decision making, reviewed example list of questions, showed where to find answers in PtDA, gave final list of questions to men, encouraged to read PtDA, use question list, and participate in decision making nurse researcher Once in person DC at 1 community urology clinic
(length of time n/r)
n/r n/r
Deschamps 2004 Pharmacist consultation Reviewed risks and benefits of medication based on clinical practice guidelines, charts and graphs to visually show population data, agreed on plan, noted in consult letter to MD pharmacist Once for 40 minutes DC in person at family medicine study clinic and encouraged to consult MD within 2 to 4 weeks n/r charts and graphs to provide consistency between encounters
Green 2001 Genetic counselling General information about breast cancer risk and heredity; risks/benefits, limitations, implications of genetic testing; possible outcomes, worries, cancer prevention strategies genetic counsellor Once for 60‐100 minutes DC in person at a community clinic Tailored to individual risk same information as PtDA group
Hacking 2013 Decision navigation for prostate cancer
treatment decisions
Coaches assisted patients in identifying and framing key questions and concerns
regarding cancer management options to generate a personal consultation plan
two research assistants Pre‐consultation by
telephone or in person, during the consultation, and post‐consultation coaches gave each navigated patient an audio record of the visit and a typed summary
personalised consultation plan trained by developer of the intervention (2‐day workshop), audio recorded consultation and typed summary, monthly case reviews
Hamann 2006* SDM group to inform patients about their treatment options and prepare them for a ‘planning talk’ with their MD Coaches used the PtDA and assisted patients in working through the booklet and answered questions nurse managers Once for 30‐60 minutes DC in inpatient acute psychiatric ward of state hospital n/r trained, PtDA, physicians trained
Hunter 2005 Individual prenatal diagnosis genetic counselling Information about risks and limitations, laboratory results, conditions being tested, patient's values and beliefs re birth of an abnormal child and pregnancy termination  genetic counsellor Once for 1 hour DC in person at regional genetics clinic n/r coaching with same content as the PtDA, tape recorded for analysis
Kearing 2016 DC to help patients with their treatment decision process DC used Ottawa Personal Decision Guide to identify patient treatment intention, knowledge gaps, values clarification, support needs, and planning Nurse, genetic counsellor, social workers Within 2 weeks using PtDA, one DC session on the telephone from the Centre for SDM prior to consult with orthopaedic surgeon at spine clinic 
 
n/r n/r
Kennedy 2002 Structured interview group to help patients clarify and articulate preferences PtDA (video, booklet) plus DC with values clarification, elicit preference and  desired involvement in decision making research nurses Once for 20 minutes (SD 6.2) in person pre‐first MD consult at hospital Only in building a rapport highly structured coaching and questions documented on summary form to share with surgeon
Langston 2010 Structured contraceptive counselling DC using contraceptive flipchart PtDA and samples, wrote down questions for MD research co‐ordinator Once for 20 minutes (SD 8 min) DC in person at private practice n/r standardised, write questions for MD on note cards
Lepore 2012 Decision‐support intervention for black men about prostate cancer testing DC established rapport, provided information, helped clarify testing preferences, prepared them to talk to MD public health graduate students A week after PtDA sent, up to two telephone calls of 20 minutes (SD 2.3) + 5 min (SD 6.3 ) and prior to MD consult tailored to knowledge and beliefs manual, training, treatment fidelity checks in 44% calls
Lerman 1997 Education plus counselling approach to support genetic testing decisions After PtDA, DC discussed experience with cancer in family, anticipated impact of positive/negative results, anticipated outcomes if not tested, coping resources/skills, intention to tell family oncology nurses or genetic counsellor Post‐PtDA, one 30‐minute DC in person at 2 cancer centres in Washington DC n/r trained, PtDA, structured protocol
Matloff 2006 Personalised risk assessment and genetic counselling to women considering menopause options DC using a counselling script using flipbook on benefits/risks of options, future risks of diseases, personalised letter summarising her data (copied to MD) genetic counsellor Two DC sessions (60 + 60 minutes) in person (setting n/r) tailored to questions, concerns, personal history standardised counselling flipbook, counselling script, letter summarising results
McBride 2016 Decision navigation using SCOPED to increase SDM for diabetic foot care DC used semi‐structured interview to produce consult plan for MD consult (forwarded to MD), attended MD consult & encouraged use of plan, audio‐recorded consult, written summary of main points health psychologist One week after PtDA, DC telephoned from 1 diabetes foot clinic
(length of time n/r) to plan for MD consult in 1 week
personalised consultation plan training, fidelity tests, PtDA, consultation plan
Mishel 2009 Decision‐making uncertainty management intervention to address the stimuli frame concepts of symptom pattern, event congruence, and event familiarity DC reviewed patient’s questions on prostate cancer information booklet, review handout 'the competent patient', helped patient identify questions on his concerns, reviewed communication skills nurse After information materials and DVD on communication strategies, DC provided 4 telephone calls over 7 to 10 days (averaged 20‐30 minutes) and before the treatment consultation with MD n/r training, evidence‐based question and answer prostate cancer information, calls were audiotaped for quality control
Miller 2005a Educational intervention on risk of inherited cancer and benefits/ limitations of genetic testing DC reviewed PtDA, detailed family history, discussed benefits and limitations of genetic screening, referred to a high‐risk genetic counselling (if appropriate)
 
Cancer Information Services Specialist A self‐initiated telephone call to the National Cancer Institute’s Cancer Information Service for
20‐30 minutes
n/r Training, written PtDA, intervention protocols for standard and enhanced
Myers 2005 Enhanced intervention (decision education) to enable men to consider decision information DC discussed PtDA information, personal values for alternative options, clarified personal preference, shared calculated preference score, and encouraged to make decision with MD health educator One month after receiving PtDA, DC done on telephone or in person from 3 primary care practices in Philadelphia
(length of time n/r)
42% (n = 51) did not receive DC because too difficult to contact or set up DC session training, preference scoring process and algorithm
Myers 2011 Enhanced intervention (decision education) to enable men to consider decision information DC discussed PtDA information, elicited factors influencing screening decision, computed decision preference score, discussed score, placed note to MD on chart nurse educator After receiving the PtDA, DC for 28 minutes (SD14) in person at 2 primary care practices n/r training, fidelity tests, PtDA, monthly meetings
Rahn 2018 Decision‐coaching intervention for people with multiple sclerosis DC using evidence‐based Wiki information on pros/cons of options, patient expectations, decision, next steps nurses DC in person at 2 multiple sclerosis centres
(length of time n/r) followed by up to two MD consults where decision was made
n/r training, structured 6 steps, patient workbooks, coaching guide
Shepherd 2019 Consultation planning with summary and audio‐recording (SCOPED) DC met to identify a list of questions for patient and MD, DC attended 3 clinic appointments to type notes, audio‐record and create plain language typed summary research psychologists DC telephone call pre‐consult and in person at MD consult (x3) at a clinic in a tertiary cancer centre n/r protocol, manual, training programme
Sheridan 2012
  Counsellor‐delivered DC DC to answer men’s questions about prostate screening, help clarify their values, prepare to discuss with MD, given summary sheet health counsellor After information video, one DC for 8 minutes in person prior to MD consult at a primary care practice tailored to discussion barriers training, video information, training for physicians, scripted materials, brochure
Van Peperstraten 2010
  Multifaceted empowerment strategy involving PtDA, DC, and reimbursement if fourth cycle DC by trained in vitro fertilisation nurse vitro fertilisation nurse After PtDA, one 32‐minute DC session in person at an in vitro fertilisation clinic with follow‐up telephone call before oocytes pick up n/r training, PtDA, reimbursement offer
Vodermaier 2009 Decision board coaching DC with PtDA on invitation to participate in decision making, options, verify understanding, motivated to ask questions in MD consult, discuss with family research psych‐ologists Once for 20 minutes in person at a gynaecology 
department of a university hospital before surgeon consult within a few hours
n/r decision board PtDA, information brochure

DC=decision coachingEBinfo=evidence‐based informationMD=physiciann/r=not reportedPtDA=patient decision aidSCOPED=Situation, Choices, Objectives, People, Evaluation, DecisionsSDM=Shared Decision Making

*Cluster‐RCT

Twenty studies reported the coaching intervention comprised of a single decision‐coaching session, duration median was 31 minutes with a range from 8 to 120 minutes (Table 8Table 9). Six studies reported multiple decision‐coaching sessions (2 to 4 sessions) including three where the coach was present for the consultation, duration 20 to 90 minutes for each session, and two studies with one or two sessions. Of 28 studies, only six reported the decision‐coaching intervention was tailored to individual patient/participant needs (Green 2001Hacking 2013Lepore 2012Matloff 2006McBride 2016Sheridan 2012). Twenty‐five studies reported strategies to improve or maintain the intervention fidelity.

5. Characteristics of decision coaching (all studies facilitated progress in decision making and clarified the decision) (N = 28 studies).
 
Author (year)
 
 
Theoretical framework Training Assess/discuss decision making needs Provide/discuss information Clarify values Encourage communication Screen for implementation needs
Adam 2019 IPDAS for PtDA yes checklist n/r yes (same as PtDA) yes (same as PtDA) n/r n/a
Aoki 2019 IPDAS yes  n/r PtDAs yes yes n/r
Berger‐Höger 2019* 6 steps of shared decision making (Kasper 2012) Yes n/r PtDA yes yes n/r
Bozic 2013 SCOPED Yes n/r PtDA yes, PtDA yes n/r
Brown 2019 ODSF Yes yes PtDA yes, worksheet yes n/r
Col 2007 n/r Yes n/r yes yes, PtDA yes n/r
Davison 1997 Empowerment Model (Conger 1988) No yes PtDA PtDA yes n/r
Deschamps 2004 ODSF for PtDA No n/r yes  no yes ‐ consult letter n/r
Green 2001 n/r Yes yes yes yes n/r n/r
Hacking 2013 SCOPED Yes yes identified questions/concerns about options for MD consult yes yes yes, consultation plan
Hamann 2006* n/r Yes n/r PtDA PtDA yes n/r
Hunter 2005 ODSF No n/r yes yes n/r n/r
Kearing 2016 ODSF Yes yes PtDA yes n/r n/r
Kennedy 2002 n/r Yes yes PtDA yes yes n/r
Langston 2010 n/r Yes yes PtDA yes, PtDA yes n/r
Lepore 2012 ODSF Yes yes PtDA yes yes yes, speaking to physician
Lerman 1997 Kessler 1979 genetic counselling, Janis  1977 decision making, Engel 1995 consumer behaviour Yes n/r PtDA yes no n/r
Matloff 2006 Health belief model No yes yes no no n/r
McBride 2016 SCOPED Yes yes PtDA yes, PtDA yes‐ consultation plan yes, consultation plan
Miller 2005a Cognitive‐Social Health Information Processing (C‐SHIP) model Yes n/r yes (PtDA) PtDA n/r n/r
Mishel 2009 Uncertainty in Illness Theory Yes yes evidence‐based booklet n/r yes n/r
Myers 2005 Preventive Health Model Yes yes PtDA yes yes n/r
Myers 2011 Preventive Health Model Yes yes PtDA yes no n/r
Rahn 2018 Shared Decision Making (Elwyn 2001 ) Yes yes evidence‐based Wiki yes yes yes
Shepherd 2019 SCOPED Yes n/r no no yes n/r
Sheridan 2012 n/r Yes yes yes yes yes yes
Van Peperstraten 2010 IPDAS Yes n/r PtDA yes n/r yes
Vodermaier 2009 n/r n/r yes PtDA yes yes n/r

Note: All studies reported “facilitate progress in decision making” and “focus on specific decision”.

C‐SHIP=Cognitive‐Social Health Information ProcessingIPDAS=International Patient Decision Aid Standardsn/r=not reportedODSF=Ottawa Decision Support FrameworkPtDA=patient decision aidSCOPED=Situation, Choices, Objectives, People, Evaluation, DecisionsSDM=Shared Decision Making
 

* Cluster‐RCT

Most studies cited theoretical frameworks as a foundation for the decision‐coaching intervention. Frameworks which included the Ottawa Decision Support Framework (n = 5), SCOPED (Situation, Choices, Objectives, People, Evaluation, Decisions) (Belkora 2015Belkora 2021) (n = 4), IPDAS (International Patient Decision Aid Standards) (Elwyn 2006) (n = 3), other individual theories (n = 8), or a combination of theories (n = 1). Seven studies did not identify a theoretical framework.

Of the eight elements of decision coaching (training/protocol, facilitate progress in decision making, focus on specific decision, decision‐making needs assessment/discussion, provide information/discuss options, clarify values, encourage communication, screen for implementation), studies reported between four and eight elements. All studies reported 'facilitate progress in decision making' and 'focus on specific decision' (data not shown). The least reported (n = 3 studies) was 'screen for implementation needs' (see Table 9. Characteristics of decision coaching).

Excluded studies

We excluded 234 studies after close scrutiny of the relevant papers (see Characteristics of excluded studies). The reasons for exclusion were: not decision coaching, wrong publication type (e.g. conference abstract, thesis), decision coaching in both intervention arms, wrong study design, physician counselling, lifestyle choice, advanced care planning, not non‐directive, no actual decision, group counselling, hypothetical decision, genetic counselling not described, wrong patient population.

Risk of bias in included studies

All 28 studies had at least some risk of bias. We report the details for risk of bias in the Characteristics of included studiesFigure 2 and Figure 3.

2.

2

3.

3

Allocation

Risk of bias for random sequence generation was low in 17 studies (60.7%), and unclear in 11 studies (39.3%). For concealment of allocation, risk of bias was low in 15 studies, (53.6%), and unclear in 13 studies (46.4%) (see Figure 2).

Blinding

Risk of bias for performance bias was low in six studies (21.4%), unclear in 20 studies (71.4%), and high for two studies (7.1%). For the high‐risk studies, one did not describe blinding and reported self‐assessed outcomes (Brown 2019). The other study reported that envelopes were opened by a research team member after baseline measures (McBride 2016), and group allocation was communicated to both participants and the clinical team. Risk of bias for outcome assessment was low for 18 studies (64.3%), unclear for nine studies (32.1%), and high for one study (3.6%) as outcome‐assessor blinding was not explicitly described (Berger‐Höger 2019) (see Figure 2).

Incomplete outcome data

Risk of bias for attrition was low in 14 studies (50%), and unclear for 13 studies (46.4%). There was high risk of bias for one study (3.6%) due to missing outcome data with imbalance between groups for outcomes measured post‐first consultation (12% decision coaching versus 28% usual care), and an overall high rate of attrition over time (44.5%) (Shepherd 2019) (see Figure 2).

Selective reporting

Risk of bias for reporting bias was low for eight studies (28.6%) and unclear for 20 studies (71.4%).

Other potential sources of bias

Risk of bias for other potential sources of bias was low for 22 studies (78.6%), unclear for four (14.3%), and high for two studies (7.1%). We rated two studies as having high risk of bias due to instrument limitations, overlap of personnel between intervention and control groups, disproportionate randomisation, and loss to follow‐up (Aoki 2019); and clustering not accounted for in the analysis of data (Hamann 2006). For the two cluster‐RCTs, risk of bias for selective recruitment of cluster participants was low in one study (Berger‐Höger 2019), and unclear in one study (Hamann 2006).

Effects of interventions

See: Table 1; Table 2; Table 3; Table 4

Summary of findings 1. Comparison #1: Decision coaching versus usual care ‐ Summary of findings.

Outcomes Relative effect (95% CI) Number of participants (studies) Quality of evidence (GRADE) Comments
Preparation for decision‐making scale (Bennett 2010) (higher scores = feeling more prepared).
Measured: Post‐consultation (Shepherd 2019)
The mean score for usual care was 74.0 (SD 20.1).
The mean score was higher (better) for the intervention group: 90.2 (SD 12.6) (P < 0.0001).
110
(1 study)
 ⊕⊖⊖⊖[1]
Very low
 
We are uncertain if decision coaching improves preparation for decision making, compared with usual care.
Decision self‐confidence: Decision self‐efficacy scale (O'Connor 1995): range 0 (no self‐efficacy) to 100 (perfect self‐efficacy).
Measured: Post‐consultation (Hacking 2013Shepherd 2019) (Analysis 1.1)
Mean scores ranged from 83 to 86 with usual care. The mean meta‐analysis score in the intervention groups was 5.2 points higher (better) than usual care (95% CI: 1.7 to 8.6).
  201
(2 studies)
⊕⊖⊖⊖[2]
 Very low
We are uncertain if decision coaching improves decision self‐confidence, compared to usual care.
 
 Feeling uniformed  ‐  ‐  ‐  Not measured
 Unclear values  ‐  ‐  ‐  Not measured
 Feeling unsupported  ‐  ‐  ‐  Not measured
 Knowledge tests:
Standardised on score from 0 (no knowledge)
to 100 (perfect knowledge)
Measured using different knowledge tests: post‐intervention (Green 2001) or one month (Matloff 2006) post‐intervention (Analysis 1.2)
Mean scores ranged from 63.3 to 74.0 with usual care. The mean meta‐analysis score in the intervention groups was 13.0 points higher (better) than usual care (95% CI: 6.2 to 19.8). 97
(2 studies) 
 ⊕⊖⊖⊖[3]
Very Low We are uncertain if decision coaching improves knowledge, compared with usual care. 
Adverse effects:
Decision Regret Scale (Brehaut 2003): Standardised on score from 0 to 100 (none to worst regret) measured 3 (Shepherd 2019) and 6 months (Hacking 2013) post‐consultation
 
The mean scores for usual care groups were 19.0 (SD 22.9) (Shepherd 2019) and 17.1 (SD 16.0) (Hacking 2013).
The mean scores were lower (better) in intervention group: 9.3 (SD 12.3) (P = 0.039) (Shepherd 2019) and 10.8 (SD 13.7) (P = 0.036) (Hacking 2013).
 
170
(2 studies)
⊕⊖⊖⊖[4]
 Very low
We are uncertain if decision coaching improves (reduces) decision regret compared with usual care.
Hospital Anxiety and Depression (HAD) Scale (Zigmond 1983)
Measured 3 months post‐consultation (Shepherd 2019) and 6 months (Hacking 2013) post‐intervention. Matloff 2006 measured worry about cancer 6 months post‐intervention (Diefenbach 1999) and therefore not included in the summary of findings for this outcome.
 
There was no difference between groups. For one study, data were not reported (Hacking 2013). ~175
(2 studies)
⊕⊖⊖⊖[5]
 Very low
 
We are uncertain if decision coaching has an effect on anxiety compared with usual care.

[1] Evidence was downgraded by ‐1 level for methodological limitations (high risk of attrition bias), and ‐2 for imprecision as results were based on one small study.

[2] Evidence was downgraded ‐2 for methodological limitations (items rated as high risk of attrition bias in one study, unclear sequence generation in one study, mixed unclear and low risk of bias across other domains in the studies); ‐1 for imprecision as results were based on small studies and  overall sample size.

[3] Evidence was downgraded ‐2 for methodological limitations (items rated as unclear risk of bias including sequence generation for one study, and allocation concealment for both studies, with mixed unclear and low risk of bias across other domains); ‐1 for imprecision as results were based on small studies and overall sample size.  

[4] Evidence was downgraded ‐2 for methodological limitations (items rated as high risk of attrition bias, unclear sequence generation in one study, mixed unclear and low risk of bias across other domains in the studies); ‐1 for imprecision as results were based on small studies and overall sample size.

[5] Evidence was downgraded ‐2 for methodological limitations (items rated as high risk of attrition bias in one study, unclear sequence generation in two studies, allocation concealment in one study, mixed unclear and low risk of bias across other domains); ‐1 for imprecision as results were based on small studies and overall sample size.

Summary of findings 2. Comparison #2: Decision coaching versus evidence‐based information ‐ Summary of findings.

Outcomes Relative effect (95% CI) Number of participants (studies) Quality of evidence (GRADE) Comments
Preparation for decision‐making Not measured
Decision self‐confidence:
Empowerment scale (McAllister 2011): Standardised on score from 0 to 100 (none to highest efficacy) measured 1 week post‐intervention (Adam 2019)
The mean score showed no difference between groups.
 
106
(1 study)
⊕⊖⊖⊖[1]
 Very low
 
We are uncertain if decision coaching improves decision self‐confidence compared with evidence‐based information.
Feeling uninformed subscale of
Decisional conflict Scale (O'Connor 1995b) measured post‐consultation (Deschamps 2004)
The mean score showed no difference between groups. 91
(1 study)
⊕⊖⊖⊖[2]
 Very low
We are uncertain if decision coaching improves (reduces) feeling uninformed compared with evidence‐based information.
Unclear values Not measured
Feeling unsupported Not measured
Knowledge tests:
Standardised on score from 0 to 100 (none to perfect) knowledge measured within one week post‐interventions (Analysis 2.1)
The mean scores across evidence‐based information groups were 64.2 to 96.0.
The mean meta‐analysis score was no different between groups (SMD ‐0.23 95% CI: ‐0.50
 to 0.04).
406
(3 studies)
⊕⊕⊖⊖[3]
Low Decision coaching may have little or no difference in improving knowledge compared with evidence‐based information.
 
Adverse effects:
State and Trait Anxiety Inventory (Spielberger 1983): Standardised score from 0 to 100 (none to worst anxiety) measured post‐ intervention (Hunter 2005)
The mean score showed no difference between groups. 242
(1 study)
 
⊕⊕⊖⊖[4]
 Low 
 
 
Decision coaching may have little or no effect on anxiety compared with evidence‐based information.
 

 [1] Evidence was downgraded ‐2 for methodological limitations (6 of 7 items rated as unclear risk of bias including sequence generation and allocation concealment); ‐2 for imprecision as results were based on one small study.

[2] Evidence was downgraded ‐2 for methodological limitations (4 of 7 items rated as unclear risk of bias including sequence generation and allocation concealment); ‐2 for imprecision as results were based on one small study.

 [3] Evidence was downgraded ‐2 for methodological limitations (items rated as unclear risk of bias including sequence generation and allocation concealment for 2 of 3 studies).

 [4] Evidence was downgraded ‐2 for imprecision as results were based on one, small study.

Summary of findings 3. Comparison #3: Decision coaching plus evidence‐based information versus usual care ‐ Summary of findings.

Outcomes Relative effect (95% CI) Number of participants (studies) Quality of evidence (GRADE) Comments
Preparation for decision‐making scale (Bennett 2010): standardised scored from 0 to 100 (none to highest prepared) measured one month post‐intervention (Brown 2019) The mean score showed no difference between groups.
 
 
37
(1 study)
⊕⊖⊖⊖[1]
 Very low
We are uncertain if decision coaching plus evidence‐based information improves preparation for decision‐making compared with usual care.
Decision self‐confidence:
Decision self‐efficacy
scale (O'Connor 1995): range 0 to 100 (none to perfect self‐efficacy) measured 12 weeks post‐intervention (McBride 2016)
The mean score showed no difference between groups.
 
 
48
(1 study)
 
⊕⊖⊖⊖[2]
 Very low
We are uncertain if decision coaching plus evidence‐based information improves decision self‐confidence compared with usual care.
Feeling uninformed subscale of Decisional Conflict Scale (O'Connor 1995b): standardised scored 0‐100 (lower score indicates feeling more informed) measured post‐intervention and post‐consultation (Analysis 3.1). A fourth study (Col 2007) measured change in feeling uninformed at 2 weeks post‐consultation and therefore not included in the summary of findings for this outcome. They reported a greater reduction (16.5 out of 100) for the decision coaching plus evidence‐based information compared with usual care (5.8 out of 100). The mean scores across usual care groups were from 6.4 to 29.3.
The mean difference was 5.83 lower (better) for the intervention group (95% CI: ‐8.9 to ‐2.8). 
212
(3 studies)
⊕⊖⊖⊖[3]
Very low We are uncertain if decision coaching plus evidence‐based information improves (reduces) feeling uninformed compared with usual care.
 
 
Unclear values subscale of
Decisional Conflict Scale (O'Connor 1995b):  standardised scored 0‐100 (lower scores indicate feeling clearer values) measured post‐intervention or post‐consultation (Analysis 3.2). A fourth study (Col 2007) measured change in unclear values at 2 weeks post‐consultation and therefore not included in the summary of findings for this outcome. They reported a greater reduction for the decision coaching plus evidence‐based information (7.3 out of 100) compared with usual care (‐0.25 out of 100).
The mean meta‐analysis score showed no difference between groups (SMD 0.02; 95% CI: ‐7.1 to 7.2). 212
(3 studies)
⊕⊖⊖⊖[4]
 Very low
 
 
We are uncertain if decision coaching plus evidence‐based information  improves (reduces) unclear values compared with usual care.
Feeling unsupported subscale of Decisional Conflict Scale (O'Connor 1995b) standardised scored 0‐100 (lower score indicates feeling more supported) measured post‐intervention or post‐consultation (Analysis 3.3).
A fourth study (Col 2007) measured change in feeling unsupported at 2 weeks post‐consultation and therefore not included in the summary of findings for this outcome. They reported a greater reduction for the decision coaching plus evidence‐based information (11.8 out of 100) compared with usual care (3.5 out of 100).
The mean meta‐analysis score showed no difference between groups (SMD ‐1.6; 95% CI: ‐5.4 to 2.2). 212
(3 studies)
⊕⊖⊖⊖[5]
Very low
 
 
We are uncertain if decision coaching plus evidence‐based information  improves (reduces) feeling unsupported compared with usual care.
Knowledge tests:
Standardised on score from 0 to 100 (none to perfect knowledge), using various knowledge tests.
Measured within one month post‐intervention or post‐consultation (Analysis 3.4). For a further five studies not included in the meta‐analysis, two studies reported no differences, measured post‐intervention (Miller 2005a) and two weeks post‐consultation (Col 2007). Three studies (Bozic 2013Hamann 2006Sheridan 2012) reported the proportion of patients who scored higher on a knowledge test was better for decision coaching plus evidence‐based information compared with usual care (58.3% versus 33.3%; P = 0.01) (Bozic 2013); (15.0 versus 10.9; P = 0.01) (Hamann 2006); (47% versus 13%) (Sheridan 2012). Measures were post‐intervention (Bozic 2013), and post‐consultation (Sheridan 2012Hamann 2006). 
The mean scores across usual care groups was from 27.5 to 54.7.
The mean meta‐analysis score in the intervention groups was 9.3 SD higher (better) (6.6 to 12.1 higher) than usual care.
1073
(5 studies)
⊕⊕⊖⊖[6]
Low
 
 
Decision coaching plus evidence‐based information may improve knowledge compared with usual care.
Adverse effects:
 
Decision Regret Scale (Brehaut 2003) (Brown 2019McBride 2016)
Other DecisionRegret (Clark 1997), (Mishel 2009).
Measured at up to 3 months post‐intervention
The mean scores showed no difference between groups (Brown 2019McBride 2016). The mean score for other decision regret was 4.2 (SD 2.0) intervention group versus 3.9 (1.8) usual care group (P < 0.05) (Mishel 2009).  250
(3 studies)
 
⊕⊖⊖⊖[7]
 Very Low
 
 
We are uncertain if decision coaching plus evidence‐based information improves (reduces) decision regret compared with usual care.
State and Trait Anxiety Inventory (Spielberger 1983) (Davison 1997Kennedy 2002Van Peperstraten 2010).
Measured post‐intervention (Van Peperstraten 2010), 6 weeks post‐consultation (Davison 1997), and 12 months post‐consultation (Kennedy 2002).
 Hospital Anxiety and Depression Scale (Zigmond 1983) (Lepore 2012). Measured: post‐intervention
The mean scores showed no difference between groups. 1017
(4 studies)
⊕⊖⊖⊖[8]
 Very low
 
 
We are uncertain if decision coaching plus evidence‐based information has an effect on anxiety compared with usual care.

 [1] Evidence was downgraded ‐2 for methodological limitations (items rated as unclear risk of bias for allocation concealment, high risk of bias for blinding); ‐2 for imprecision as results were based on one small study.  

[2] Evidence was downgraded ‐1 for methodological limitations (items rated as high risk of bias for blinding, 2 of 7 items unclear risk of bias); ‐2 for imprecision as results were based on one small study.

[3] Evidence was downgraded ‐2 for methodological limitations (items rated as high risk of bias for blinding in two studies, unclear sequence generation in one study, unclear allocation concealment in one study); ‐1 for imprecision (small studies).

[4] Evidence was downgraded ‐2 for methodological limitations (items rated as high risk of bias for blinding in two studies, unclear sequence generation in one study, allocation concealment in one study); ‐1 for imprecision (small studies).

[5] Evidence was downgraded ‐2 for methodological limitations (items rated as high risk of bias for blinding in two studies, unclear sequence generation in one study, allocation concealment in one study); ‐1 for imprecision (small studies).

[6] Evidence was downgraded ‐1 for methodological limitations (items rated as unclear sequence generation in two studies, allocation concealment in four studies), and ‐1 due to inconsistency (heterogeneity; 2 of 5 studies that did not contribute to pooled results reported no effect). 

[7] Evidence was downgraded ‐1 for methodological limitations (items rated as unclear allocation concealment in one study), ‐1 for inconsistency (1 of 3 studies showed an effect in favour of the intervention), and ‐2 for imprecision as results were based on small studies and overall sample size.

[8] Evidence was downgraded ‐1 for methodological limitations (items rated as unclear risk of bias for allocation concealment in two studies), and ‐2 for imprecision (missing data for two studies, small sample for remaining two studies).

Summary of findings 4. Comparison #4: Decision coaching plus evidence‐based information versus evidence‐based information ‐ Summary of findings.

Outcomes Relative effect (95% CI) Number of participants (studies) Quality of evidence (GRADE) Comments
Preparation for decision‐making Not measured
Decision self‐confidence Not measured
Feeling uninformed subscale of Decisional Conflict Scale (O'Connor 1995b) standardised scored 0 to 100 (lower score indicate feeling more informed) change in score from baseline measured 2 weeks post‐consultation (Col 2007) The mean score from baseline to post‐intervention showed no difference between groups. 67
(1 study)
⊕⊖⊖⊖[1]
Very low We are uncertain if decision coaching plus evidence‐based information improves (reduces) feeling uninformed compared with evidence‐based information.
Unclear values subscale of
Decisional Conflict Scale (O'Connor 1995b) standardised scored 0 to 100 (lower scores indicate feeling more clear values) change in score from baseline measured post 2 weeks post‐consultation (Col 2007)
The mean score from baseline to post‐intervention showed no difference between groups.
 
67
(1 study)
 
⊕⊖⊖⊖[2]
 Very low
We are uncertain if decision coaching plus evidence‐based information improves (reduces) unclear values compared with evidence‐based information.
Feeling unsupported subscale of Decisional Conflict Scale (O'Connor 1995b) standardised scored 0 to 100 (lower score indicates feeling more supported) change in score from baseline measured 2 weeks post‐consultation (Col 2007) The mean score from baseline to post‐intervention showed no difference between groups. 67
(1 study)
 
⊕⊖⊖⊖[3]
 Very low
We are uncertain if decision coaching plus evidence‐based information improves (reduces) feeling unsupported compared with evidence‐based information.
Knowledge tests:
Standardised on score from 0
to 100 (none to perfect knowledge) measured within a month post‐intervention (Analysis 4.1). A fourth study (Col 2007) 
measured change from baseline at two weeks post‐consultation and therefore not included in the summary of findings for this outcome. They reported no difference between groups. A fifth study, measured at two weeks post‐intervention (Kearing 2016), did not provide data on standard deviations and therefore not included in the summary of findings for this outcome. They reported no difference in knowledge for decision coaching plus evidence‐based information compared with evidence‐based information (65% versus 58%).
The mean scores across evidence‐based information groups were 44.0 to 70.4.
The mean meta‐analysis score was no different between groups
(SMD 0.18; CI: ‐0.20
 to 0.56).
573
(3 studies)
⊕⊖⊖⊖[4]
Very low We are uncertain if decision coaching plus evidence‐based information improves knowledge compared with evidence‐based information.
Adverse effects:
State and Trait Anxiety Inventory (Spielberger 1983): (Kennedy 2002). Hospital Anxiety and Depression Scale (Zigmond 1983) (Rahn 2018). Measured 2 weeks post‐intervention to 12 months post‐consultation
The mean score showed no difference between groups.
 
 
 
340
(2 studies)
 
⊕⊖⊖⊖[5]
 Very low
We are uncertain if decision coaching plus evidence‐based information has an effect on anxiety compared with evidence‐based information.

[1] Evidence was downgraded ‐1 for methodological limitations (3 of 7 items rated as unclear risk of bias that include blinding, selective reporting, and other bias (recruitment prematurely ended due to publication of findings)); ‐2 for imprecision as results were based on a single small study.

[2] Evidence was downgraded ‐1 for methodological limitations (3 of 7 items rated as unclear risk of bias that include blinding, selective reporting, and other bias (recruitment prematurely ended due to publication of findings)); ‐2 for imprecision as results were based on a single small study.

[3] Evidence was downgraded ‐1 for methodological limitations (3 of 7 items rated as unclear risk of bias that include blinding, selective reporting, and other bias (recruitment prematurely ended due to publication of findings)); ‐2 for imprecision as results were based on a single small study.

[4] Evidence was downgraded ‐2 for methodological concerns (items for unclear risk of bias for allocation concealment for four studies and sequence generation for three studies); ‐1 for inconsistency (due to heterogeneity).

[5] Evidence was downgraded ‐2 for methodological concerns (items rated as unclear risk of bias including allocation concealment and sequence generation for one study); ‐1 for imprecision as results were based on small studies and overall sample size.

See Table 1Table 2Table 3, and Table 4. We reported on timing of the intervention in relation to post‐intervention (exposure to the intervention), or post‐consultation (post‐exposure to the intervention followed by consultation with healthcare provider).

Patients or public as research partners

None of the studies reported on a role for patients as research partners according to the GRIPP2 criteria: patients on research team, patient advisory team, training for patients, aim is patient and public involvement (PPI), methods to support PPI, results about PPI, discuss PPI, reflection on PPI (Table 10).

6. Patients as Research Partners: Guidance for Reporting Involvement of Patients and Public (GRIPP2) (N = 28 studies).
Author (year) Patients on research
or advisory team
Training for patients Aim PPI Methods PPI Results PPI Discuss PPI Reflection PPI
Adam 2019 no n/r no n/a n/a n/a n/a
Aoki 2019 no n/r no n/a n/a n/a n/a
Berger‐Höger 2019* no n/r no n/a n/a n/a n/a
Bozic 2013 no n/r no n/a n/a n/a n/a
Brown 2019 no n/r no n/a n/a n/a n/a
Col 2007 no n/r no n/a n/a n/a n/a
Davison 1997 no n/r no n/a n/a n/a n/a
Deschamps 2004 no n/r no n/a n/a n/a n/a
Green 2001 no n/r no n/a n/a n/a n/a
Hacking 2013 no n/r no n/a n/a n/a n/a
Hamann 2006* no n/r no n/a n/a n/a n/a
Hunter 2005 no n/r no n/a n/a n/a n/a
Kearing 2016 no n/r  no n/a n/a n/a n/a
Kennedy 2002 no n/r no n/a n/a n/a n/a
Langston 2010 no n/r no n/a n/a n/a n/a
Lepore 2012 no n/r no n/a n/a n/a n/a
Lerman 1997 no n/r no n/a n/a n/a n/a
Matloff 2006 no n/r no n/a n/a n/a n/a
McBride 2016 no n/r no n/a n/a n/a n/a
Miller 2005a no n/r no n/a n/a n/a n/a
Mishel 2009 no n/r no n/a n/a n/a n/a
Myers 2005 no n/r no n/a n/a n/a n/a
Myers 2011 no n/r no n/a n/a n/a n/a
Rahn 2018 no n/r no n/a n/a n/a n/a
Shepherd 2019 no n/r no n/a n/a n/a n/a
Sheridan 2012 no n/r no n/a n/a n/a n/a
Van Peperstraten 2010 no n/r no n/a n/a n/a n/a
Vodermaier 2009 no n/r no n/a n/a n/a n/a

n/a =not applicable
n/r =not reported
PPI=Patient and Public Involvement

* Cluster‐RCT

1. Comparison #1: Decision coaching versus usual care

Four studies evaluated decision coaching versus usual care (Green 2001Hacking 2013Matloff 2006Shepherd 2019) (see Table 1 and Table 11). 

7. Comparison #1: Decision coaching versus usual care (n = 4 studies) for outcomes not reported in meta‐analysis.
Study (year)
  Outcome and Instrument Timing N coaching Mean (SD) coaching N usual care Mean (SD) usual care Notes
  1.1 PREPARATION FOR ACTIVE PARTICIPATION IN MAKING A HEALTH DECISION
             
Shepherd 2019
  Preparation for decision making: 4 of 10 items scored 0 to 100. Preparation for Decision Making Scale ©Graham 1995 (Zigmond 1983)
  Post‐1st consultation 60 90.21 (12.62) 50 74.0 (20.1) p<0.0001
Hacking 2013
  Decision self‐confidence; DSE scale ©O'Connor 1995
  6 months post‐consultation 50 89.0 (9.91) 40 82.7 (16.6) p=0.032
  1.2 RESOLVED DECISIONAL NEEDS            
  1.3 ADVERSE EFFECTS            
Shepherd 2019
  Decision regret: 5 items scale of 1 to 5; scored 0 to 100; Decision Regret Scale ©O'Connor 1996 (Brehaut 2003)
  3 months post‐ consultation 37 9.32 (12.26) 31 19.03 (22.86) P=0.039
Hacking 2013
  Decision regret; Decision Regret Scale ©O'Connor 1996 (Brehaut 2003)
  6 months post‐consultation 58 10.8 (13.7) 44 17.1 (16.0) p=0.036
Shepherd 2019
  Anxiety; 7 items on 0‐3 scale; scored 0 to 21; Hospital Anxiety and Depression Scale (HADS) (Zigmond 1983)
  3 months post‐ consultation 39 5.67 (4.13) 34 6.00 (4.46) no difference
Hacking 2013
  Anxiety; HADS (Zigmond 1983)
  6 months post‐consultation n/r n/r n/r n/r no difference
Matloff 2006
  Worry about cancer; 1 item (1 not at all to 4 almost all the time); modified from Diefenbach 1999
  6 months post‐intervention         No results provided for comparison
  1.4 SECONDARY OUTCOMES
none reported
           

Abbreviations:
DSE=decision self‐efficacyHADS=Hospital Anxiety and Depression Scalen/r=not reportedSD=standard deviation

 

Note: values are mean (SD) unless otherwise stated. 

*Values reported in the text were standardised out of 100

1.1 Preparation for active participation in making a health decision (patient‐reported)
1.1.1 Preparation for decision making

One study reported the mean Preparation for Decision Making score measured post‐consultation was higher in the decision coaching compared with usual care group (90.2 versus 74 out of 100; P < 0.0001) (Shepherd 2019). We are uncertain if decision coaching improves preparation for decision making compared with usual care due to very low certainty of evidence; downgraded ‐1 for methodological limitations (high risk of attrition bias), and ‐2 for imprecision as results were based on one small study.

1.1.2 Decision self‐confidence 

Meta‐analysis of two studies reported decision self‐confidence (using the decision self‐efficacy measure) was higher in the decision‐coaching group compared with usual care (SMD 5.16, 95% CI: 1.74, 8.58; 2 studies, 201 participants) (Analysis 1.1) (Hacking 2013Shepherd 2019). Measures were post‐consultation. At six months’ post‐decision coaching, decision self‐confidence remained higher in the decision‐coaching group (89.0 versus 82.7 out of 100; P = 0.032) (Hacking 2013). We are uncertain if decision coaching improves decision self‐confidence compared with usual care due to very low certainty of evidence; downgraded ‐2 for methodological limitations (items rated as high risk of attrition bias in one study, unclear sequence generation in one study, mixed unclear and low risk of bias across other domains in the studies), and ‐1 for imprecision as results were based on small studies and overall sample size.

1.1. Analysis.

1.1

Comparison 1: Comparison #1: Decision coaching versus usual care, Outcome 1: Decision self‐confidence

1.1.3 Patient involvement in decision making

No studies reported this outcome.

1.1.4 Stage of decision making

No studies reported this outcome.

1.2 Resolution of modifiable decisional needs (patient‐reported)
1.2.1 Feeling uninformed

No studies reported this outcome.

1.2.2 Unclear values

No studies reported this outcome.

1.2.3 Feeling unsupported

No studies reported this outcome.

1.2.4 Knowledge

Meta‐analysis of two studies showed knowledge was higher in the decision‐coaching group compared with usual care (SMD 12.98, 95%CI: 6.21, 19.76; 2 studies, 97 participants) (Analysis 1.2) (Green 2001Matloff 2006). Measures were reported immediately (Green 2001), and at one month post‐intervention (Matloff 2006). We are uncertain if decision coaching improves knowledge compared with usual care due to very low certainty of evidence; downgraded ‐2 for methodological limitations (items rated as unclear risk of bias including sequence generation for one study, and allocation concealment for both studies, with mixed unclear and low risk of bias across other domains), and ‐1 for imprecision as results were based on small studies and overall sample size.  

1.2. Analysis.

1.2

Comparison 1: Comparison #1: Decision coaching versus usual care, Outcome 2: Knowledge

1.3 Adverse effects (patient, observer‐reported)
1.3.1 Decision regret

Two studies reported the mean decision‐regret score was lower, indicating less decision regret, in the decision‐coaching group measured at three months post‐consultation compared with usual care (9.3 versus 19.0 out of 100; P = 0.039) (Shepherd 2019), and six months post‐consultation (10.8 versus 17.1 out of 100; P = 0.036) (Hacking 2013). We are uncertain if decision coaching improves (reduces) decision regret compared with usual care due to very low certainty of evidence; downgraded ‐2 for methodological limitations (items rated as high risk of attrition bias in one study, unclear sequence generation in one study, mixed unclear and low risk of bias across other domains in the studies), and ‐1 for imprecision as results were based on small studies and overall sample size.

1.3.2 Anxiety

One study measured anxiety at three months post‐consultation (Shepherd 2019), and two studies measured anxiety at six months post‐intervention (Hacking 2013Matloff 2006). There was no difference in anxiety in the decision‐coaching group compared with usual care. For one study, data were not reported (Hacking 2013). We are uncertain if the decision has an effect on anxiety compared with usual care due to very low certainty of evidence; downgraded ‐2 for methodological limitations (items rated as high risk of attrition bias in one study, unclear sequence generation in two studies, allocation concealment in one study, mixed unclear and low risk of bias across other domains), and ‐1 for imprecision as results were based on small studies and overall sample size.

1.4 Secondary outcomes
1.4.1 Satisfaction with decision making

No studies reported this outcome.

1.4.2 Decision quality

No studies reported this outcome.

1.4.3 Health systems resources (length of consultation, cost to health system)

No studies reported this outcome.

1.4.4 Quality of life

No studies reported this outcome.

1.4.5 Quality of decision coaching (observer‐reported)

No studies reported this outcome.

 

2. Comparison #2: Decision coaching versus evidence‐based information

Four studies evaluated decision coaching versus evidence‐based information (Adam 2019Deschamps 2004Green 2001Hunter 2005) (see Table 2 and Table 12). 

8. Comparison #2: Decision coaching versus evidence‐based information (n = 4 studies) for outcomes not reported in meta‐analysis.
Study (year)
 
  Outcome and Instrument
  Timing N coaching
  Mean (SD) coaching
  N EBinfo
  Mean (SD) EBinfo
  Notes
 
  2.1 PREPARATION FOR ACTIVE PARTICIPATION IN MAKING A HEALTH DECISION
             
Adam 2019 Decision self‐confidence: Empowerment (range 24 low to 168 high); GCOS‐24 (McAllister 2011) 1 week post‐intervention 54 67.7 (11.6)* 52 62.4 (11.3)* no difference
Deschamps 2004 Patient involvement in decision making: not MD controlled (n = proportion that did not indicate decision was mostly controlled by the MD); Control preferences scale (Degner 1997) Post‐consultation 43 n = 41 (95.3%) 48 n = 47 (97.9%)  
  2.2 RESOLVED DECISIONAL NEEDS
             
Deschamps 2004 Feeling uninformed: 16 items, unclear which scale, unable to standardise; Decisional Conflict Scale (DCS) uninformed subscale
©O'Connor 1995b
Post‐consultation 43 1.8 (SD n/r) 48 1.7 (SD n/r) no difference
  2.3 ADVERSE EFFECTS
             
Hunter 2005 Anxiety: State anxiety (women): 20 items, range 20‐80; State and trait anxiety inventory (STAI) (Spielberger 1983) Post‐intervention 126 47.98 (10.14) 116 45.50 (9.69) no difference
  2.4 SECONDARY OUTCOMES
             
Deschamps 2004 Satisfaction with intervention: 10 items, 0‐4 scale (not at all helpful) to 4 (helped a great deal), total possible score of 40 Post‐consultation 42 27 (5.5) 48 28 (6.1) no significant differences

Abbreviations:
DCS=Decisional Conflict ScaleEBinfo=evidenced‐based informationGCOS‐24=Genetic Counselling Outcome Scale 24‐itemMD=physiciann/r=not reportedSD=standard deviationSTAI=State and trait anxiety inventory

Note: values are mean (SD) unless otherwise stated.

*Values reported in the text were standardised out of 100.

2.1 Preparation for active participation in making a health decision (patient‐reported)
2.1.1 Preparation for decision making

No studies reported this outcome.

2.1.2 Decision self‐confidence

One study reported decision self‐confidence (measured at one week post‐intervention with an empowerment measure) was no different for decision coaching compared with evidence‐based information (Adam 2019). We are uncertain if decision coaching improves decision self‐confidence compared with evidence‐based information due to very low certainty of evidence; downgraded ‐2 for methodological limitations (six of seven items rated as unclear risk of bias including sequence generation and allocation concealment), and ‐2 for imprecision as results were based on one small study.

2.1.3 Patient involvement in decision making

One study measured patient perceived involvement with a healthcare provider post‐consultation and reported there was no difference for decision coaching compared with evidence‐based information (Deschamps 2004). We are uncertain if decision coaching increases patient involvement in decision making compared with evidence‐based information due to very low certainty of evidence; downgraded ‐2 for methodological limitations (four of seven items rated as unclear risk of bias including sequence generation and allocation concealment), and ‐2 for imprecision as results were based on one small study.

2.1.4 Stage of decision making

No studies reported this outcome.

 

2.2 Resolution of modifiable decisional needs (patient‐reported)
2.2.1 Feeling uninformed

One study measured feeling informed immediately post‐consultation and reported the feeling uninformed subscale score was no different with decision coaching compared with evidence‐based information (Deschamps 2004). We are uncertain if decision coaching improves (reduces) feeling uninformed compared with evidence‐based information due to very low certainty of evidence; downgraded ‐2 for methodological limitations (four of seven items rated as unclear risk of bias including sequence generation and allocation concealment), and ‐2 for imprecision as results were based on one small study.

2.2.2 Unclear values

No studies reported this outcome.

2.2.3 Feeling unsupported

No studies reported this outcome.

2.2.4 Knowledge

Meta‐analysis of three studies reported that knowledge was no different between decision coaching and evidence‐based information groups (SMD ‐0.23, 95% CI: ‐0.50 to 0.04; 3 studies, 406 participants) (Analysis 2.1) (Adam 2019Green 2001Hunter 2005). Measures were reported immediately (Green 2001Hunter 2005), and at one week post‐intervention (Adam 2019). Decision coaching may have little or no difference on knowledge compared with evidence‐based information due to low certainty of evidence; downgraded ‐2 for methodological limitations (items rated as unclear risk of bias including sequence generation and allocation concealment for two of three studies).

2.1. Analysis.

2.1

Comparison 2: Comparison #2: Decision coaching versus evidence‐based information, Outcome 1: Knowledge

 

2.3 Adverse effects (patient, observer reported)
2.3.1 Decision regret

No studies reported this outcome.

2.3.2 Anxiety

One study reported the mean anxiety score measured post‐intervention was no different with decision coaching compared with evidence‐based information (Hunter 2005). Decision coaching may have little or no effect on anxiety compared with evidence‐based information due to low certainty of evidence; downgraded ‐2 for imprecision as results were based on one small study.

 

2.4 Secondary outcomes
2.4.1 Satisfaction with decision making

One study reported the mean post‐consultation satisfaction score was no different with decision coaching compared with evidence‐based information (Deschamps 2004). We are uncertain if decision coaching improves satisfaction with decision making compared with evidence‐based information due to very low certainty of evidence; downgraded ‐2 for methodological limitations (four of seven items rated as unclear risk of bias including sequence generation and allocation concealment), and ‐2 for imprecision as results were based on one small study.

2.4.2 Decision quality

No studies reported this outcome.

2.4.3 Health systems resources (e.g. length of consultation, cost to health system)

No studies reported this outcome.

2.4.4 Quality of life

No studies reported this outcome.

2.4.5 Quality of decision coaching (observer‐reported)

No studies reported this outcome.

 

3. Comparison #3: Decision coaching plus evidence‐based information versus usual care

Seventeen studies evaluated decision coaching plus evidence‐based information versus usual care (Aoki 2019Berger‐Höger 2019Bozic 2013Brown 2019Col 2007Davison 1997Hamann 2006Kennedy 2002Langston 2010Lepore 2012Lerman 1997McBride 2016Miller 2005aMishel 2009Sheridan 2012Van Peperstraten 2010Vodermaier 2009) (see Table 3 and Table 13).

9. Comparison #3: Decision coaching plus evidence‐based information versus usual care (n = 17 studies) for outcomes not reported in meta‐analysis.
Study (year) Outcome and Instrument Timing
  N coaching + EBinfo
  Mean (SD) coaching + EBinfo
  N usual care
  Mean (SD) usual care
  Notes
   3.1 PREPARATION FOR ACTIVE PARTICIPATION IN MAKING A HEALTH DECISION            
Brown 2019 Preparation for decision making: 10 items scored 0 to 100. Preparation for Decision Making Scale ©Graham 1995 1 month post‐ intervention 16 83.44 (13.26) 21 77.74 (22.3) no difference
McBride 2016 Decision self‐confidence: 11 items; scored 0 to 100; Decision Self‐Efficacy (DSE) scale ©O'Connor 1995 12 weeks post‐intervention 25 93.18 (7.1) 23 86.88 (16.69) no difference (high baseline self‐efficacy)
Aoki 2019 Patient involvement in decision making: 10 items, 5‐point scale; Combined Outcome Measure for Risk Communication and Treatment Decision‐making Effectiveness COMRADE (Edwards 2003) Post‐ intervention 32 88.0 median; 9 IQR 53 76.0 median; 7 IQR P<0.001
Hamann 2006* Patient‐perceived involvement in decision making (10 items, 5‐point scale, total 100); COMRADE (Edwards 2003) Post‐ intervention
Post‐ consultation
49
49
79.5 (18.6)
76.8 (20.9)
58
58
69.7 (20.0)
73.5 (19.3)
p=0.03
p=0.18 (after MD consult)
Berger‐Höger 2019* Patient involvement in decision making: SDM behaviours: range 0 (fully disagree) to 4 (fully agree); Multifocal APProach to the sharing‘ IN Shared Decision‐Making (MAPPIN‐Q) (Kasper 2012) Post‐ consultation 36 3.87 [95% CI 3.78 to 3.96] patient‐reported; 3.42 [95% CI 3.09 to 3.74] MD‐reported 28 3.82 [95% CI 3.68 to 3.96] patient reported; 3.44 [95% CI 3.04 to 3.83] MD reported  
Davison 1997 Observed role in decision making Post‐consultation         significantly more assumed active role than  control group
Sheridan 2012 Patient involvement in decision making: Reported SDM (n = proportion reporting shared decisions) Post‐consultation 38 n = 28 (74%) 51 n=39 (76%) no difference
Van Peperstraten 2010 Impact on decision‐making process Post‐intervention         no difference between groups
Vodermaier 2009 Patients’ perception of decision making – 5‐point scale (n = proportion who reported shared decision making or patient made the decision versus physician‐made decision) 1 week post‐consultation 53 n = 39 (73.6%) 54 n=38 (70.4%) no difference
 
Davison 1997 Preferred level of involvement in decision making (n = proportion with assumed role as active or collaborative versus passive); Control preferences scale (Degner 1997) 6 weeks post‐consultation 30 n = 27 (90%) 30 n=20 (66.7%) p<0.001
Van Peperstraten 2010 Patient involvement in decision making: Empowerment (n = proportion of couples who wanted to decide for themselves on the number of embryos transferred); Self‐Efficacy Scale (Luszczynska 2005); 5‐point scale dichotomised as fully empowered (wanting to make the decision with the doctor only as adviser) and not fully empowered (wanting to make the decision with the doctor as a decision maker) Post‐ intervention 127 n = 116 (91%) 135 n=99 (73%) p<0.001
Sheridan 2012 Patient involvement in decision making: participated at preferred level (n = proportion reporting participation at preferred level) Post‐consultation 38  n = 27 (71%) 51 n=39 (76%)  
   3.2 RESOLVED DECISIONAL NEEDS            
Col 2007 Uninformed: 1‐5; DCS uninformed subscale ©O'Connor 1995b Baseline and 2 weeks post‐consultation 36 change of 16.5 (20.75) 32 change of 5.75 (11.25) greater reduction compared to usual care
Col 2007 Unclear values: 1‐5; DCS unclear values subscale ©O'Connor 1995b Baseline and 2 weeks post‐consultation 36 change of 7.25 (24.25) 32 change of
‐0.25 (20.5)
greater reduction compared to usual care
Col 2007 Unsupport: 1‐5; DCS unsupport subscale ©O'Connor 1995b Baseline and 2‐week post‐consultation 36 change of 11.75 (18.0) 32 Change of 3.5 (14.5) greater reduction compared to usual care
Bozic 2013 Knowledge: 19 items (n = proportion who scored > 50%); Decision quality instrument (Sepucha 2011) Post‐1st consultation 60 n = 35 
(58.3%)
 60 n=20 (33.3%)  P=0.01 
Col 2007 Knowledge:  7‐item multiple choice, change from baseline Baseline and 2 weeks post‐consultation 36 +1.17 (1.65)/7 31 0.41 (1.21)/7 no difference
Hamann 2006* Knowledge: 7‐item multiple choice (possible range of scores n/r) Post‐consultation 49 15.0 (4.4) 58 10.9 (5.4) p=0.01
Sheridan 2012 Knowledge: 4‐item true/false, n =  % men having 100% knowledge Post‐intervention 58 n = 27 (47%) 70 n=9 (13%)  
Miller 2005a Knowledge: 17‐item true/false Post‐intervention nr   nr   no difference
   3.3 ADVERSE EFFECTS            
Brown 2019 Decision regret: 5‐item scale of 1 to 5; scored 0 to 100; Decision Regret Scale ©O'Connor 1996 (Brehaut 2003) 1 and 3 months post‐intervention         no difference‐authors say likely measured too soon
McBride 2016 Decision regret: 0‐100; ©O'Connor 1996 (Brehaut 2003) 12 weeks post‐intervention 25 40.4 (10.3) 22 38.4 (17) no difference 
Mishel 2009 Decision Regret: 3 items only; Quality of life scale (Clark 1997) 3 months post‐intervention 93 3.93 (1.82) 74 4.17 (1.96) p<0.05
Davison 1997 Anxiety: State anxiety, 20 items, range 20‐80; State and Trait Anxiety Inventory (STAI) (Spielberger 1983) 6 weeks post‐consultation 30 35.5 (down 9.0) 30 34.5 (down 2.5) no difference
Lepore 2012 Anxiety: State anxiety, 7 items on a scale of 0‐3; scored 0‐21: 
≤ 7 = normal, 
≥ 11 = abnormal; Hospital Anxiety and Depression Scale (HADS) (Zigmond 1983)
Post‐intervention 215 2.02 (SE.147) 216 2.16 (SE.146) no difference
Van Peperstraten 2010 Anxiety: 20‐80; STAI (Spielberger 1983Van der Bij 2003) Post‐intervention n/r 36.4 [95% CI 34.7‐38.2] n/r 34.7 [95% CI 33.3‐36.1] no difference
Kennedy 2002 Anxiety; STAI – short form (Marteau 1992) 12 months post‐consultation 143 n/r 121 n/r No difference
  3.4 SECONDARY OUTCOMES            
Miller 2005a Satisfaction with decision‐making process: Five items (5‐point Likert scales); instrument n/r 2 weeks post‐intervention   84.25 (21)   87.75 (18.75) no differences between groups
Vodermaier 2009 Satisfaction with decision‐making process: Yes/No (n = proportion satisfied with the process); One item from scale by Man‐Son‐Hing 1999 1 week post‐intervention 47 n = 42 (89.4%) 54 n=50 (92.6%) no difference
Col 2007 Satisfaction with decision‐making process: range 0‐100; instrument n/r 2 weeks post‐consultation 36 63.5% (15.90) 32 56.4% (19.2) no difference
Kennedy 2002 Satisfaction with decision‐making process (n = proportion of participants); One item from scale by Single question: “How would you rate the opportunities you have been given to become involved in making decisions about your treatment” 2 years post‐consultation 199 excellent:
n = 75 (37.7%) good:
n = 69 (34.7%)
fair:
n = 31 (15.6%)
poor:
n = 24 (12.1%)
183 excellent
n=44 (24.0%) 
good
n=78 (42.6%)
fair
n=46 (25.1%) poor
n=15 (8.2%)
OR 1.49; 95% CI 1.11‐2.01; p=0.008 controls; no diff PtDA only
Berger‐Höger 2019* Decision quality: Informed choice (%); Adequate risk knowledge and a positive attitude towards the chosen option were classified as making informed choice (Marteau 2001) Post‐consultation 36 47.66 [95% CI 12.64 to 82.68] 28 0 [95% CI 0.00 to 0.00] p = 0.016
Berger‐Höger 2019* Length of consultation: duration of whole decision making process; minutes Post‐consultation 36 58.1 (13.4) 28 24.3 (6.3)  
Bozic 2013 Length of consultation: entire patient visit; minutes Post‐consultation 61 53.5 (23.8) 62 51 (21.1) p=0.38 no difference
Bozic 2013 Length of consultation: Surgeon visit; minutes Post‐consultation 59 20.9 (6.8) 60 21 (7.2) p=0.91 no difference
Hamann 2006* Length of consultation: Psychiatrist visit; minutes Post‐consultation n/r 64 n/r 60 no difference
Vodermaier 2009 Length of consultation: MD consult; minutes Post‐consultation 53 about  mean 15 54 about mean 15 no difference; time reported by # 10 min, 15 min, 25 min, 35 min
Van Peperstraten 2010 Costs Post‐consultation         saved €169.75 per couple in intervention group
Kennedy 2002 Costs; mean costs Post‐consultation   $1566   $2,751 mean difference $1184 95% CI $684‐2110 control
Brown 2019 Quality of life: Health‐related quality of life; SF‐36v2 (Ware 2007) 1 month, 3 months post‐intervention 15 n/r 21 n/r No differences
Kennedy 2002 Quality of life: Role physical dimension; SF‐36 (Brazier 1992) Baseline, 2 years post‐consultation 176 n/r 157 n/r Favours coaching+PtDA versus usual care p=0.04
Kennedy 2002 Quality of life: SF‐36 (Brazier 1992)
  • physical function

  • social function

  • role emotional

  • mental health

  • energy or vitality

  • pain

  • general health

Baseline, 2 years post‐consultation 176 n/r 157 n/r No difference
Kennedy 2002 Quality of life: EuroQol‐5 dimensions (EQ‐5D) Health utility index (0‐1); 1 = the value of full health; EQ‐5D (Brooks 1996) Baseline, 2 years post‐consultation 300 0.835 298 0.797 No difference
McBride 2016 Quality of life: Health‐related quality of life; EQ‐5D (Brooks 1996) Baseline, 12 weeks post‐intervention 26 69.42 (21.28) 23 64.13 (23.92) No difference
Mishel 2009 Quality of life: Perception of overall quality of life; Single item 1 to 10 scale Baseline, 1 and, 3 months post‐intervention 93 7.24 (0.20)
7.61 (1.79)
7.57 (1.73)
74 7.18 (0.26)
7.33 (2.23)
7.72 (1.72)
No differences

Abbreviations:
CI=confidence intervalCOMRADE=Combined Outcome Measure for Risk Communication and Treatment Decision‐making EffectivenessDCS=Decisional conflict scaleDSE=Decision self‐efficacyEBinfo=evidence‐based informationEQ‐5D=EuroQol‐5 HADS=Hospital Anxiety and Depression Scale IQR=Interquartile rangeMAPPIN‐Q=Multifocal APProach to the sharing‘ INMD=physiciann/r=not reported 

PtDA=patient decision aidSD=standard deviationSDM=shared decision makingSE=standard errorSF‐36(v2)=36‐Item Short Form Health Survey (version 2)STAI=State and Trait Anxiety Inventory
 

Note: values are mean (SD) unless otherwise stated.

*Cluster‐RCT

Values reported in the text were standardised out of 100.

3.1 Preparation for active participation in making a health decision (patient‐reported)
3.1.1 Preparation for decision making

One study measured preparation for decision making and/or related elements at one month post‐intervention (Brown 2019). The mean preparation for the decision‐making score was no different with decision coaching plus evidence‐based information compared with usual care. We are uncertain if decision coaching plus evidence‐based information improves preparation for decision making compared with usual care due to very low certainty of evidence; downgraded ‐2 for methodological limitations (items rated as unclear risk of bias for allocation concealment, high risk of bias for blinding), and ‐2 for imprecision as results were based on one small study. 

3.1.2 Decision self‐confidence

One study reported that decision self‐confidence (using decision self‐efficacy measure) measured at 12 weeks post‐intervention was no different between the decision coaching plus evidence‐based information compared with usual care groups (McBride 2016). We are uncertain if decision coaching plus evidence‐based information improves decision self‐confidence compared with usual care due to very low certainty of evidence; downgraded ‐1 for methodological limitations (items rated as high risk of bias for blinding, two of seven items unclear risk of bias), and ‐2 for imprecision as results were based on one small study.

3.1.3 Patient involvement in decision making

Seven studies measured patient ‘perceived involvement’ in decision making. Two studies measured post‐intervention (Aoki 2019), and post‐consultation (Hamann 2006), using the same validated scale (Combined Outcome Measure for Risk Communication and Treatment Decision‐making Effectiveness (COMRADE) (Edwards 2003)). These studies reported a higher score for the decision coaching plus evidence‐based information group compared with usual care: 88.0 median (9 IQR) versus 76.0 median (7 IQR) (P < 0.001) (Aoki 2019); 79.5 versus 69.7% (P = 0.03) (Hamann 2006). One additional study, measuring post‐consultation and using another validated scale, reported no difference between groups (Berger‐Höger 2019) (Table 13). 

The remaining four studies reported results from observed (Davison 1997), or unvalidated measures of perceived involvement in decision making (Sheridan 2012Van Peperstraten 2010Vodermaier 2009). Davison 1997 reported that more men perceived themselves as taking an active role in decision making for the decision coaching plus evidence‐based information group. Three studies reported no differences between groups (Sheridan 2012Van Peperstraten 2010Vodermaier 2009). Measures were reported immediately post‐intervention (Van Peperstraten 2010), post‐consultation (Sheridan 2012), and at one (Vodermaier 2009), and six weeks post‐consultation (Davison 1997).

One study reported the mean preferred level of involvement was higher in the decision coaching plus evidence‐based information group compared with usual care (90% versus 66.7%; P < 0.001) (Davison 1997). Van Peperstraten 2010 reported that the proportion of patients indicating they wanted to decide for themselves was higher in the decision coaching plus evidence‐based information group (91% versus 73%; P < 0.001). Another study reported that the numbers of participants reporting they had participated at preferred level of involvement was lower for the decision coaching plus evidence‐based information (71%) compared to usual care (76%) (Sheridan 2012). 

We are uncertain if decision coaching plus evidence‐based information has any effect on patients’ perceived involvement, preferred level of involvement or participation at preferred level of involvement in decision making compared with usual care due to very low certainty of evidence; downgraded ‐1 for methodological limitations (items rated as high risk of ‘other’ bias in two studies and for blinding in one study, unclear sequence generation in two studies, allocation concealment in two studies), and ‐2 for inconsistency (differences in methodological approaches and effects of interventions across studies).

3.1.4 Stage of decision making

No studies reported on this outcome.

 

3.2 Resolution of modifiable decisional needs (patient‐reported)
3.2.1 Feeling uninformed

Meta‐analysis of three studies showed reduced feeling uninformed (Decisional Conflict subscale) in the decision coaching plus evidence‐based information group compared with usual care (SMD ‐5.83; 95% CI: ‐8.90 to ‐2.76; 3 studies, 212 participants) (see Analysis 3.1) (Berger‐Höger 2019Brown 2019Vodermaier 2009). Measures were post‐intervention (Brown 2019), one week post‐intervention (Vodermaier 2009), and post‐consultation (Berger‐Höger 2019). A fourth study, measured at two weeks post‐consultation, reported a greater reduction (16.5 out of 100) in feeling uninformed for the decision coaching plus evidence‐based information compared with usual care (5.8 out of 100) (Col 2007). We are uncertain if decision coaching plus evidence‐based information improves (reduces) feeling uninformed compared with usual care due to very low certainty of evidence; downgraded ‐2 for methodological limitations (items rated as high risk of bias for blinding in two studies, unclear sequence generation in one study, unclear allocation concealment in one study), and ‐1 for imprecision (small studies).

3.1. Analysis.

3.1

Comparison 3: Comparison #3: Decision coaching plus evidence‐based information versus usual care, Outcome 1: Uninformed subscale ‐ Decisional conflict

3.2.2 Unclear values

Meta‐analysis of three studies showed the unclear values (Decisional Conflict subscale) was no different for the decision coaching plus evidence‐based information compared with usual care (SMD 0.02, 95% CI ‐7.10 to 7.15; 3 studies, 212 participants) (see Analysis 3.2) (Berger‐Höger 2019Brown 2019Vodermaier 2009). Measures were post‐consultation (Berger‐Höger 2019), at one week (Vodermaier 2009), and one month post‐intervention (Brown 2019). A fourth study, measured at two weeks post‐consultation, reported a greater reduction for the decision coaching plus evidence‐based information group (7.3 out of 100) compared with usual care (‐0.25 out of 100) (Col 2007). We are uncertain if decision coaching plus evidence‐based information improves (reduces) unclear values compared with usual care due to very low certainty of evidence; downgraded ‐2 for methodological limitations (items rated as high risk of bias for blinding in two studies, unclear sequence generation in one study, allocation concealment in one study) and ‐1 for imprecision (small studies).

3.2. Analysis.

3.2

Comparison 3: Comparison #3: Decision coaching plus evidence‐based information versus usual care, Outcome 2: Unclear values ‐ Decisional conflict

3.2.3 Feeling unsupported

Meta‐analysis of three studies showed that feeling unsupported (Decisional Conflict subscale) was no different for decision coaching plus evidence‐based information compared with usual care (SMD ‐1.59, 95% CI ‐5.40 to 2.22; 3 studies, 212 participants) (see Analysis 3.3) (Berger‐Höger 2019Brown 2019Vodermaier 2009). Measures were post‐consultation (Berger‐Höger 2019), at one week (Vodermaier 2009), and one month post‐intervention (Brown 2019). A fourth study, measured at two weeks post‐consultation, reported a greater reduction for the decision coaching plus evidence‐based information group (11.75 out of 100) compared with usual care (3.5 out of 100) (Col 2007). We are uncertain if decision coaching plus evidence‐based information improves (reduces) feeling unsupported compared with usual care due to very low certainty of evidence; downgraded ‐2 for methodological limitations (items rated as high risk of bias for blinding in two studies, unclear sequence generation in one study, allocation concealment in one study), and‐1 for imprecision (small studies).

3.3. Analysis.

3.3

Comparison 3: Comparison #3: Decision coaching plus evidence‐based information versus usual care, Outcome 3: Feeling Unsupported ‐ Decisional conflict

3.2.4 Knowledge

Ten studies reported on knowledge using a range of measures. Meta‐analysis of five studies showed increased knowledge for decision coaching plus evidence‐based information compared with usual care (SMD 9.3, 95% 6.6 to 12.1; 5 studies, 1073 participants) (see Analysis 3.4) (Berger‐Höger 2019Brown 2019Lepore 2012Lerman 1997Van Peperstraten 2010). Measures were post‐intervention (Lepore 2012Van Peperstraten 2010), post‐consultation (Berger‐Höger 2019), and one month post‐intervention (Brown 2019Lerman 1997). Of these studies, one study (Lepore 2012) was an outlier, but there were no obvious reasons for this from the published report. For the remaining five studies not included in meta‐analysis, two studies reported no differences (Col 2007Miller 2005a), measured post‐intervention (Miller 2005a) and two weeks post‐consultation (Col 2007). Three studies reported a higher proportion of patients who scored better on a knowledge test with decision coaching plus evidence‐based information compared with usual care (58.3% versus 33.3%; P = 0.01) (Bozic 2013); (15.0 versus 10.9; P = 0.01) (Hamann 2006) (47% versus 13%) (Sheridan 2012). Measures were post‐intervention (Sheridan 2012), and post‐consultation (Bozic 2013Hamann 2006). Decision coaching plus evidence‐based information may improve knowledge compared with usual care due to low certainty of evidence; downgraded ‐1 for methodological limitations (items rated as unclear sequence generation in two studies, allocation concealment in four studies), and ‐1 due to inconsistency (heterogeneity; two of five studies that did not contribute to pooled results reported no effect).  

3.4. Analysis.

3.4

Comparison 3: Comparison #3: Decision coaching plus evidence‐based information versus usual care, Outcome 4: Knowledge

 

3.3. Adverse effects
3.3.1 Decision regret

Two studies reported no difference in the mean decision regret score for decision coaching plus evidence‐based information compared with usual care (Brown 2019McBride 2016). Brown 2019 reported measures at one and three months, and McBride 2016 at 12 weeks post‐intervention. Another study (Mishel 2009), at three months post‐intervention, reported reduced decision regret for decision coaching plus evidence‐based information compared with usual care (3.9 versus 4.2; P < 0.05). We are uncertain if decision coaching plus evidence‐based information improves (reduces) decision regret compared with usual care due to very low certainty of evidence; downgraded ‐1 for methodological limitations (items rated as unclear allocation concealment in one study), ‐1 for inconsistency (one of three studies showed an effect in favour of the intervention), and ‐2 for imprecision as results were based on small studies and overall sample size. 

3.3.2 Anxiety

Four studies reported no difference in the mean anxiety scores for decision coaching plus evidence‐based information compared with usual care (Davison 1997Kennedy 2002Lepore 2012Van Peperstraten 2010). Measures were post‐intervention (Lepore 2012Van Peperstraten 2010), at six weeks (Davison 1997), and twelve months post‐consultation (Kennedy 2002). We are uncertain if decision coaching plus evidence‐based information has an effect on anxiety compared with usual care due to very low certainty of evidence; downgraded ‐1 for methodological limitations (items rated as unclear risk of bias for allocation concealment in two studies), and ‐2 for imprecision (missing data for two studies, small sample for remaining two studies).

 

3.4 Secondary outcomes
3.4.1 Patient‐reported satisfaction with decision coaching

Four studies reported no difference in satisfaction with the decision‐making process for the decision coaching plus evidence‐based information compared with usual care (Col 2007Kennedy 2002Miller 2005aVodermaier 2009). Measures were at one week (Vodermaier 2009), and two weeks post‐intervention (Miller 2005a); and two weeks (Col 2007), and two years post‐consultation (Kennedy 2002). We are uncertain if decision coaching plus evidence‐based information improves satisfaction compared with usual care due to very low certainty of evidence; downgraded ‐1 for methodological limitations (items rated at low and unclear risk of bias across all studies, plus unclear risk of bias for allocation concealment in one study), ‐1 for inconsistency (due to different instruments, timing), and ‐1 for imprecision (small studies).

3.4.2 Decision quality

One study measured post‐consultation reported that the number of patients making an informed choice was higher with decision coaching plus evidence‐based information (47.6%) compared with usual care (0%) (Berger‐Höger 2019). For quality decisions, participants require adequate risk knowledge and a positive attitude towards the chosen option. We are uncertain if decision coaching plus evidence‐based information improves decision quality compared with usual care due to very low certainty of evidence; downgraded ‐1 for methodological limitations (items rated as high risk of bias for blinding (detection bias)), and ‐2 for imprecision as results were based on a single small study.

3.4.3 Health systems resources (length of consultation, costs to health system)

Four studies reported on length of consultation for decision coaching plus evidence‐based information compared with usual care. For duration of the whole decision‐making visit, one study reported longer time ((58.1; SD 13.4 versus 24.3; SD 6.3) minutes) (Berger‐Höger 2019), and one study reported no difference between groups ((53.5; SD 23.8 versus 51.0; SD 21.1) minutes; P = 0.38) (Bozic 2013). For the healthcare provider visit, three studies reported no difference in time ((20.9; SD 6.8 versus 21.0; SD 7.2) minutes; P = 0.91) (Bozic 2013), (60.4 versus 60.0 minutes) (Hamann 2006), (15.0 versus 15.0 minutes) (Vodermaier 2009).

Two studies reported on costs to the health system for decision coaching plus evidence‐based information compared with usual care. One study reported limited data on overall savings per couple in the intervention group (saved €169.75) (Van Peperstraten 2010), and the other reporting mean difference between groups (mean difference $1184; 95% CI $684 to 2110) (Kennedy 2002). The timing of measures for length of consultation and costs to the health system were reported post‐consultation. We are uncertain if decision coaching plus evidence‐based information improves length of consultations or costs to the health system, compared with usual care due to very low certainty of evidence; downgraded ‐2 for methodological concerns (mix of high risk of bias for blinding and 'other' bias, unclear risk of bias for sequence generation for two studies and allocation concealment for one study), and ‐1 for imprecision (small studies).

3.4.4 Quality of life

Three studies reported no difference in quality of life for the decision coaching plus evidence‐based information group compared with usual care (Brown 2019McBride 2016Mishel 2009). Another study reported improved scores for the physical dimension of the SF‐36 tool in favour of decision coaching plus evidence‐based information (P = 0.04) (Kennedy 2002). But for more generic quality of life measures (SF‐36 overall, Euro‐QoL), there were no differences between groups. Measures were at twelve weeks (McBride 2016); one and three months (Mishel 2009); one and three months post‐intervention (Brown 2019); and at two years post‐consultation (Kennedy 2002). We are uncertain if decision coaching plus evidence‐based information has an effect on quality of life compared with usual care due to very low certainty of evidence; downgraded ‐2 for methodological concerns (items for unclear risk of bias for allocation concealment for two studies and sequence generation for one study), ‐1 for inconsistency (due to different instruments, timing), and ‐1 for imprecision (small numbers of participants).

3.4.5 Quality of decision coaching (observer‐reported)

No studies reported this outcome.

 

4. Comparison #4: Decision coaching plus evidence‐based information versus evidence‐based information

Seven studies evaluated decision coaching plus evidence‐based information compared with evidence‐based information (Col 2007Kearing 2016Kennedy 2002Lerman 1997Myers 2005Myers 2011Rahn 2018) (see Table 4 and Table 14).

10. Comparison #4: Decision coaching plus evidence‐based information versus evidence‐based information (n = 7 studies) for outcomes not reported in meta‐analysis.
Study (year) Outcome and Instrument Timing
  N coaching + EBinfo
  Mean (SD) coaching + EBinfo
  N EBinfo
  Mean (SD) EBinfo
  Notes
  4.1 PREPARATION FOR ACTIVE PARTICIPATION IN MAKING A HEALTH DECISION            
Rahn 2018 Patient involvement in decision making: SDM, scale range from 0 to 4 with 4 indicating the highest levels of shared decision‐making; MAPPIN’SDM (Kasper 2012) n/r 33 87.5 (15.0)* 26 80.0 (10.0)*  
Kearing 2016 Stage of decision making: % that already made choice; Single question: ‘How far along are you with this decision?’ 2 weeks post‐intervention
 
82 74% 86 52% p=0.003
  4.2 RESOLVED DECISIONAL NEEDS            
Col 2007 Feeling uninformed: 3 items on a scale of 1‐5, scored 0‐100; Decisional Conflict Scale (DCS) uninformed subscale ©O'Connor 1995b Baseline and 2‐week post‐consultation 36 Change of 16.5 (20.75)* 31 Change of 23.0 (23.0)* no difference
Col 2007 Unclear values: 3 items on a scale of 1‐5, scored 0 to 100; DCS unclear values subscale ©O'Connor 1995b Baseline and 2‐week post‐consultation 36 change of 7.25 (24.25)* 31 change of 18.25 (21.5)* no difference
Col 2007 Feeling unsupported: 3 items on a scale of 1‐5, scored 0 to 100; DCS unsupport subscale ©O'Connor 1995b Baseline and 2‐week post‐consultation 36 change of 11.75 (18.0)* 31 Change of 13.75 (14.5)* no difference
Col 2007 Knowledge: 7 items multiple choice, change from baseline; instrument n/r Baseline and 2 weeks post‐consultation 36 +1.17 (1.65)/7 31 +1.94 (1.71)/7 no difference
Kearing 2016 Knowledge: 5 multiple choice (unable to standardise); instrument n/r 2 weeks post‐ intervention 82 65% (SD n/r) 86 58% (SD n/r) P<0.001 from baseline; no diff btw groups
  4.3 ADVERSE EFFECTS            
Kennedy 2002 Anxiety; the State and Trait Anxiety Inventory (STAI) – short form (Marteau 1992) 12 months post‐consultation 143 n/r 124 n/r No difference
Rahn 2018 Anxiety; Hospital Anxiety and Depression Scale (HADS) (Zigmond 1983) Baseline, 2 weeks, 6 months 38 n/r 35 n/r anxiety scores were inconspicuous
  4.4 SECONDARY OUTCOMES            
Col 2007 Satisfaction with decision‐making process: range 0‐100; instrument n/r
  2 weeks post‐consultation 36 63.5% (15.90) 31 63.7% (13.10) no difference
Kennedy 2002 Satisfaction with decision‐making process (n = proportion of participants); Single question: “How would you rate the opportunities you have been given to become involved in making decisions about your treatment” 2 years post‐consultation 199 excellent
n=75 (37.7%)
good
n=69 (34.7%)
fair
n=31 (15.6%)
poor
n=24 (12.1%)
186 excellent
n=51 (27.4%)
good
n=85 (45.7%) fair
n=33 (17.7%) poor
n=17 (9.1%)
no difference
Kennedy 2002 Agreement between preference and treatment (n = proportion who stated a preference
post‐consultation and underwent treatment)
12 months post‐consultation 186 n=118
(63.40%)
170 n=100 (58.80%) p=0.372
Rahn 2018 Decision quality: Informed choice (%); Multi‐dimensional
Measure of Informed Choice (MMIC) (Marteau 2001)
6 months post‐consultation 31 n=15 (48%) 20 n=6 (30%) p=0.193
Kennedy 2002 Costs; mean costs
  Post‐consultation   $1,566   $2,026 mean difference $461 95% CI $236‐696 PtDA only
Kennedy 2002 Quality of life: Role physical dimension; SF‐36 (Brazier 1992) Baseline, 2 years post‐consultation 176 n/r 164 n/r No difference
Kennedy 2002 Quality of life: SF‐36 (Brazier 1992)
  • physical function

  • social function

  • role emotional

  • mental health

  • energy or vitality

  • pain

  • general health

Baseline, 2 years post‐consultation 176 n/r 164 n/r No difference
Kennedy 2002 Quality of life: EuroQol‐5 dimensions (EQ‐5D) Health utility index (0‐1); 1 = the value of full health; EQ‐5D (Brooks 1996) Baseline, 2 years post‐consultation 300 0.835 296 0.839 No difference
Rahn 2018 Quality of life: Disease‐specific quality of life Baseline, post‐intervention, post‐consultation, 2 wks, 3, 6 months         High quality of life and stable

Abbreviations:
DCS=Decisional conflict scaleEQ‐5D=EuroQol‐5 HADS=Hospital Anxiety and Depression Scale MAPPIN=Multifocal APProach to the sharing‘ INMMIC=Multi‐dimensional Measure of Informed Choicen/r=not reportedSD=standard deviation

SDM=shared decision makingSF‐36=36‐Item Short Form Health Survey STAI=State and Trait Anxiety Inventory

Note: values are mean (SD) unless otherwise stated.

*Values reported in the text were standardised out of 100.

                                                                                                                                    

4.1 Preparation for active participation in making a health decision (patient‐reported)
4.1.1 Preparation for decision making

No studies reported this outcome.

4.1.2 Decision self‐confidence

No studies reported this outcome.

4.1.3 Patient involvement in decision making

In one study that did not report timing of the measure (Rahn 2018), patient‐reported perceived involvement was higher with decision coaching plus evidence‐based information compared with evidence‐based information (87.5% versus 80%). We are uncertain if decision coaching plus evidence‐based information increases levels of patient perceived involvement in decision making compared with evidence‐based information only due to very low certainty of evidence; downgraded ‐2 for methodological concerns (four of seven items rated as unclear risk of bias including allocation concealment and sequence generation), and ‐2 for imprecision as results were based on one small study and sample size.

4.1.4 Stage of decision making

One study, measured at two weeks post‐intervention, reported a higher proportion who indicated their stage of decision making as already having made a choice in the decision coaching plus evidence‐based information compared with evidence‐based information (74% versus 52%; P = 0.003) (Kearing 2016). We are uncertain if decision coaching plus evidence‐based information improves stage of decision making compared with evidence‐based information only due to very low certainty of evidence; downgraded ‐1 for methodological limitations (five of seven items rated as unclear risk of bias including allocation concealment), and ‐2 for imprecision as results were based on one small study and sample size.

 

4.2 Resolution of modifiable decisional needs (patient‐reported). 
4.2.1 Feeling uninformed

One study reported that the mean change in feeling uninformed (Decisional Conflict subscale) measured two weeks post‐consultation was no different between decision coaching plus evidence‐based information compared with evidence‐based information only (Col 2007). We are uncertain if decision coaching plus evidence‐based information improves levels of feeling uninformed compared with evidence‐based information due to very low certainty of evidence; downgraded ‐1 for methodological limitations (three of seven items rated as unclear risk of bias that include blinding, selective reporting, and other bias (recruitment prematurely ended due to publication of findings)), and ‐2 for imprecision as results were based on one small study.

4.2.2 Unclear values

One study reported that the mean change in unclear values (Decisional Conflict subscale) measured two weeks post‐consultation was no different between decision coaching plus evidence‐based information compared with evidence‐based information only (Col 2007). We are uncertain if decision coaching plus evidence‐based information improves (reduces) unclear values compared with evidence‐based information due to very low certainty of evidence; downgraded ‐1 for methodological limitations (three of seven items rated as unclear risk of bias that include blinding, selective reporting, and other bias (recruitment prematurely ended due to publication of findings)), and ‐2 for imprecision as results were based on one small study.

4.2.3 Feeling unsupported

One study reported that the mean change in feeling unsupported (Decisional Conflict subscale) measured two weeks post‐consultation was no different between decision coaching plus evidence‐based information compared with evidence‐based information only (Col 2007). We are uncertain if decision coaching plus evidence‐based information improves (reduces) feeling unsupported compared with evidence‐based information due to very low certainty of evidence; downgraded ‐1 for methodological limitations (three of seven items rated as unclear risk of bias that include blinding, selective reporting, and other bias (recruitment prematurely ended due to publication of findings)), and ‐2 for imprecision as results were based on one small study.

4.2.4 Knowledge

Five studies reported results using a range of measures (Col 2007Kearing 2016Lerman 1997Myers 2011Rahn 2018). Meta‐analysis of three studies showed knowledge was no different between decision coaching plus evidence‐based information compared to evidence‐based information groups (SMD 0.18, 95% CI ‐0.20 to 0.56; 3 studies, 573 participants) (see Analysis 4.1) (Lerman 1997Myers 2011Rahn 2018). Measures were at one week (Myers 2011), two weeks (Rahn 2018), and one month post‐intervention (Lerman 1997). Another study measured change in knowledge at two weeks post‐consultation and reported no difference between groups (Col 2007). A fifth study, measured at two weeks post‐intervention (Kearing 2016), reported no difference in knowledge for decision coaching plus evidence‐based information compared with evidence‐based information (65% versus 58%); however, they did not provide data on standard deviations and, therefore, were not included in the meta‐analysis. We are uncertain if decision coaching plus evidence‐based information improves knowledge compared with evidence‐based information due to very low certainty of evidence; downgraded ‐2 for methodological concerns (items for unclear risk of bias for allocation concealment for four studies and sequence generation for three studies), and ‐1 for inconsistency (due to heterogeneity).

4.1. Analysis.

4.1

Comparison 4: Comparison #4: Decision coaching plus evidence‐based information versus evidence‐based information, Outcome 1: Knowledge

 

4.3 Adverse effects (patient, observer‐reported)
4.3.1 Decision regret

No studies reported this outcome.

4.3.2 Anxiety

Two studies reported that anxiety scores were no different between decision coaching plus evidence‐based information compared with evidence‐based information (Kennedy 2002Rahn 2018). Measures were at two weeks and six months post‐intervention (Rahn 2018), and at 12 months post‐consultation (Kennedy 2002). We are uncertain if decision coaching plus evidence‐based information has an effect on anxiety compared with evidence‐based information due to low certainty of evidence; downgraded ‐2 for methodological concerns (items rated as unclear risk of bias including allocation concealment and sequence generation for one study), and ‐1 for imprecision as results were based on small studies and overall sample size.

 

4.4 Secondary outcomes
4.4.1 Patient‐reported satisfaction with decision coaching

Two studies reported no difference in the satisfaction with decision coaching scores between decision coaching plus evidence‐based information compared with evidence‐based information (Col 2007Kennedy 2002). Measures were at two weeks (Col 2007), and two years post‐consultation (Kennedy 2002). We are uncertain if decision coaching plus evidence‐based information affects satisfaction compared to evidence‐based information due to very low certainty of evidence; downgraded ‐2 for inconsistency (due to different instruments, timing), and ‐1 for imprecision as results were based on small studies.

4.4.2 Decision quality

One study (Rahn 2018), measured at six months post‐intervention, reported that the proportion of patients who made an informed choice was no different for decision coaching plus evidence‐based information compared to evidence‐based information only. We are uncertain if decision coaching plus evidence‐based information has an effect on decision quality compared to evidence‐based information due to very low certainty of evidence; downgraded ‐2 for methodological concerns (four of seven items rated as unclear risk of bias including allocation concealment and sequence generation), and ‐2 for imprecision as results were based on one small study.

4.4.3 Health systems resources (length of consultation, cost to health system)

One study (Kennedy 2002), measured at post‐consultation, reported lower costs to the health system (mean difference $461) for decision coaching plus evidence‐based information compared to evidence‐based information. We are uncertain if decision coaching plus evidence‐based information has an effect on costs to the health system compared to evidence‐based information due to very low certainty of evidence; downgraded ‐2 for inconsistency (due to no reporting of instrument, timing), and ‐2 for imprecision as results were based on one small study.

4.4.4 Quality of life

One study (Kennedy 2002), measured at two years post‐consultation, reported no difference in quality of life physical dimensions or general quality of life for decision coaching plus evidence‐based information compared with evidence‐based information only. One study measured disease‐specific quality of life post‐intervention and at two weeks and six6 months post‐consultation but did not report any data (Rahn 2018). We are uncertain if decision coaching plus evidence‐based information has an effect on quality of life compared to evidence‐based information due to very low certainty of evidence; downgraded ‐2 for methodological limitations (several items rated at unclear risk of bias including allocation concealment and sequence generation in one study), ‐1 for inconsistency (due to limited reporting on outcomes, timing), and ‐2 for imprecision as results were based on small studies.

4.4.5 Quality of decision coaching (observer reported)

No studies reported this outcome.

Discussion

Summary of main results

We identified 28 included studies using a range of decision‐coaching interventions alone or in combination with evidence‐based information (e.g. a patient decision aid). All intervention‐comparator groups reported some studies that measured the outcome of ‘knowledge’. There was variable reporting on the other six primary outcomes (e.g. preparation for decision making, decision self‐confidence, feeling uninformed, unclear values, feeling unsupported, and adverse effects (decision regret, anxiety)). 

For decision coaching compared to usual care (n = 4 studies), we are uncertain of the effects on primary outcomes due to either these outcomes not being measured or due to very low certainty of evidence (i.e. preparation for decision making, decision self‐confidence, knowledge, decision regret, anxiety). 

For decision coaching compared to evidence‐based information only (n = 4 studies), there is low certainty of evidence that participants exposed to decision coaching may have little or no changes in knowledge or anxiety. The other primary outcomes were either not measured by included studies, or we are uncertain of the effects due to very low certainty of evidence (i.e. decision self‐confidence, feeling uninformed).

For decision coaching plus evidence‐based information compared to usual care (n = 17 studies), there is low certainty‐evidence that participants may have improved knowledge with the intervention. The other primary outcomes were either not measured by included studies, or we are uncertain of the effects due to very low certainty of evidence (i.e. preparation for decision making, decision self‐confidence, feeling uninformed, unclear values, feeling unsupported, decision regret, anxiety).

For decision coaching plus evidence‐based information compared to evidence‐based information only (n = 7 studies), we are uncertain of the effects on primary outcomes due to either the outcomes not being measured or due to very low certainty‐evidence (i.e. feeling uninformed, unclear values, feeling unsupported, knowledge, anxiety).

Only knowledge and adverse effects (e.g. decision regret or anxiety) were measured consistently enough to consider some conclusions but, due to low certainty‐evidence, no strong conclusions were possible. Our results must be interpreted with caution, due to the small number of eligible studies within comparisons and generally small sample sizes, and the variation in the design and quality of these studies.

Overall completeness and applicability of evidence

Our international and interdisciplinary team is composed of knowledge users (e.g. patient partners, healthcare providers, educators) and researchers with experience evaluating and/or teaching decision coaching. Our team provided guidance and support throughout the review processes. The patient partner on our executive team participated on project governance and study decision making. We feel quite confident that the review is complete and knowledge users on our research team describe the evidence as applicable.

Our review was set up to be inclusive and to report on studies from a range of settings with a broad range of participants (e.g. patients, decision coaches), so that we could best identify evidence on decision coaching as an intervention. Given the extensiveness of our search strategy for electronic databases and handsearching, our team feels confident that we were able to identify the relevant published studies. We are also aware that there is the possibility that a relevant study was missed or not identified for inclusion in the review. There were challenges when the intervention appeared to meet the definition of decision coaching but there were too few details provided on the intervention in the published study. Hence, we added a third round of screening for included studies that focused on the decision‐coaching intervention. If there were not enough details in the published paper, we contacted the authors requesting additional information to determine whether studies were about decision coaching and to confirm if the study should have been included (see Characteristics of excluded studies). 

Our synthesis of the evidence showed a high degree of heterogeneity which is to be expected with the design and testing of a complex intervention such as decision coaching. Furthermore, heterogeneity was greater when there were different evaluation measures, such as knowledge tests, that had to be specific to the healthcare decision.

The comparison with the greatest number of studies was decision coaching with evidence‐based information compared with usual care. In these studies, the evidence‐based information component was most often a patient decision aid. Previous research has shown that, compared to usual care, people who have used a patient decision aid have improved knowledge, feel more informed, feel clearer about their values, and participate more in decision making (Stacey 2017b). As we can only report on the outcomes when exposed to the complete intervention, it was difficult for us to draw conclusions about decision coaching used alone as an intervention, rather than in conjunction with a decision aid. The other decision‐coaching intervention‐comparator groups had too few studies with small sample sizes to determine the effectiveness of decision coaching. It is unclear if decision coaching always needs to be paired with evidence‐based information or if decision coaching alone is an effective intervention.

Our findings about the decision coaching intervention reflect the challenges of determining the effective and ineffective components of complex interventions (Danko 2018). For example, there are a range of names and descriptions for decision coaching and the steps described for different decision‐coaching interventions are multifaceted. The reported contextual descriptions (who, how, where, when, how much) for the decision coaching interventions were limited and showed variability between studies (Table 8). As a result, it is not yet possible to determine the dose and intensity of decision coaching required to achieve positive outcomes. 

Decision coaching interventions have been evaluated with men and women having a range of ages (18 to 85 years) and for 13 different types of decisions. Interestingly, none of the included studies evaluated the use of decision coaching with children, or evaluated decision coaching provided by peer‐support workers. In addition, most of the studies overlooked whether decisions were congruent with values, and did not consider involvement in decision making. 

The included studies in our review were conducted in higher‐income countries with no studies set in lower‐or middle‐ income countries. Evaluation of decision coaching in higher‐income countries was not surprising given the costs associated with human resources required to deliver decision coaching. Interestingly, only one of the 28 studies conducted a cost‐analysis and determined that, for the group who received decision coaching plus the evidence‐based information, it was less costly than the two comparators of evidence‐based information only or usual care (Kennedy 2002). While one other study also reported on costs (Van Peperstraten 2010), a full cost‐analysis was not conducted. Further research is required to determine costs and their associate impacts within health systems (Scalia 2020Trenaman 2014), and to determine the impacts of decision coaching from patient, organisational and societal perspectives.

Quality of the evidence

The GRADE appraisal of the certainty of evidence indicates low or very low certainty for all the outcomes. Common reasons for downgrading included small number of studies, small sample sizes, and inconsistencies in measurement.

Many of the individual studies, appraised using the Cochrane Risk of Bias tool, had items that commonly were rated as having ‘low’ or ‘unclear’ risk of bias (Figure 2Figure 3). Six studies had items judged to be at ‘high’ risk of bias due to not blinding participants and personnel (McBride 2016Brown 2019), not blinding the person conducting the outcome assessment (Berger‐Höger 2019), incomplete outcome data (Shepherd 2019), and other (e.g. only self‐reports used, disproportionate numbers randomised to each arm and loss to follow‐up, clustering was not accounted for in analysis) (Aoki 2019Hamann 2006).

Potential biases in the review process

We identified no potential biases in the review process. According to AMSTAR II (Shea 2017), we met 16 of 16 review quality criteria. In our review, we placed boundaries on how decision coaching was defined as a concept (i.e. healthcare providers trained or using a protocol et cetera) because it is poorly defined in the literature. We also excluded group decision coaching as we could not distinguish the effects of peer support from the effects of decision coaching. These decisions may be made differently by other review teams and might influence what is included in other reviews of decision‐coaching interventions.

Agreements and disagreements with other studies or reviews

Our review is focussed on decision coaching as an intervention to prepare patients for participating in making healthcare decisions. Our findings for decision coaching with evidence‐based information compared to usual care (e.g. improved knowledge) are consistent with previous reviews evaluating decision coaching within trials evaluating patient decision aids (Rahn 2021Stacey 2012); likely because 14 of the 17 included studies used a patient decision aid as the source of evidence‐based information. These findings are also consistent with the systematic review of 105 RCTs evaluating patient decision aids for preparing patients for making healthcare decisions (Stacey 2017b). The previous review on coaching (Alders 2017) indicated that all but one of the interventions used additional material such as question prompt lists, audiotape of the consultation, or an educational DVD booklet; however, the review did not identify the DVD booklet as also supporting patients’ preparation for communicating with their physician (Mishel 2009). This same study was included in our review and this DVD booklet met the description of a patient decision aid that is known to independently improve patients’ outcomes. 

Our review showed decision coaching with evidence‐based information may improve knowledge compared to usual care. When decision coaching was compared to evidence‐based information, there was little or no difference in knowledge. Previous reviews of decision coaching used with patient decision aids also reported improved knowledge (Rahn 2021Stacey 2012Stacey 2017b) and knowledge of options, benefits and harms is a key element required when patients are making healthcare decisions (Joseph‐Williams 2014Makoul 2006).

The fact that decision coaching was frequently combined with evidence‐based information confirms that decision coaching can be used as part of a multifaceted intervention for some healthcare decisions. These multifaceted decision‐coaching interventions also provided patients with the information they could review on their own at home. Previous reviews of interventions to enhance SDM identified the need for interventions targeting the patient (e.g. patient decision aids) and interventions targeting the healthcare professional (e.g. training) (Légaré 2018). In our review, the interventions targeting healthcare professionals included training and/or protocols for decision coaching.

Decision coaching with or without evidence‐based information did not appear to worsen any adverse effects. In fact, anxiety measured using the State‐Trait inventory (Spielberger 1983) or the Hospital Anxiety and Depression Scale (Zigmond 1983) showed that there may be little or no difference between any of the four comparison groups using decision‐coaching interventions alone or in combination with evidence‐based information, although there is considerable uncertainty associated with these results. These findings are consistent with anxiety measured in studies of patient decision aids that also indicated no worsening of anxiety (Bekker 2003Stacey 2017b). For decision coaching with or without evidence‐based information, we are uncertain if there is an effect on decision regret (very low certainty‐evidence of no difference). Our findings on regret are consistent with the other recent reviews (Rahn 2021Stacey 2017b).

Authors' conclusions

Implications for practice.

Given the limited findings from our review, it is difficult to discuss implications for practice. For those providing non‐directive decision coaching to patients facing healthcare decisions, it is unlikely to cause adverse effects and may result in some benefits. At a minimum, healthcare providers can use decision coaching with evidence‐based information such as patient decision aids as supported in our review and consistent with strong evidence in the Cochrane review of patient decision aids (Stacey 2017b). The intent of our study was to determine the effectiveness of decision coaching with healthcare providers, and to be inclusive of healthcare professionals and health support workers  who may be situated in lower‐ or middle‐income countries (e.g. peer support workers, lay health workers) (Jull 2019WHO 2010). However, the restriction to inclusion of RCTs only meant that we screened out other study designs that included health support workers (e.g. Simmons 2017). We will use the information to inform plans for future updates of our decision‐coaching review, to ensure that such gaps are addressed with adjustments to the selection criteria. Further research is required to determine the contributions of decision coaching; that is, what works for whom, and in what circumstances.

Implications for research.

Future studies need to have adequate sample sizes and more consistent reporting of the coaching intervention to properly evaluate the effectiveness of decision coaching as an intervention to improve preparation for decision making and resolving decisional needs without causing adverse effects for patients facing healthcare decisions for themselves or a family member. It would be beneficial if subsequent studies used more consistent outcome measures that could facilitate meta‐analysis. Our review highlights the need for further studies to evaluate the effectiveness of decision coaching. Further research needs to be done, to determine if decision coaching has a role as a stand‐alone intervention or may be more useful as part of the implementation of evidence‐based information such as patient decision aids. 

Given the complexity of the decision‐coaching intervention, future studies should include better descriptions of the intervention (e.g. logic models) and process measures to aid in understanding the function of decision coaching as an intervention (Thomas 2020). As previously mentioned, further research is required to determine costs and related impacts within healthcare systems (Scalia 2020Trenaman 2014).

Another area identified in our review is the lack of patient partner engagement in the conduct of studies about decision coaching. Most of the included studies in our review (Table 5) were conducted in countries that are advancing patient‐oriented research including USA, Canada, and the UK; however, the studies in our review did not report on engagement with patients as partners (Staniszewska 2017). Finally, given the relational aspect of decision coaching, it was interesting to see none of the decision‐coaching sessions had been recorded and analysed to measure the decision‐coaching process. Future research that reports on the decision‐coaching encounters will benefit the field of patient‐oriented healthcare and support the development of decision coaching as a healthcare intervention.

What's new

Date Event Description
30 July 2019 Amended Updated affiliations

History

Protocol first published: Issue 7, 2019

Notes

This paper is based on standard text and guidance provided by Cochrane Consumers and Communication (CCCG 2021).

Acknowledgements

We thank Rebecca Ryan and the editors and staff of Cochrane Consumers and Communication, for their input to this paper. We thank Anne Parkhill for the Information Specialist support. We thank Brian Hutton, Angela Coulter, and Wakako Osaka for their contributions to the study proposal.

Appendices

Appendix 1. CENTRAL search strategy

ID             Search

#1             MeSH descriptor: [Decision Making] this term only

#2             MeSH descriptor: [Decision Support Techniques] this term only

#3             (decision* or decid* or choice or choose or prefer*):ti

#4             ((informed or aid*) NEAR (choice* or decision*)):ti

#5             #1 OR #2 OR #3 OR #4

#6             MeSH descriptor: [Directive Counseling] this term only

#7             MeSH descriptor: [Counseling] this term only

#8             MeSH descriptor: [Health Education] this term only

#9             MeSH descriptor: [Patient Education as Topic] this term only

#10          MeSH descriptor: [Patient Participation] this term only

#11          MeSH descriptor: [Physician‐Patient Relations] this term only

#12          MeSH descriptor: [Referral and Consultation] this term only

#13          (assess* or coach* or guidance or counsel* or prepar*):ti

#14          #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13

#15          #5 AND #14

Appendix 2. MEDLINE search strategy

Ovid MEDLINE® In‐Process & Other Non‐Indexed Citations and Ovid MEDLINE® 1946 to Present:

‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐

Jull_Medline_final
1. *Decision Making/ 2. decision support techniques/
3. (decision* or decid* or choice or choose or prefer*).ti.
4. (informed adj (choice* or decision*)).tw.
5. or/1‐4
6. Directive Counseling/ or *Counseling/
7. *Health Education/
8. Patient Education as Topic/
9. *Patient Participation/
10. *Physician‐Patient Relations/
11. "Referral and Consultation"/
12. (assess* or coach* or guidance or counsel* or prepar*).ti.
13. or/6‐12
14. and/5,13
15. randomized controlled trial.pt.
16. controlled clinical trial.pt.
17. randomized.ab.
18. placebo.ab.
19. drug therapy.fs.
20. randomly.ab.
21. trial.ab.
22. groups.ab.
23. or/15‐22
24. exp animals/ not humans.sh.
25. 23 not 24
26. and/14,25

Appendix 3. Embase search strategy

1. *decision making/        

2. exp decision support system/ 

3. (decision* or decid* or choice or choose or prefer*).ti.                  

4. ((aid* or informed) adj (choice* or decision*)).tw.          

5. or/1‐4                

6. directive counseling/ or *counseling/ 

7. *health education/      

8. patient education/      

9. *Patient Participation/               

10. *doctor patient relation/       

11. patient referral/          

12. "empowerment"/      

13. (assess* or coach* or guidance or counsel* or prepar* or knowledg* or power* or empower*).ti.

14. or/6‐13          

15. and/5,14       

16. randomized controlled trial/                 

17. controlled clinical trial/          

18. single blind procedure/ or double blind procedure/   

19. crossover procedure/                

20. random*.tw.                

21. placebo*.tw.                

22. ((singl* or doubl*) adj (blind* or mask*)).tw. 

23. (crossover or cross over or factorial* or latin square).tw.           

24. (assign* or allocat* or volunteer*).tw.               

25. or/16‐24       

26. 15 and 25     

Appendix 4. PsycInfo search strategy

1. random*.ti,ab,hw,id.                  

2. intervention.ti,ab,hw,id.          

3. trial.ti,ab,hw,id.           

4. placebo*.ti,ab,hw,id.                  

5. groups.ab.       

6. ((singl* or doubl* or trebl* or tripl*) and (blind* or mask*)).ti,ab,hw,id.                

7. (cross over or crossover).ti,ab,hw,id.   

8. latin square.ti,ab,hw,id.            

9. (assign* or allocat* or volunteer*).ti,ab,hw,id.                 

10. (control or controlled).ti,ab,hw,id.   

11. treatment effectiveness evaluation/  

12. mental health program evaluation/   

13. exp experimental design/       

14. "2100".md. 

15. or/1‐14          

16. animal.po.   

17. 15 not 16      

18. *Decision Making/    

19. decision support systems/     

20. (decision* or decid* or choice or choose or prefer*).ti.               

21. ((aid* or informed) adj (choice* or decision*)).tw.       

22. or/18‐21       

23. *Counseling/                

24. *Health Education/ or *"Educational Programs"/         

25. client education/       

26. exp Client Participation/        

27. Therapeutic Processes/            

28. Professional Referral/ or Professional Consultation/   

29. exp interpersonal control/    

30. empowerment/          

31. (assess* or coach* or guidance or counsel* or prepar* or knowledg* or power* or empower*).ti.

32. or/23‐31       

33. and/22,32    

34. 17 and 33     

Appendix 5. CINAHL search strategy

# Query
S25 S5 AND S14 AND S24
S24 S15 or S16 or S17 or S18 or S19 or S20 or S21 or S22 or S23
S23 TI (singl* or doubl* or tripl* or trebl*) and TI (blind* or mask*)
S22 AB (singl* or doubl* or tripl* or trebl*) and AB (blind* or mask*)
S21 AB (random* or trial or placebo*) or TI (random* or trial or placebo*)
S20 MH Quantitative Studies
S19 MH Placebos
S18 MH Random Assignment
S17 MH Clinical Trials+
S16 PT Clinical Trial
S15 "randomi?ed controlled trial" or PT randomized controlled trial
S14 S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13
S13 TI (assess* or coach* or guidance or counsel* or prepar*)
S12 (MM "Referral and Consultation")
S11 (MM "Physician‐Patient Relations")
S10 (MM "Consumer Participation")
S9 MM patient education
S8 MM health education
S7 (MH "Counseling")
S6 "Directive Counseling"
S5 S1 OR S2 OR S3 OR S4
S4 TX ((informed OR aid*) (choice* or decision*))
S3 TI (decision* or decid* or choice or choose or prefer*)
S2 MM decision support techniques
S1 MM Decision Making

Appendix 6. Proquest search strategy

S7 S2 AND S5 AND noft(random*)
  • Nursing & Allied Health Database

S6 S2 AND S5
  • Nursing & Allied Health Database

S5 ti((assess* OR coach* OR guidance OR counsel* OR prepar*)) OR mainsubject((health OR patient) education) OR mainsubject(patient participation) OR mainsubject(counseling) OR mainsubject(referral) OR mainsubject(consultation model)
  • Nursing & Allied Health Database

S2 mainsubject.Exact("decision making" OR "decision making, computer‐assisted") OR noft(((informed OR aid*) adj (choice* OR decision*))) OR ti((decision* OR decid* OR choice OR choose OR prefer*))
  • Nursing & Allied Health Database

Appendix 7. Web of Science search strategy

STUDY author TITLE
Adam Assessing an Interactive Online Tool to Support Parents' Genomic Testing Decisions.
Rahn Nurse‐led immunotreatment DEcision Coaching In people with Multiple Sclerosis
Berger‐Hoger Informed shared decision‐making supported by decision coaches for women with ductal carcinoma in
Myers Preparing African‐American men in community primary care practices to decide whether or not to have prostate cancer screening.
Hunter A randomized trial comparing alternative approaches to prenatal diagnosis counseling in advanced maternal age patient
Kennedy Effects of decision aids for menorrhagia on treatment choiceshealth outcomes
Green Education about genetic testing for breast cancer susceptibility
Rothert An educational intervention as decision support for menopausal women.
Lerman Controlled trial of pretest education approaches to enhance informed decisio

Data and analyses

Comparison 1. Comparison #1: Decision coaching versus usual care.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1.1 Decision self‐confidence 2 201 Mean Difference (IV, Random, 95% CI) 5.16 [1.74, 8.58]
1.2 Knowledge 2 97 Mean Difference (IV, Random, 95% CI) 12.98 [6.21, 19.76]

Comparison 2. Comparison #2: Decision coaching versus evidence‐based information.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
2.1 Knowledge 3 406 Std. Mean Difference (IV, Random, 95% CI) ‐0.23 [‐0.50, 0.04]

Comparison 3. Comparison #3: Decision coaching plus evidence‐based information versus usual care.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
3.1 Uninformed subscale ‐ Decisional conflict 3 212 Mean Difference (IV, Random, 95% CI) ‐5.83 [‐8.90, ‐2.76]
3.2 Unclear values ‐ Decisional conflict 3 212 Mean Difference (IV, Random, 95% CI) 0.02 [‐7.10, 7.15]
3.3 Feeling Unsupported ‐ Decisional conflict 3 212 Mean Difference (IV, Random, 95% CI) ‐1.59 [‐5.40, 2.22]
3.4 Knowledge 5 1073 Std. Mean Difference (IV, Random, 95% CI) 9.33 [6.55, 12.10]

Comparison 4. Comparison #4: Decision coaching plus evidence‐based information versus evidence‐based information.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
4.1 Knowledge 3 573 Std. Mean Difference (IV, Random, 95% CI) 0.18 [‐0.20, 0.56]

Characteristics of studies

Characteristics of included studies [ordered by study ID]

Adam 2019.

Study characteristics
Methods RCT
Participants 54 (coaching) versus 52 (decision aid) parents of children with early‐onset (age ≤ 5 years) epilepsy of unknown cause considering genome‐wide sequencing
Interventions Intervention: standard pre‐test genetic counselling
Comparator: DECIDE (an interactive online educational tool and decision aid)
Outcomes Primary: Knowledge 
Secondary: Empowerment
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "Parents were randomized as a couple to receive one of the two interventions"
Allocation concealment (selection bias) Unclear risk "Parents were randomized as a couple to receive one of the two interventions"
Blinding of participants and personnel (performance bias) ‐ Study Level Unclear risk No information
Blinding of outcome assessment (detection bias) ‐ Study Level Unclear risk No information
Incomplete outcome data (attrition bias) ‐ Study level Unclear risk 106 of 121 completed, but unclear how many in which group 
Selective reporting (reporting bias) Unclear risk No protocol/registration identified
Other bias Low risk Appeared to be free of other sources of bias

Aoki 2019.

Study characteristics
Methods RCT
Participants 35 (coaching + decision aid) versus 53 (usual care) undergraduate and postgraduate students aged 20 years and older who visited the outpatient services for first‐time diagnosis of major depressive episode including depressive phase of bipolar disorder
Interventions Intervention: 7‐day shared decision‐making programme with option presentation consultation, external deliberation with a decision‐aid booklet, decision coaching by a nurse, and decision‐making consultation
Comparator: usual care with decision about treatment made in the initial consultation
Outcomes Primary: patient‐perceived involvement in medical decisions (COMRADE)
Secondary: satisfaction, consultation duration, sharing information with others, looking up information on options/treatments,  persistence with treatment, severity of depressive symptoms, medication adherence
Notes No health consumers were described as being on the team; no funding received; research ethics board approval obtained
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk "Participants were randomly assigned to one of two arms, following the restricted randomization and minimization method of item 8 in CONSORT 2010 (Moher 2012)" COMMENT:   *Minimisation may be implemented without a random element, and this is considered to be equivalent to being random.
Allocation concealment (selection bias) Low risk The randomisation was conducted by a research assistant not directly involved in the study.
Blinding of participants and personnel (performance bias) ‐ Study Level Low risk Clinicians and nurses were not blinded because of the design of the study. Low risk because objective measures used
Blinding of outcome assessment (detection bias) ‐ Study Level Low risk A research assistant blinded to group allocation collected data at baseline, after the decision‐making consultation, and at each visit during the 6‐month trial period.
Incomplete outcome data (attrition bias) ‐ Study level Unclear risk Reasons for attrition clearly described (see Figure 1). Missing outcome data balanced across groups: Intervention 20/35 (57%), control 32/53 (60%). However, it was unclear how the high rate of missing data influenced the results.
Selective reporting (reporting bias) Low risk Registered with the University Hospital Medical Information Network Clinical Trials Registry (UMIN000009239) before the commencement of data collection. Outcomes reported were consistent with the study protocol.
Other bias High risk The numbers randomised to each arm were disproportionate (35 intervention; 53 control) and there was an extremely high rate of loss to follow‐up before the 6‐month follow‐up: intervention 20/35 (57%) and control 32/53 (60%).

Berger‐Höger 2019.

Study characteristics
Methods Cluster‐RCT
Participants 37 (coaching + decision aid) versus 30 (usual care) German women, aged 18 years or older, with primary histologically confirmed ductal carcinoma in situ facing primary treatment decisions
Interventions Intervention: Nurse‐led coaching of shared decision making. Patients were provided with the decision aid, at least one nurse‐led decision coaching session, and a final shared decision making physician encounter.
Comparator: Standard care
Outcomes Primary: Extent of informed shared decision making
Secondary: patients and healthcare professionals perspectives of shared decision making, informed choice (knowledge, attitude, uptake), decisional conflict, duration of coaching sessions and physician encounters
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk "The statistician (BH) provided a computer‐generated allocation sequence. During study progress, allocation might have become predictable. Thus, we used a random permuted block design with block sizes of 4, 6 or 8 to randomize clusters."
Allocation concealment (selection bias) Low risk "The allocation was concealed. An independent external person prepared sealed opaque envelopes. After baseline assessment of the respective cluster and its professionals, two researchers (BBH, KL) opened the sealed opaque envelope and revealed the center’s allocation on site. Patients were recruited by the participating physicians (electronic supplementary material S2) and kept unaware of their allocation status. After the final physician encounter, they were asked to guess whether they had received standard care or the new counselling approach."
Blinding of participants and personnel (performance bias) ‐ Study Level Unclear risk "[P]erson prepared sealed opaque envelopes"... "After baseline assessment of the respective cluster and its professionals, two researchers (BBH, KL) opened the sealed opaque envelope and revealed the center’s allocation on site"... "Patients were recruited by the participating physicians (electronic supplementary material S2) and kept unaware of their allocation status. After the final physician encounter, they were asked to guess whether they had received standard care or the new counselling approach." Participants were blinded so low risk of bias for that item. Unclear if personnel blinded
Blinding of outcome assessment (detection bias) ‐ Study Level High risk "The primary outcome was the extent of informed shared decision‐making assessed by the observer‐based instrument of the validated inventory Multifocal APProach to the sharing‘ IN Shared Decision‐Making (MAPPIN’SDM). It assesses the mutual shared decision‐making‐behavior of health professionals and patients based on video‐recordings." "Due to the structural inequality between intervention and control group, video raters could not be blinded."
Incomplete outcome data (attrition bias) ‐ Study level Low risk For eight patients, missing values were imputed (5 patients with missing values in 1, 2 or 3 items, 3 patients with missing values in all 11 items).
Selective reporting (reporting bias) Low risk The study protocol was available and all of the study’s prespecified (primary and secondary) outcomes that were of interest in the review have been reported in the prespecified way.
Other bias Low risk Cluster analysis on an individual level was planned; however, there were unanticipated low cluster sizes that resulted in unstable intracluster correlation coefficient estimations. As a result, cluster analysis was used as this is more robust, given the limitations of their recruitment/clusters. 
Selective recruitment of cluster participants: low risk of bias

Bozic 2013.

Study characteristics
Methods RCT
Participants 95 (coaching + decision aid) versus 103 (usual care) patients with a primary diagnosis of osteoarthritis of the hip or knee seeing an orthopaedic surgeon for the first time for this problem, and no history of a lower‐extremity joint arthroplasty and considered medically appropriate for total joint arthroplasty
Interventions Intervention: Shared decision making intervention. decision aid (DVD, booklet), communication aid, question listing with coach, taped consultation, surgeon's dictated note
Comparator: Usual care. Map, directions, one‐page info on signs and symptoms, diagnosis and treatment options for hip and knee osteoarthritis
Outcomes Primary: Informed decision (knowledge)
Secondary: Treatment choice (uptake), patient and provider satisfaction with the process of using shared decision making tools,  length of consultation time
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk “The randomization was blocked with use of random permuted blocks in groups of four, six, or eight to help ensure that the groups were balanced” (p. 1634).
Allocation concealment (selection bias) Low risk “Patients were randomized to either the intervention group or the control group with use of the sealed envelop method” (p. 1634).
Blinding of participants and personnel (performance bias) ‐ Study Level Unclear risk “[S]urgeons were not blinded to the intervention” (p. 1635). Knowing the allocation could be due to greater investment in decision‐making. Insufficient information to make a judgement
Blinding of outcome assessment (detection bias) ‐ Study Level Low risk Outcomes were objectivelymeasured and not subject to interpretation.
Incomplete outcome data (attrition bias) ‐ Study level Unclear risk 62% (123/198) retention rate, therefore, high attrition rate ‐ however the attrition was balanced between groups.
Selective reporting (reporting bias) Low risk Protocol available
Other bias Low risk Appeared to be free of other sources of bias

Brown 2019.

Study characteristics
Methods Pragmatic RCT
Participants 19 (coaching + decision aid) versus 22 (usual care) adults ≥ 70 years of age with advanced chronic kidney disease attending hospital‐based nephrology services considering renal replacement therapy
Interventions Intervention: OPTIONS PtDA (booklet, audio, worksheet); coaching renal nurse trained in delivering the OPTIONS intervention 1 month later, 3 months later if no decision yet
Comparator: Standard care
Outcomes Primary: Decision regret, decisional conflict
Secondary: Knowledge, quality of life, participants’ and nurses’ perceptions of the usefulness of the PtDA (preparation for decision making)
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk ...through a computer‐generated program using block randomisation
Allocation concealment (selection bias) Unclear risk Randomisation occurred once the eligibility of the participant was confirmed, consent provided and baseline data collected. Allocation of the participant to either intervention or standard care occurred through a computer‐generated program using block randomisation. Nurse not blinded
Blinding of participants and personnel (performance bias) ‐ Study Level High risk No blinding and self‐assessed outcomes
Blinding of outcome assessment (detection bias) ‐ Study Level Low risk To minimise bias, the outcome research assistant and the lead researcher were blinded to group allocation.
Incomplete outcome data (attrition bias) ‐ Study level Low risk Few dropouts. All participants included
Selective reporting (reporting bias) Low risk Primary outcomes as reported in study registration (ACTRN 12614001090606)
Other bias Low risk Appeared to be free of other sources of bias

Col 2007.

Study characteristics
Methods RCT
Participants 50 (coaching + decision aid) versus 45 (decision aid) versus 50 (usual care) perimenopausal and postmenopausal women ages 45 to 60 years considering menopausal treatment
Interventions Intervention: Coaching plus decision aid
Comparison: Decision aid only
Control: usual care (pamphlet about hormone therapy and menopause)
Outcomes Primary: decisional conflict
Secondary: patient satisfaction with the decision making process, satisfaction with the decision made,  knowledge about hormone therapy
Notes Funded by Robert Wood Johnson Foundation and Agency for Healthcare Research and Quality; research ethics board approval at all sites; no health consumers on the research team
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Central allocation: "Participants were centrally and securely randomized at the time of enrolment into 1 of 3 arms using sealed envelopes."
Allocation concealment (selection bias) Low risk Central allocation: "Participants were centrally and securely randomized at the time of enrolment into 1 of 3 arms using sealed envelopes."
Blinding of participants and personnel (performance bias) ‐ Study Level Unclear risk No mention of blinding
Blinding of outcome assessment (detection bias) ‐ Study Level Low risk No mention of blinding, however, the outcomes were objectively measured.
Incomplete outcome data (attrition bias) ‐ Study level Low risk See Figure 3 for numbers lost to follow‐up. Missing data balanced across groups
Selective reporting (reporting bias) Unclear risk No study protocol available; not enough information to permit judgement
Other bias Unclear risk Recruitment was prematurely ended at 145 participants of the planned sample size of 240 in August 2002 when the Women's Health Initiative findings were published.

Davison 1997.

Study characteristics
Methods RCT
Participants 30 (coaching + decision aid) versus 30 (usual care) men newly diagnosed with prostate cancer facing treatment decisions
Interventions Intervention: Empowerment intervention (asked to think of information they need to assist with choosing treatment, reviewed list of questions to give them an idea of types of questions they may wish to ask, showed men where to find answers in written information package, gave final list of questions to men, encouraged to read info and use list of questions, encouraged to participate in decision‐making)
Comparator: Usual care
Outcomes Patients' preferences for control over treatment decision making ‐ preferred roles and assumed roles (preparation for decision making), anxiety and depression (adverse effects)
Note: Outcomes not classified as primary or secondary
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk “The group to which subjects were assigned was predetermined by a block randomization procedure. This ensured there were an equal number of subjects in both groups for each physician.” (p. 5, Data collection)
Allocation concealment (selection bias) Unclear risk Not mentioned; group assignment predetermined by block randomisation procedure (p. 5)
Blinding of participants and personnel (performance bias) ‐ Study Level Unclear risk No blinding; study did not report on how the results could be influenced by lack of blinding.
Blinding of outcome assessment (detection bias) ‐ Study Level Unclear risk Unclear blinding and whether outcomes could be affected by unblinded assessor
Incomplete outcome data (attrition bias) ‐ Study level Low risk No flow diagram; p. 12 explains why certain men did not listen to audiotape. All men approached by study investigator agreed to participate; only 1 man refused to complete the second set of questionnaires.
Selective reporting (reporting bias) Unclear risk Protocol not mentioned
Other bias Low risk Appeared to be free of other sources of bias

Deschamps 2004.

Study characteristics
Methods RCT
Participants 67 (coaching) versus 61 (decision aid) peri‐ and postmenopausal females considering hormone replacement therapy
Interventions Intervention: Pharmacist consultation (reviewed risks and benefits of hormone replacement therapy based on prescribing guidelines of Society of Obstetricians and Gynaecologists of Canada, charts and graphs to visually show population data, agreed on plan, noted in consult letter to the patient’s attending physician)
Comparator: Decision aid
Outcomes Perception of being informed, decisional conflict, satisfaction with the intervention, patient's role in decision making (preparation for decision making), uptake of the decision,  satisfaction with decision, adherence
Note: Outcomes not classified as primary or secondary
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk No information provided
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of participants and personnel (performance bias) ‐ Study Level Unclear risk Unclear blinding
Blinding of outcome assessment (detection bias) ‐ Study Level Low risk Unclear blinding but outcomes were objectively measured
Incomplete outcome data (attrition bias) ‐ Study level Low risk P. 4 ‐ flow diagram; p. 3 reasons for attrition mentioned. Baseline characteristics included
Selective reporting (reporting bias) Unclear risk No information provided
Other bias Low risk Appeared to be free of other potential biases

Green 2001.

Study characteristics
Methods RCT
Participants 29 (coaching) versus 29 (decision aid) versus 14 (usual care) women aged 18 years and older with a first‐degree relative diagnosed with breast cancer considering genetic testing for breast cancer susceptibility
Interventions Intervention: Genetic counselling
Comparator: Decision aid (education by an interactive computer)
Control: Usual care
Outcomes Knowledge, uptake
Note: Outcomes not classified as primary or secondary
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk “[B]lock randomization schedule to one of three groups in a 2:2:1 ratio” (p. 2)
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of participants and personnel (performance bias) ‐ Study Level Unclear risk “[G]enetic counsellor blinded to randomization until just prior to the session” (p. 2); unclear if participants were blinded
Blinding of outcome assessment (detection bias) ‐ Study Level Low risk Unclear blinding but outcomes were objectively measured and not subjective for interpretation
Incomplete outcome data (attrition bias) ‐ Study level Unclear risk “Values do not always add up to the number of participants due to missing data”; reasons not mentioned (p. 4). “Participants’ baseline knowledge was reflected in the control group’s answers”; participants balanced in study groups
Selective reporting (reporting bias) Unclear risk No information provided
Other bias Low risk Appeared to be free of other sources of bias

Hacking 2013.

Study characteristics
Methods RCT
Participants 63 (coaching) versus 60 (usual care) patients who had just received a diagnosis of localised or early stage primary prostate cancer who had a decision to make regarding cancer management
Interventions Intervention: Decision navigation. Intervention group patients met with their navigator by telephone or in person prior to their specialist treatment consultation. The aim of this meeting was to assist patients in identifying and framing key questions and concerns regarding cancer management options to generate a personal consultation plan for the appointment. The navigator produced a draft consultation plan and, after incorporating patient edits, gave copies to the physician in advance.
Comparator: Usual care
Outcomes Decision self‐efficacy; decision regret; decisional conflict; anxiety; depression
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "[R]andomised by computer" (the sequence generation process was not described)
Allocation concealment (selection bias) Low risk “The allocation sequence was concealed from the researcher enrolling participants. Patient details were entered into the web tool which allocated participants to one of two parallel groups, to receive decision navigation (intervention group) or usual care (control group). Patients’ allocation was revealed after consent and before baseline measures were completed.”
Blinding of participants and personnel (performance bias) ‐ Study Level Low risk “It was not possible to blind patients or physicians to patient group allocation, given that both patient and physician were actively involved in the intervention, and although patient report measures were collected by an independent researcher, again it was not possible to conceal the patient’s group”. Low because objective measures used
Blinding of outcome assessment (detection bias) ‐ Study Level Low risk “Analysis was conducted by a researcher (JKA) blind to allocation and study procedures”. Low ‐ objective measures used
Incomplete outcome data (attrition bias) ‐ Study level Unclear risk Loss to follow‐up was 3/63 (4.8%) in the intervention group and 7/60 (11.7%) in the control group.
Selective reporting (reporting bias) Unclear risk "The RCT protocol was approved by the National Health Service Lothian and the National Health Service Lothian ethics committee (Ref:08/F1102/45)." No access to the protocol provided
Other bias Low risk Appeared to be free of other potential sources of bias

Hamann 2006.

Study characteristics
Methods RCT
Participants 54 (coaching + decision aid) versus 59 (usual care) men and women aged 18–65 years who had an International Classification of Diseases, Tenth Revision diagnosis of schizophrenia or schizophreniform disorder considering treatment options
Interventions Intervention: Shared decision making to inform patients about their treatment options and prepare them for a planning talk with their physicians
Comparator: Usual care 
Outcomes Severity of illness, doctor–patient relationship, rating patients' performance in the planning talk, physician satisfaction with treatment results, consultation time, uptake of decisions, patient's attitudes towards treatment, knowledge, patients' perceived involvement in medical decisions, satisfaction with care
Note: Outcomes not classified as primary or secondary
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk “[O]ne member of each pair being randomly assigned to the control or to the interventional condition” (p. 266). Sequence generation method was not stated
Allocation concealment (selection bias) Unclear risk No mention of allocation concealment
Blinding of participants and personnel (performance bias) ‐ Study Level Unclear risk No information provided
Blinding of outcome assessment (detection bias) ‐ Study Level Unclear risk No information provided
Incomplete outcome data (attrition bias) ‐ Study level Low risk Reasons for attrition mentioned
Selective reporting (reporting bias) Unclear risk No information provided
Other bias High risk Clustering was not accounted for in the analysis (high risk of bias).
Selective recruitment of cluster participants: the participants in the study went to where there was an empty bed but with no explicit system in place (unclear risk of bias).

Hunter 2005.

Study characteristics
Methods RCT
Participants 126 (coaching) versus 116 (decision aid) [110 group coaching participants excluded from this review] pregnant women aged ≥ 35 years with  gestational age ≤ 18 weeks considering prenatal diagnosis testing
Interventions Intervention: Individual decision coaching (information about risks and limitations, laboratory results, and conditions being tested for, patient's values and beliefs about prenatal diagnosis, the birth of an abnormal child, and pregnancy termination)
Comparator: Decision aid
Outcomes Primary: knowledge, anxiety, decisional conflict
Secondary: satisfaction with the intervention, uptake, pregnancy outcomes
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk p. 4 ‐ randomised in blocks of 30, 10 to each intervention group
Allocation concealment (selection bias) Low risk p. 4 ‐ “the allocations were provided in opaque envelopes”.
Blinding of participants and personnel (performance bias) ‐ Study Level Unclear risk Unclear blinding
Blinding of outcome assessment (detection bias) ‐ Study Level Low risk Unclear blinding but outcomes were objectively measured and not subjective to interpretation.
Incomplete outcome data (attrition bias) ‐ Study level Unclear risk Outcomes reported on fewer participants but no rationale provided for missing data
Selective reporting (reporting bias) Unclear risk No information provided
Other bias Low risk Appeared to be free of other potential biases

Kearing 2016.

Study characteristics
Methods RCT
Participants 98 (coaching + decision aid) versus 101 (decision aid) patients with lumbar spinal stenosis considering treatment options 
Interventions Intervention: coaching plus a patient decision aid (video)
Control: patient decision aid (video)
Outcomes Primary: knowledge, decisional conflict
Secondary: uptake of treatment choice, satisfaction with treatment, stage of decision making
Notes No involvement of consumers on the research team; funding from the Informed Medical Decisions Foundation and the National Institute for Arthritis, Musculoskeletal and Skin Diseases
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk "[P]articipants were randomly assigned using a computer generated permuted block randomization sequence".
Allocation concealment (selection bias) Unclear risk No further information
Blinding of participants and personnel (performance bias) ‐ Study Level Unclear risk Not reported
Blinding of outcome assessment (detection bias) ‐ Study Level Unclear risk Not reported
Incomplete outcome data (attrition bias) ‐ Study level Low risk Balanced between groups
Selective reporting (reporting bias) Unclear risk No protocol/registration identified
Other bias Unclear risk Cross‐over study and unclear when outcomes were assessed

Kennedy 2002.

Study characteristics
Methods RCT
Participants 300 (coaching + decision aid) versus 296 (decision aid) versus 298 (usual care) women referred from primary to secondary care with uncomplicated menorrhagia facing treatment options
Interventions Intervention: Structured interview group plus PtDA (video, booklet) 
Comparator: PtDA (video, booklet) 
Control: A standard practice control group with no intervention
Outcomes Primary: General health status, change in treatment preferences, uptake
Secondary: Agreement between women’s preferences and treatments uptake, anxiety (short‐term follow‐up), health system costs, severity of condition, satisfaction, quality of life
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Allocation sequence was generated by computer and stratified by consultant and the age at which the woman left full‐time education (p. 3).
Allocation concealment (selection bias) Low risk “Secure randomization ensured by using a central telephone randomization system” (p. 3)
Blinding of participants and personnel (performance bias) ‐ Study Level Unclear risk Possibility of contamination bias; clinicians could have applied the experience gained from consultations with the intervention groups in their consultations with the control group (p. 6).
Blinding of outcome assessment (detection bias) ‐ Study Level Low risk Unclear if blinding used but most outcomes were objectively measured and not subjective to interpretation
Incomplete outcome data (attrition bias) ‐ Study level Low risk Table 1 and Figure 1 flow diagram (p. 4‐5)
Selective reporting (reporting bias) Unclear risk No information provided
Other bias Low risk Appeared to be free from other sources of bias

Langston 2010.

Study characteristics
Methods RCT
Participants 114 (coaching + decision aid) versus 108 (usual care) women aged ≥ 18 years seeking a first trimester procedure for a spontaneous or induced abortion considering treatment to avoid pregnancy
Interventions Intervention: Structured contraceptive counselling and PtDA (contraceptive flipchart and samples)
Comparator: Usual care
Outcomes Primary: Uptake (proportion of participants choosing a very effective contraceptive method)
Secondary: Timing of initiation (immediate or delayed), adherence (continuation of the chosen option)
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk “Using a random‐number table, we determined the sequence for 1:1 allocation constrained by blocks of 10” (p. 363, Methods ‐ study procedures)
Allocation concealment (selection bias) Low risk “Randomization assignments were sealed inside numbered, opaque envelopes” (p. 363, Methods ‐ study procedures)
Blinding of participants and personnel (performance bias) ‐ Study Level Low risk “No blinding of participants or coordinators was feasible due to the nature of the intervention. Physician‐providers did not know the participant’s allocation group, did not discuss the study with patients, and were asked not to change their counselling” (p. 363, Methods ‐ study procedures)
Blinding of outcome assessment (detection bias) ‐ Study Level Low risk Unclear blinding but outcomes were objectively measured and not subjective to interpretation
Incomplete outcome data (attrition bias) ‐ Study level Unclear risk For “method initiation on the day of the procedure”, it was only said that the “[p]articipants in the intervention group were not more likely to initiate the requested method immediately compared to those in the usual care group”; possible that the results contradicted the hypothesis and were excluded for this reason
Selective reporting (reporting bias) Unclear risk No mention of study protocol; not enough information to permit judgement
Other bias Low risk Appeared to be free of other potential biases

Lepore 2012.

Study characteristics
Methods RCT
Participants 244 (coaching + decision aid) versus 246 (usual care) men aged 45 to 70 years old of black African descent for prostate cancer screening
Interventions Intervention: decision‐support intervention with PtDA (consisting of tailored telephone education about prostate cancer testing)
Comparator: education on fruit and vegetable consumption
Outcomes Primary: knowledge, decisional conflict, verified physician visit to discuss testing
Secondary: uptake, anxiety
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk “The principal investigator used a computer‐generated randomization schedule to randomize the participant.” (p. 322)
Allocation concealment (selection bias) Unclear risk “The principal investigator used a computer‐generated randomization schedule to randomize the participant and emailed the randomization assignment to the  interventionist.” (p. 322)
Blinding of participants and personnel (performance bias) ‐ Study Level Unclear risk Interventionists were not blind to condition. We can assume that patients were blinded as the study design was a telephone call for both intervention and control groups (p. 322).
Blinding of outcome assessment (detection bias) ‐ Study Level Low risk “Data collectors were blind to condition but the interventionists were not” (p. 322).
Incomplete outcome data (attrition bias) ‐ Study level Low risk Did not appear to be missing any outcome data
Selective reporting (reporting bias) Low risk Appeared to have reported on all prespecified outcomes (protocol)
Other bias Low risk Appeared to be free of other potential sources of bias

Lerman 1997.

Study characteristics
Methods RCT
Participants 122 (coaching + decision aid) versus 114 (decision aid) versus 164 (waiting‐list control) women at low to moderate risk who have a family history of breast and/or ovarian cancer considering BRCA1 testing
Interventions Intervention: Counselling plus education
Comparator: Education
Control: waiting‐list control
Outcomes Primary: knowledge, perceived risk
Secondary: uptake
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk No information provided
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of participants and personnel (performance bias) ‐ Study Level Unclear risk Unclear blinding
Blinding of outcome assessment (detection bias) ‐ Study Level Low risk Unclear blinding but outcomes were objectively measured and not subjective to interpretation
Incomplete outcome data (attrition bias) ‐ Study level Unclear risk Of 440 women, 400 completed 1‐month follow‐up interviews; no reasons provided; baseline data/characteristics included (p. 2)
Selective reporting (reporting bias) Unclear risk No information provided
Other bias Low risk Appeared to be free of other potential biases

Matloff 2006.

Study characteristics
Methods RCT
Participants 32 (coaching) versus 32 (usual care) women with one first‐degree relative with breast cancer considering genetic testing
Interventions Intervention: Genetic counselling and personalised risk assessment
Comparator: Usual care
Outcomes Knowledge, perceived risk, worry (about breast cancer, heart disease, and osteoporosis),  decisional conflict, uptake, satisfaction with the counseling intervention (intervention group only)
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Not described
Allocation concealment (selection bias) Unclear risk Not described
Blinding of participants and personnel (performance bias) ‐ Study Level Unclear risk No mention of blinding
Blinding of outcome assessment (detection bias) ‐ Study Level Unclear risk No mention of blinding
Incomplete outcome data (attrition bias) ‐ Study level Low risk Numbers lost to follow‐up provided in Figure 1. Missing data balanced across groups
Selective reporting (reporting bias) Unclear risk No mention of study protocol; not enough information to permit judgement
Other bias Low risk Appeared to be free of other sources of bias

McBride 2016.

Study characteristics
Methods Pilot RCT
Participants 30 (coaching + decision aid) versus 26 (usual care) patients with a diabetic foot ulcer considering treatment options
Interventions Intervention: Decision coaching (decision navigation) plus PtDA
Comparator: Usual care
Outcomes Primary outcomes: decisional self‐efficacy, adherence
Secondary outcomes: severity of the condition, health‐related quality of life, decision conflict and decision regret.
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Group allocation sequence was determined by an external researcher through the use of a computerised generated random number table (www.randomizer.org).
Allocation concealment (selection bias) Low risk To ensure allocation concealment from the research team and participants, opaque, sealed envelopes were employed which contained a note of group allocation. Envelopes were opened by a member of the research team after baseline measures had been taken.
Blinding of participants and personnel (performance bias) ‐ Study Level High risk Envelopes were opened by a member of the research team after baseline measures had been taken. Group allocation was then communicated to participants and the foot team. Because of the interactive nature of the intervention, it was not possible for group allocation to be blinded.
Blinding of outcome assessment (detection bias) ‐ Study Level Unclear risk There was no mention that outcomes assessors were blinded. Outcomes were measured using self‐report (clinician and patient perspectives).
Incomplete outcome data (attrition bias) ‐ Study level Low risk Numbers lost to follow‐up provided in Figure 1. Missing data balanced across groups. Intention‐to‐treat analysis was also conducted and reported separately, whereby baseline (last) scores were carried forward and entered in place of missing data for repeated measures.
Selective reporting (reporting bias) Unclear risk No information about study registration or protocol publication given
Other bias Low risk Appeared to be free of other sources of bias

Miller 2005a.

Study characteristics
Methods RCT
Participants 279 randomised to coaching plus PtDA versus usual care (numbers per group not reported) women over the age of 18 years and who expressed concerns about their risks for breast or ovarian cancer or requested information about risk assessment services or genetic testing during a self‐initiated call to the Cancer Information Service
Interventions Intervention: Educational intervention on risk of inherited cancer and benefits/limitations of genetic testing
Comparator: Usual care
Outcomes Uptake, knowledge, perceived risk, actual risk, satisfaction with service, coping self‐efficacy
Note: outcomes not classified as primary or secondary
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Low risk ("[R]andomized by the CATI system" (p. 4) after self‐initiated telephone contact)
Allocation concealment (selection bias) Low risk "[C]omputerized assisted telephone interview system (CATI)" (p. 4)
Blinding of participants and personnel (performance bias) ‐ Study Level Unclear risk Blinding was not addressed.
Blinding of outcome assessment (detection bias) ‐ Study Level Low risk Unclear blinding but outcomes were objectively measured and not subjective to interpretation
Incomplete outcome data (attrition bias) ‐ Study level Low risk Reasons stated for initial dropout of study participants (p. 8). Patients contacted offered reasons for dropping out. Study protocol allowed patients to be reached up to 13 times at follow‐up; but some still not able to be reached
Selective reporting (reporting bias) Unclear risk No indication that the trial was registered in a central trials registry
Other bias Low risk Appeared to be free of other sources of bias

Mishel 2009.

Study characteristics
Methods RCT
Participants 93 (coaching + written information + video) + 74 (control) men with prostate cancer staging (T1a, b, c or T2a, b), Gleason score less than 10, prostate‐specific antigen level less than 20, at least 10 days before the treatment consultation appointment. There was a second intervention group with 89 + a support person receiving the same intervention (results not reported in this review).
Interventions Intervention: booklet on prostate cancer "Treatment Choices for Early Stage Prostate Cancer: Patients' Questions ‐ Doctors' Answers" from members of the Radiation Oncology Research Unit in Canada (before it was changed to be a patient decision aid), digital video disc presenting communication strategies, 4 decision‐coaching telephone calls by trained nurse  
Control: handout on staying healthy during treatment
Outcomes Primary: uncertainty management: problem‐solving subscale, patient‐provider communication subscale, prostate cancer knowledge scale
Secondary: patients' perception of self‐communication, types of information used and its helpfulness, decisional regret, mood disturbances, quality of life
Notes No patients were partners on the research team; trial registration not reported; funded by the NIH NINR; research ethics approval obtained; no reported conflicts of interest
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "The design for the study was a 3 x 2 randomized block, repeated measures design with three levels of the intervention: (treatment direct, treatment supplemented and control) and two levels of ethnicity (Caucasian and African‐American). Patients were randomly assigned to one of the treatment groups or to the control groups." No further information provided
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of participants and personnel (performance bias) ‐ Study Level Unclear risk No information provided
Blinding of outcome assessment (detection bias) ‐ Study Level Unclear risk No information provided
Incomplete outcome data (attrition bias) ‐ Study level Unclear risk Numbers analysed or lost to follow‐up after baseline not reported.  No information provided, no flow chart
Selective reporting (reporting bias) Unclear risk No information about study registration or protocol publication given
Other bias Low risk Appeared to be free from other potential bias

Myers 2005.

Study characteristics
Methods RCT
Participants 121 (coaching + decision aid) versus 121 (decision aid) African‐American men aged 40‐69 considering prostate cancer screening
Interventions Intervention: Enhanced intervention group. Screening decision education session plus informational booklet
Comparator: Standard intervention group (informational booklet)
Outcomes Uptake of option (complete or partial screening)
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk No information provided
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of participants and personnel (performance bias) ‐ Study Level Unclear risk Unclear blinding
Blinding of outcome assessment (detection bias) ‐ Study Level Low risk Unclear blinding but outcomes were objectively measured and not subjective to interpretation
Incomplete outcome data (attrition bias) ‐ Study level Low risk P. 4 ‐ flow diagram; reasons for not receiving intervention or completing endpoint chart mentioned. Baseline characteristics included
Selective reporting (reporting bias) Unclear risk No information provided
Other bias Unclear risk Baseline characteristics similar except the enhanced intervention group consisted of more men who were educated beyond high school and who were married

Myers 2011.

Study characteristics
Methods RCT
Participants 156 (coaching plus decision aid) versus 157 (decision aid) males 50–69 years of age, had no history of prostate cancer or benign prostatic hyperplasia, and did not have a prostate‐specific antigen test in the previous 11 months considering prostate cancer screening
Interventions Intervention: Enhanced intervention. Nurse‐led decision counselling session plus brochure on prostate cancer screening
Comparator: Brochure on prostate cancer screening
Outcomes Primary: knowledge, decisional conflict
Secondary: completeness of informed decision‐making, uptake
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk No mention of how sequence was generated
Allocation concealment (selection bias) Low risk P. 241 (section 2.1): “Using a system of sealed envelopes”
Blinding of participants and personnel (performance bias) ‐ Study Level Unclear risk No mention of blinding of either personnel or participants; all patient charts had a generic note placed in them by the nurse educator to prompt the physician to discuss prostate cancer screening.
Blinding of outcome assessment (detection bias) ‐ Study Level Low risk Unclear blinding but outcomes assessed were not subjective to interpretation
Incomplete outcome data (attrition bias) ‐ Study level Unclear risk P. 243 (section 3.3): did not account for why 24 audio‐recordings were excluded
Selective reporting (reporting bias) Unclear risk No mention of study protocol; not enough information to permit judgement
Other bias Low risk Appeared to be free of other potential biases

Rahn 2018.

Study characteristics
Methods Pilot RCT
Participants 38 (coaching + evidence‐based information) versus 35 (usual care) participants with multiple sclerosis aged 18 years or older with suspected or relapsing‐remitting multiple sclerosis facing immunotreatment decisions on first‐line drugs
Interventions Intervention: Coaching plus evidence‐based information (up to three structured nurse‐led decision coaching sessions, access to an evidence‐based online information platform DEcision Coaching In people with Multiple
Sclerosis (DECIMS‐Wiki))
Comparator: Usual care (access to the DECIMS‐Wiki, but received otherwise care‐as‐usual)
Outcomes Primary: informed choice
Secondary: decisional conflict, perceived involvement in shared decision making, values matched choice, coping self‐efficacy, trust in physicians and decision coaches, anxiety, depression, quality of life
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk No comments
Allocation concealment (selection bias) Unclear risk We agreed it was hard to know how this was maintained: unclear
Blinding of participants and personnel (performance bias) ‐ Study Level Low risk Reviewers discussed comments and agreed on low risk of bias.
Blinding of outcome assessment (detection bias) ‐ Study Level Unclear risk No comments
Incomplete outcome data (attrition bias) ‐ Study level Unclear risk While the authors were transparent about missing data, we agreed that there was concern about how this significant attrition impacted the results in terms of bias. Given the transparency, however, we agreed on unclear risk of bias.
Selective reporting (reporting bias) Low risk No comments
Other bias Low risk Appeared to be free of other sources of bias

Shepherd 2019.

Study characteristics
Methods RCT
Participants 68 (coaching) versus 69 (usual care) patients diagnosed with Stage II, III, and IV colorectal cancer considering oncology treatment (chemotherapy) following surgery
Interventions Intervention: Consultation planning, recording and summarising
Comparator: Usual care
Outcomes Primary: Decision self‐efficacy, decisional conflict, decision regret, preparation for decision making
Secondary: anxiety, depression
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Author SS used an online automated randomisation service to determine group allocation.
Allocation concealment (selection bias) Low risk Author SS used an online automated randomisation service to determine group allocation. Upon notification of group allocation, the intervention participants took part in a telephone “consultation planning” appointment before their clinic appointment. Usual care participants were informed, and subsequent contact was limited to answering questions about and delivery of questionnaires. Two 'navigators' delivered the intervention; they were research psychologists not involved in data collection or randomisation.
Blinding of participants and personnel (performance bias) ‐ Study Level Unclear risk Upon notification of group allocation, the intervention participants took part in a telephone “consultation planning” appointment before their clinic appointment. Usual care participants were informed, and subsequent contact was limited to answering questions about and delivery of questionnaires. One author conducted recruitment and (possibly) notified the participants (not clear that the author was part of the team directly involved in delivering the intervention). Participants would probably be unaware of assignment. Other team members delivered the intervention and would be aware of who was receiving the intervention.
Blinding of outcome assessment (detection bias) ‐ Study Level Unclear risk Not reported. Only those receiving the intervention were asked to complete the DSE. Unclear if or how blinding was managed
Incomplete outcome data (attrition bias) ‐ Study level High risk Reason for missing outcome data likely to be related to true outcome with imbalance in numbers across intervention groups for outcomes measured post‐first consultation (12% decision coaching versus 28% usual care), and an overall high rate of attrition over time (44.5%) 
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judgement
Other bias Low risk Appeared to be free of other sources of bias

Sheridan 2012.

Study characteristics
Methods RCT
Participants 60 (coaching + video + information) versus 70 (control) men aged 40–80 years old with no prior history of prostate cancer considering prostate cancer screening
Interventions Intervention: Coaching plus video based decision aid plus additional information on two more clearly beneficial men’s health screening services (cardiovascular disease screening and colon cancer screening)
Comparator: Video on seat belt safety
Outcomes Primary: perception that prostate cancer screening requires a decision, knowledge, patient role in decision making, participated at preferred role
Secondary: uptake
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Randomisation used computer‐generated random numbers that were sealed in opaque envelopes.
Allocation concealment (selection bias) Low risk Randomisation used computer‐generated random numbers that were sealed in opaque envelopes.
Blinding of participants and personnel (performance bias) ‐ Study Level Low risk "Men then proceeded to their visit with their physician (who was notified only about patients’ participation, but not group assignment)." Although described as single‐masked in the study registration, due to the attention control intervention in the control groups, both participants and staff could be considered blinded.
Blinding of outcome assessment (detection bias) ‐ Study Level Low risk Self‐reported outcome measures, therefore, low risk considering masking of participants.
Incomplete outcome data (attrition bias) ‐ Study level Low risk See Figure 1 for reporting on missing data (only 2 participants in intervention group due to false inclusion)
Selective reporting (reporting bias) Low risk Applied outcome measures as described in the study registration (clinicaltrials.gov/ct2/show/NCT00630188?term=00630188&draw=2&rank=1)
Other bias Unclear risk The small size of our study resulted in differential distribution of confounders among study groups.

Van Peperstraten 2010.

Study characteristics
Methods RCT
Participants 152 (coaching + decision aid) versus 156 (usual care) couples on the waiting list (women < 40 years old) for a first in vitro fertilisation cycle ever or a first cycle after previous successful in vitro fertilisation deciding how many embryos should be transferred
Interventions Intervention: multifaceted empowerment strategy
Comparator: standard in vitro fertilisation care
Outcomes Primary: uptake
Secondary: empowerment, decision evaluation (satisfaction/uncertainty, informed choice, and decision control), knowledge, anxiety, depression, costs of implementing the intervention
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Computer‐generated list (p. 2, Methods section)
Allocation concealment (selection bias) Low risk Central allocation (p. 2, Methods section)
Blinding of participants and personnel (performance bias) ‐ Study Level Low risk “Because of the nature of the intervention it was not possible to blind the participants or in vitro fertilisation doctors to the allocation. Participation in our trial did not change the normal in vitro routine.” (p. 2, Methods section)
Blinding of outcome assessment (detection bias) ‐ Study Level Low risk Unclear blinding but outcomes assessed were not subjective to interpretation
Incomplete outcome data (attrition bias) ‐ Study level Unclear risk There were categories in each column of table 1 (p. 3) where the denominators did not match the number of people in the group and no reason was given to explain why this would be or if this affected the study.
Selective reporting (reporting bias) Low risk Outcomes same as those registered with ClinicalTrials.gov
Other bias Low risk The study appeared to be free of other sources of bias

Vodermaier 2009.

Study characteristics
Methods RCT
Participants 74 (coaching + decision aid) versus 78 (usual care) patients aged 18 and 75 years with a histologically proven breast cancer or strong suspicion through diagnostic procedures considering treatment decisions
Interventions Intervention: Decision board coaching (an informational and decisional intervention and a brochure in addition to standard care)
Comparator: Standard care
Outcomes Primary: decisional conflict
Secondary: uptake, length of consultation, time point of decision making, patient perception of role in treatment decision making, perceived involvement in care, satisfaction
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk “Randomisation after the patient gave written informed consent”; “Random assignment was performed by means of numbered cards in envelopes”; “stratified by age group” (p. 2)
Allocation concealment (selection bias) Low risk “[N]umbered cards in envelopes” (p. 2)
Blinding of participants and personnel (performance bias) ‐ Study Level Unclear risk Not blinded ‐ unclear if this would introduce bias to outcome assessed
Blinding of outcome assessment (detection bias) ‐ Study Level Low risk Not blinded but outcomes were objectively measured and not subjective to interpretation
Incomplete outcome data (attrition bias) ‐ Study level Unclear risk Flow diagram, p. 5; baseline characteristics not included
Selective reporting (reporting bias) Unclear risk No information provided
Other bias Low risk Appeared to be free of other potential biases

BRCA1: Breast cancer type 1 susceptibility proteinCOMRADE: Combined Outcome Measure for Risk Communication and Treatment Decision‐making EffectivenessDECIMS: DEcision Coaching In people with MultipleSclerosisDSE: Decision Self‐EfficacyMAPPIN'SDM: Multifocal APProach to the sharing‘ IN Shared Decision‐MakingPtDA: Patient decision aid
 

Characteristics of excluded studies [ordered by study ID]

Study Reason for exclusion
Aboumatar 2013 Not decision coaching
Adanikin 2013 Physician counselling
Adarkwah 2017 Conference abstract
Adekpedjou 2020 Not decision coaching
Akman 2010 Directive counselling
Aktan‐Collan 2000 Wrong study design
Alegria 2018 Not decision coaching
Allen 2018 Wrong intervention
AlSagheir 2020 Not decision coaching
Andaroon 2020 Not decision coaching
Arimori 2006 Decision coaching in both groups
Athens 2017 Wrong study design
Augstein 2007 Not decision coaching
Bailey 2021 Not decision coaching
Barnieh 2011 Not decision coaching
Barry 1997 Not decision coaching
Basu 2015 Conference abstract
Becker 2009 Not decision coaching
Belkora 2012 Decision coaching in both groups
Belkora 2015 Not an RCT
Benoit 2020 Conference abstract
Bergeron 2019 Not decision coaching
Berry 2013 Not decision coaching
Berry 2018 Not decision coaching
Biesecker 2018 Not decision coaching
Bjorklund 2012 Not decision coaching
Boulware 2018 Not decision coaching
Bowen 2002 Decision coaching in both groups
Bowen 2017 Not decision coaching
Briggs 2004 Advanced care planning
Brown 1999 No specific decision ‐ just prep for consult
Buhse 2015 Lifestyle choice
Buhse 2017 Conference abstract
Buhse 2018 Decision coaching delivered as a group 
Calzone 2005 Decision coaching in both groups
Carlson 2021 Not decision coaching
Causarano 2015 Decision coaching in both groups
Cervantes 2007 Wrong study design
Cha 2018 Conference abstract
Chambers 2015 Counselling couples not decision prep
Chan 2011 Not decision coaching
Chan 2018 Advanced care planning
Chaney 2011 Conference abstract
Charles 2006 Decision coaching in both groups
Chhatriwalla 2019 Wrong study design
Choi 2014 Review article
Clark 2003 Physician counselling
Clarke‐Pounder 2015 Not decision coaching
Cohan 2009 Not decision coaching
Cohen 2004 Physician counselling
Cooper 2014 Advanced care planning
Cooper 2018 Not decision coaching
Costanza 2011 Wrong study design
Coulter 2007 Wrong study design
Cuypers 2018 Not decision coaching
Cuypers 2019 Not decision coaching
Damir 2011 Conference abstract
Davison 1997a Not decision coaching
Davison 2003 Not an RCT
Davison 2007 Decision coaching in both groups
Deen 2012 Not decision coaching
Dehlendorf 2019 Not decision coaching ‐ rather SDM with provider
Deinzer 2006 Wrong study design
Deinzer 2009 Physician counselling
Di 2017 Not decision coaching
Dobke 2008 Not decision coaching
Dobscha 2006 Not decision coaching
Duncan 2010 Wrong study design
Duru 2017 Conference abstract
Dwamena 2012 Wrong patient population
Edbrooke‐Childs 2019 Not decision coaching
Edwards 2004 Physician counselling
El‐Jawahri 2015 Not decision coaching
Epstein 2018 Not decision coaching
Fan 2018 Genetic counselling not described
Farmer 2012 Not decision coaching
Ferguson 2017 Wrong study design
Finucane 1988 Not decision coaching
Fischer 2006 Not an RCT
Fischl 2010 Not decision coaching
Fitzpatrick 2016 Not decision coaching
Fooladi 2018 Advanced care planning
Foy 2019 Letter to the editor
Frijling 2003 Not decision coaching
Frosch 2001 Not decision coaching
Fujimoto 2017 Not decision coaching
Gagne 2017 Decision coaching in both groups
Gammon 2018 Not decision coaching
Garbers 2012 Not decision coaching
Ghasemi 2018 Not decision coaching
Giordano 2012 Physician counselling
Green 1997 Not an RCT. The authors described their experience with developing an interactive CD‐ROM on gene testing and breast cancer, and responded to anticipated criticisms of this technology.
Green 2004 Decision coaching in both groups
Green 2005 Decision coaching in both groups
Green 2015 Not decision coaching; advanced care planning
Green 2018 Not decision coaching; advanced care planning
Green 2020 Not decision coaching; advanced care planning
Greenfield 1985 Not decision coaching
Greenfield 1988 Not for a specific decision – it was in preparation for any decision
Guillen 2019 Decision coaching in both groups
Hamann 2011 Not decision coaching
Hamann 2013 Not decision coaching
Hamann 2020 Patients were provided with group training in SDM
Harmsen 2013 Not decision coaching
Harter 2016 Not decision coaching
Heisler 2014 Decision coaching in both groups
Helden 2012 Conference abstract
Helmes 2006 Not decision coaching
Henteleff 2006 Not decision coaching
Hess 2011a Conference abstract
Hess 2011b Conference abstract
Hippman 2016 Not decision coaching
Holt 2009 Decision coaching in both groups
Hooker 2011 Wrong intervention
Hoseini Haji 2020 Directive counselling
Hsu 2003 Lifestyle choice
Hu 2021 Not decision coaching
Hulin 2017 Decision coaching in both groups
Jacobsen 2012 Participation in a trial decision
Jalil 2020 Not decision coaching
Jayadevappa 2019 Not decision coaching
Kaplan 1989 Not for a specific decision – it was in preparation for any decision
Katz 2005 Not an RCT
Keyserling 2014 Lifestyle choice
Kim 2005 Not decision coaching; not an RCT
Kim 2007 Not an RCT
Kinney 2014 Not decision coaching
Kinney 2016 Not decision coaching
Kirk 2016 Conference abstract
Knerr 2017 Not decision coaching
Kosaka 2017 Not decision coaching
Labrias 2020 Conference abstract
Larsson 2017 Not decision coaching
Lauffenburger 2019 Not decision coaching
Lazcano 2000 Not decision coaching
Le 2015 Not decision coaching
LeBlanc 2015 Not decision coaching
Legare 2003 Not decision coaching
Levi 2017 Not decision coaching; Advanced care planning; not an RCT
Lewis 2018 The aim was to educate people about their results. Counselling (not described, delivered by providers ‐ also not clear on whether they were trained) did not aim to prepare people to make a decision with a health care provider. 
Liao 2016 Conference abstract
Liberatore 2003 Not an RCT
Lurie 2011 Compared 2 decision aids, no counselling
Manchanda 2016 Decision coaching in  both groups
Manne 2010 Not decision coaching
Martin 1999 Thesis
Maslin 1998a Not decision coaching
Maslin 1998b Not decision coaching
Massey 2016 Not decision coaching
McIlvennan 2018 Not decision coaching
Metz 2019 Not decision coaching
Miller 2005b Decision coaching in both groups
Minneci 2019 Not decision coaching
Mino 2020 Conference abstract
Mohamed 2018 Conference abstract
Moudi 2020 Not an RCT; quasi‐experimental study design
Murray 2004 Hypothetical decision
Myers 2012 Conference abstract
Myers 2019 It was about increasing colorectal screening behaviours and main outcome was adherence. It was not about a coach providing non‐directive support for a specific decision.
NCT00262899 Decision coaching in both groups
Nichol 1992 Not an RCT
Nosratabadi 2018 Decision coaching in both groups
O'Cathain 2002 Participation in a trial decision
Oduncu 2002 Not an RCT
Omer 2007 Lifestyle choice
Parapiboon 2020 NOT non‐directive
Park 2005 Not decision coaching
Paz 2020 Not decision coaching
Pearson 2020 Directive counselling
Pendley 2018 Conference abstract
Penson 2011 Commentary
Peralta 2019 Conference abstract
Peralta 2020 Not decision coaching
Perestelo‐Perez 2017 Not decision coaching
Pieterse 2005 Not an RCT
Rahn 2014 Conference abstract
Rahn 2016 Conference abstract
Rahn 2019 Conference abstract
Raphaelis 2018 Not decision coaching
Redfern 2009 Lifestyle choice
Reinhardt 2014 Hypothetical decision
Rimer 2001 Not decision coaching
Rimer 2002 Directive counselling
Rothert 1997 Decision coaching delivered as a group 
Roussi 2010 Both groups received genetic counselling
Schroy 2012 Not decision coaching
Schubart 2019 Advanced care planning
Schwartz 2014 Decision coaching in both groups
Schwartz 2018 Not decision coaching
Sepucha 2002 Not focussed on a specific decision
Sepuchra 2000 Physician counselling
Shelin 2019 Decision coaching in both groups
Sheridan 2011 Automated support
Sheridan 2014 Automated support
Simoni 2015 Lifestyle choice
Simons 2017 Conference abstract
Skinner 2002 Not decision coaching: tailored print materials versus non‐tailored print materials
Street 2010 Not decision coaching
SUPPORT 1996 Decision coaching in both groups
Sweet 2014 No description of the genetic counselling intervention, training of health care provider; seemed to be an education‐based intervention that provided directive information on conditions that people were identified as being at risk of
Swoboda 2016 Lifestyle choice
Swoboda 2017 Thesis
Talen 2011 Not decision coaching
Tea 2018 Decision coaching in both groups
Thomas 2013 Not decision coaching
Thomson 2007 Physician counselling
Tingey 2015 Not decision coaching
Toohill 2014 Not decision coaching
Van Peperstraten 2011 Conference abstract
Van Roosmalen 2004 Not decision coaching
Van Tol‐Geerdink 2013 Wrong intervention
Veroff 2013 Decision coaching in both groups
Vitinius 2019 Conference abstract
Vitinius 2020 Conference abstract
Voepel‐Lewis 2020 Not decision coaching
Volk 1999 Educational videotape versus no intervention
Wakefield 2008 Decision coaching in both groups
Walczak 2017 Advanced care planning
Wang 2005 Not decision coaching
Waterman 2015 Not decision coaching
Waterman 2017 Conference abstract
Waterman 2018a Conference abstract
Waterman 2018b Not decision coaching
Waterman 2019 Conference abstract
Wensaas 2014 Conference abstract
Wenzel 2019 Conference abstract
Westermann 2013 Directive counselling
Wevers 2013 Conference abstract
Wevers 2014 Not decision coaching
Wevers 2017 Not decision coaching
Wilkie 2020 Not decision coaching
Wolf 1996 Not decision coaching
Wolf 2000 Not decision coaching
Yee 2014 Decision coaching in both groups

CD‐ROM: Compact disc read‐only memoryRCT: Randomized control trialSDM: Shared decision making

Characteristics of studies awaiting classification [ordered by study ID]

Hadizadeh‐Talasaz 2021.

Methods RCT
Participants Pregnant women with a previous caesarean section
Interventions Intervention: 90‐min counselling session
based on the three talk model of shared decision making
Control: Usual care
Outcomes Decisional conflict, decision regret
Notes  

Perfors 2021.

Methods RCT
Participants Newly diagnosed patients with curable cancer (breast, lung, colorectal, gynaecologic and melanoma)
Interventions Intervention: Gastric Residual Volume in Feeding Advancement in Preterm Infants intervention group were offered structured follow‐up guidance from primary care consisting of two components: (1) a Time Out consultation with the physician and (2) structured follow‐up during cancer treatment by a primary care oncology nurse and the physician
Control: Usual care
Outcomes Primary: Perceived level of shared decision making
Secondary: Received information, perceived self‐efficacy
Notes  

Wagner 2021.

Methods Hybrid Cluster RCT
Participants Six HIV clinics
Clients were eligible if they met the following criteria: (1) in a serodiscordant relationship (partner’s HIV‐negative status confirmed by rapid HIV test prior to enrolment), (2) of reproductive age (men age 15‐60 years; women age 15‐45), (3) considering childbearing with their partner (determined via triage screening item), (4) not currently pregnant (determined by a pregnancy test prior to enrolment), and (5) reports having disclosed HIV status to partner.
Interventions Intervention groups: "Our Choice" using either a high intensity Safer conception counselling or low intensity Safer conception counselling approach (differentiated by amount of training and supervision)
Control: Usual care
Outcomes Primary: Use of appropriate reproductive method to achieve stated reproductive goal (among whole sample), Accurate use of safer conception methods (among those trying to conceive), use of modern contraceptives (among those not trying to conceive)
Secondary: Any use of safer conception methods (among those trying to conceive), use of any method to prevent pregnancy (among those not trying to conceive), pregnancy status, partner seroconversion
Notes See also: Additional file 2: Supplemental Table 1. Our Choice safer conception counselling topics by session for a more detailed description of the coaching intervention.

Wang 2021.

Methods RCT
Participants Males aged 40‐80 with a prostate specific antigen index higher than 4.0 ng/mL
Interventions Intervention: biopsy decision‐support intervention based on the Ottawa Decision Support Framework tailored to individual patient’s needs using counselling, decision aid, and coaching
Control: written health education flyer
Outcomes Knowledge, decision self‐efficacy, decisional conflict,  prostate biopsy decision
Notes  

HIV=human immunodeficiency virus
 

Characteristics of ongoing studies [ordered by study ID]

Chambers 2008.

Study name ProsCan for Men: Randomised controlled trial of a decision‐support intervention for men with localised prostate cancer
Methods RCT
Participants 700 men newly diagnosed with prostate cancer
Interventions A tele‐based nurse delivered 5‐session decision‐support/psychosocial intervention vs usual care
Outcomes Cancer threat appraisal; decision‐related distress and bother from treatment side effects; involvement in decision making; satisfaction with healthcare; heathcare utilisation; use of healthcare resources; and a return to previous activities
Starting date Not yet assessed
Contact information Suzanne K Chambers, Griffith University
Notes Trial #: ACTRN012607000233426

DRKS00015527.

Study name Evaluation of a decision‐coaching programme for structured decision support in preference sensitive decisions of risk‐adapted prevention for BRCA1/2 gene mutation carriers (EDCP‐BRCA)
Methods RCT
Participants 400 women newly diagnosed with a BRCA 1/2 gene mutation
Interventions Decision coaching versus standard care
Outcomes Congruence between the preferred and actual role in the decision‐making process; satisfaction with the actual role, decisional conflict, knowledge and attitude towards prevention strategies, stage of decision making, symptoms of anxiety and depression, coping self‐efficacy, subjective impact of the test result and self‐concept of BRCA1/2 carriers
Starting date 2019/11/01
Contact information Ms.  Anna  Isselhard , Institut für Gesundheitsökonomie und klinische Epidemiologie, Universitätsklinikum Köln, Germany
Notes Trial #: DRKS00015527

IRCT2017100231117N5.

Study name Comparison of effect of crisis counselling on anxiety, decision‐making style and strategies in women with unplanned pregnancy in intervention (receive crisis counselling) with control (do not receive crisis counselling) groups
Methods RCT
Participants 70 women aged 15‐49 with unplanned pregnancy
Interventions Crisis counselling versus control
Outcomes Anxiety; decision‐making style and strategies about unplanned pregnancy
Starting date 2017‐11‐01
Contact information Soghra Khani, Mazandaran University of Medical Sciences, Iran
Notes Trial #: IRCT2017100231117N5

IRCT20200105046014N1.

Study name The effect of individual counseling on the intention to choose
Methods RCT
Participants Aged 18‐35 years old Single pregnancy
Interventions The 'intervention group' received three Individual of Fogg model counselling sessions for 45‐60 minutes and once every two weeks, based on a structure developed by the researcher and approved by a professor of psychology. Intervention 2: Control group: The 'control group' received routine counselling about vaginal birth after caesarean by midwives at health centres.
Outcomes Primary: Decision conflict, decision self‐efficacy, fear of delivery, Fogg Model Structures, self‐efficacy of delivery, the intent to choose vaginal birth after caesarean
Starting date  
Contact information  
Notes Trial #: IRCT20200105046014N1
Unable to access trial record at this time

Karra 2021.

Study name User‐centered counseling and male involvement in contraceptive
decision making
Methods RCT
Participants Married women aged 18‐35
Interventions 1. A control group (T0), in which a woman received a private counselling session on the full range of 13 contraceptive methods following a standard counselling process.
2. An intervention group (T1), in which a woman was encouraged (but not compelled) to invite her husband to a joint counselling session. A woman (and her husband if she chose to invite him) then received a private counselling session on a full range of 13 contraceptive methods.
3. An intervention group (T2), in which a woman received a private counselling session on 5 targeted contraceptive methods based on her baseline preferences for family planning.
4. An intervention group (T3), in which a woman was encouraged to invite her husband to a joint counselling session. A woman (and her husband if she chose to invite him) was then counselled on 5 targeted contraceptive methods based on her baseline preferences for family planning.
Outcomes Primary: Attitude or knowledge of family planning, contraceptive use, contraceptive preferences, pregnancy and fertility outcomes, use of local health facilities, husband’s preferences, women’s autonomy, empowerment, and decision making
Starting date 2019‐06‐14
Contact information Bagrey Ngwira
Notes Trial #: AEARCTR‐0004194

Makarov 2021.

Study name Trial of community health worker‐led decision coaching
Methods RCT
Participants Black men attending a routine primary care appointment
Interventions Intervention group: a decision aid along with decision coaching on prostate specific antigen screening from a community health worker
Control Group: a decision aid along with community health worker interaction on dietary and lifestyle modification to serve as an attention control
Outcomes Decision self‐efficacy
Prostate Specific Antigen screening rates
Starting date October 15, 2019
Contact information Shannon Ciprut: shannon.ciprut@nyumc.org
Natalia Martinez‐Lopez: Natalia.Martinez-lopez@nyulangone.org
Notes Trial #: NCT03726320

NCT00685256.

Study name Standard genetic counseling with or without a decision guide in improving communication between mothers undergoing BRCA1/2 testing and their minor‐age children
Methods RCT
Participants 245 mothers at least 21 years old who self‐identified as primary caregivers to minor‐age children (ages 8‐21 years old) undergoing BRCA1/2 testing
Interventions Genetic counselling with communication aid versus standard genetic counselling
Outcomes Decision conflict;  parents' decision satisfaction with their communication decision;  decision quality; disclosure of genetic testing results by parents; child‐rearing alliance between parents; parent‐child communication; family functioning; children's stress and worry; parents' knowledge and awareness of the advantages and disadvantages of disclosing maternal BRCA1/2 test results to their children; parents' preferences and values regarding family communication of genetic test results; decision self‐efficacy; cognitive appraisals 
Starting date March 2008
Contact information Kenneth Tercyak, Lombardi Comprehensive Cancer Center
Notes Trial #: NCT00685256

NCT01263678.

Study name Helping patients with spinal stenosis make a treatment decision: a randomized study assessing the benefits of health coaching (SST HCoach RCT)
Methods RCT
Participants 199 patients over 18 years old with lumbar spinal stenosis
Interventions Decision coaching versus usual care
Outcomes Decisional conflict;  self‐efficacy; the number of treatment decision‐related clinical contacts; treatment follow‐through; decision regret
Starting date November 2010
Contact information Jon D Lurie, M.D., Dartmouth‐Hitchcock Medical Center
Notes Trial #: NCT01263678

NCT03956004.

Study name The impact of a technology‐enabled decision aid, for patients with hip and knee osteoarthritis on decision quality, level of shared decision‐making, patient satisfaction and magnitude of limitations
Methods RCT
Participants 145 patients with a presumptive diagnosis of knee osteoarthritis aged between 45 and 89
Interventions Full decision aid, consisting of education on osteoarthritis and treatment options, preferences and values elicitation, and personalised risk/benefit estimates based on patient's response to patient‐reported outcome measures versus decision aid only
Outcomes Knee Osteoarthritis Decision Quality instrument: decision process (SDM) and concordance (received treatment that matched their stated preference); level of shared decision making; patient satisfaction with management of condition; measure of patient‐reported, knee‐related stiffness, pain, and function; decision to undergo total knee replacement surgery (yes/no); average time of patient visit and average time spent with provider
Starting date March 28, 2019
Contact information Kevin Bozic, Dell Medical School at The University of Texas at Austin
Notes Trial #: NCT03956004

NCT04659005.

Study name Nurse‐led decision counseling on hepatocellular carcinoma screening
Methods RCT
Participants Patients with hepatitis B virus infection (hepatitis B surface antigen positive), aged 18‐65 years old
Interventions Intervention: Nurse‐led decision counselling
Control: Usual care
Outcomes Primary: Hepatocellular carcinoma  screening uptake rates
Secondary: Knowledge, decisional conflict, preventive health model construct instrument
Starting date January 1, 2021
Contact information Caixia LI: caixiali@link.cuhk.edu.hk
Carmen Chan: whchan@cuhk.edu.hk
Notes Trial #: NCT04659005

Nelson 2020.

Study name A web‐based intervention to reduce decision conflict regarding HIV pre‐exposure prophylaxis
Methods RCT
Participants Men and women aged 18 and older, who are racially
categorised as black, and assessed by the referring health care provider as being a good candidate for starting HIV pre‐exposure prophylaxis
Interventions Decision‐support intervention versus information only
Outcomes Decisional conflict
Starting date April 9, 2019
Contact information LaRon E Nelson, PhD, RN: laron.nelson@yale.edu
Notes Trial #: NCT03637244

Ockhuysen‐Vermey 2008.

Study name Communicating breast cancer risks: a genetic counsellor's role in improving patient understanding to increase informed decision‐making
Methods RCT
Participants 300 women with a family history of breast cancer
Interventions The intervention: additional risk information is given to healthy women with a family history of breast cancer immediately after standard counselling with the clinical geneticist. 
Outcomes Adequate risk perception; cognitive evaluation (knowledge about hereditary breast cancer, informed decisions); psychological and affective evaluation ([cancer] anxiety, worry); evaluation of perceived benefits and helpfulness of the additional risk counselling; expected intention or actual uptake of methods of breast cancer detection and prevention
Starting date 15/07/2004
Contact information Dr D R M Timmermans, VU Medisch Centrum, Afd Sociale Geneeskunde, Amsterdam, Netherlands
Notes Trial #: ISRCTN14566836

Scalia 2019.

Study name Implementation of uerine fibroid Option Grid patient decision aids across five organisational settings (UPFRONT)
Methods Stepped wedge RCT
Participants Females showing new or recurrent symptoms of uterine fibroids
Interventions Uterine Fibroid Option Grid encounter patient decision aid (text only)
Uterine Fibroid Option Grid encounter patient decision aid (text + pictures)
Uterine Fibroid Option Grid encounter patient decision aid (online)
Outcomes Primary: The number of eligible patients that can be identified who receive the uterine fibroid Option Grid patient decision aid
Secondary: Measuring Organizational Readiness for patient Engagement, Attitudes toward Decision Aids fOr PatienTs, quality of shared decision‐making, fidelity assessment, NoMAD Normalization Process Theory survey, utility of Option Grid patient decision aids and clinician approach to implementation, measuring shared decision making, Uterine Fibroid Symptom and health‐related Quality Of Life Questionnaire symptom severity subscale, the COmprehensive Score for financial Toxicity, Chew health literacy measure, resource utilisation (ambulatory and hospital), treatment choice
Starting date August 1, 2019
Contact information Glyn Elwyn, MD,PhD: glynelwyn@gmail.com         
Marie‐Anne Durand, PhD: Marie‐Anne.Durand@dartmouth.edu
Notes Trial #: NCT03985449

Shirzad 2020.

Study name Comparing the effect of "Motivational Interviewing" with "Information, Motivation and Behavioural skills" on choosing mode of delivery in pregnant women
Methods RCT
Participants Pregnant women in gestational age 24 to 32 weeks
Interventions 1:  face‐to‐face motivational interviewing 
2: face‐to‐face Information, Motivation and Behavioural skills
3: Information, Motivation and Behavioural skills using mobile app
Outcomes Behavioural intention, self‐efficacy, mode of delivery, usability of the mobile app
Starting date 2018‐11‐22
Contact information Elham Shakibazadeh: shakib@zums.ac.ir
Notes Trial #: IRCT20151208025431N7

TCTR20191226001.

Study name The effect of empowerment education on decisional conflict and attitude towards fertility and childbearing of women with a history of failed pregnancy
Methods RCT
Participants Women with a history of failed pregnancy
Interventions Empowerment education versus control
Outcomes Decision conflict; attitude towards fertility and childbearing
Starting date 30 January 2020
Contact information Masoumeh Kheirkhah, Iran University of Medical Sciences, Shahid Hemmat Highway, Tehran
Notes Trial #: TCTR20191226001

TCTR20200320002.

Study name Decisions of adolescent mothers toward using etonogestrel implant: comparison between the people that knowledge from Print Media in individual counseling and counseling from video‐based group counseling
Methods  
Participants Adolescent mothers
Interventions Intervention: group counselling by education video, individual counselling by brochure 
Outcomes Primary outcome: Decision use of  etonorgestrel implant [time frame after counselling before discharge use of  implanon] 
Secondary outcome: Continuous use of implant contraceptive [time frame 1 year follow‐up] 
Starting date  
Contact information  
Notes Trial #: TCTR20200320002
Unable to access trial record at this time

BRCA1: Breast cancer type 1 susceptibility proteinHIV: human immunodeficiency virusRCT: randomized control trialSDM: shared decision making
 

Differences between protocol and review

1. New team authors (MC, JF, AD, JZ) and three who withdrew (AC, BH, WO)

2. The term “evidence‐based information (such as a decision aid)” replaced “another intervention type, such as a patient decision aid”.

3. Updated the search strategy in May 2020 according to Anne Parkhill, Information Specialist, and this search strategy was repeated in June 2021.

4. Updates to the selection criteria: Additional detail to the description of the decision coach from “trained” to “trained or using a protocol in decision coaching”. We also excluded articles that described healthcare providers who were not prepared for decision coaching with training or a protocol, or not described as having direct interests in providing decision coaching. We also excluded studies providing decision coaching to groups because of the potential influence of others in the group on decision making.  

We defined included comparisons (e.g. usual care or other) with the qualifier “only” to be explicit about pairing decision coaching with another intervention, and we are clear that “evidence‐based information” includes patient decision aids.

5. Defined “Types of outcome measures”: We took the following steps before including outcomes in the Results and Summary of findings tables: If the outcomes of interest were reported with only one measure (Decisional Conflict subscales) by the article, then no further action was needed. If reported with more than one measure (e.g. knowledge) we had planned that the outcome measures for each article would be listed and two review authors would independently make decisions about what is most relevant to patients; any differences were resolved by the involvement of a third author. For outcomes with more than one measure (e.g. knowledge) that could not be included in meta‐analysis, we reported results descriptively.

6. For the search strategy, we made the following changes:

  • excluded databases of dissertations and conference proceedings, as these were unlikely to report on a full study that had met the peer‐reviewed requirements of our study;

  • excluded studies evaluating decision coaching delivered to a group because it is difficult to determine the unique effect of decision coaching versus the group effect;

  • excluded studies evaluating advanced care planning because values and characteristics of decisions can change as patients get closer to making the actual decision;

  • excluded genetic counselling studies when the genetic counselling intervention was not described and/or was not the primary intervention being evaluated.

7. Updated 'Primary outcomes': Given that the main aim of decision coaching is to prepare patients to participate in decision making under ‘Preparation for active participation in making a health decision’ we included other indicators of preparation for active participation in making a health decision: decisional self‐confidence and patient involvement in decision making (patient, observer‐reported) including perceived involvement, preferred level of involvement, participated at preferred level of involvement. ‘Quality of decision coaching’ was removed as primary outcome, as it is not an outcome of decision coaching: decision coaching supports patients to participate in the process of decision making with a goal of improving the quality of the decision‐making process and as a consequence, the quality of the decision. It is now included under ‘Other outcomes related to the decision‐making process’. 

8. Details on our 'Data extraction and management': Duplicate data extraction was performed on key elements only, including description of decision coaching, outcomes, and risk of bias based on editorial feedback.

Contributions of authors

The work presented here is the result of shared interests of an international network that includes patient partners who are healthcare consumers, healthcare providers, educators, and researchers with expertise in SDM, various research methodologies, Cochrane Reviews, and knowledge translation (KT). All authors have discussed and agreed upon their roles in this review, as follows.

Study proposal: JJ, SKo, LB, AC, SD, IDG, BH, JK, SKi, FL, KL, AL, WO, TR, AR, CR, MS, DS

Study: JJ, SKo, LB, SD, IDG, JK, SKi, FL, KL, AL, TR, AR, CR, MS, DS, MC, JF, AD, JZ contributed to the decisions leading to the conduct, writing, and agreed on the final version of the report.

Patient partners on this review: MS, AL

Team leaders: JJ, SKo, DS, MS

Project coordinator: MC

International collaborative research group: CR, AD, LB, AC, SD, JF, IDG, BH, JK, SKi, FL, KL, WO, TR, AR, JZ

JJ is the guarantor for this review. JJ will be responsible for conducting the review update.

Sources of support

Internal sources

  • No sources of support provided

External sources

  • CIHR Project Grant, Canada

    CIHR Project Grant April 2019‐September 2020 (FRN# PJT‐162135)

  • Canada Research Chair in Shared Decision Making and Knowledge Translation, Canada

    FL holds a Canada Research Chair in Shared Decision Making and Knowledge Translation

  • University Research Chair in Knowledge Translation to Patients, Canada

    DS holds a University Research Chair in KT to Patients

  • CIHR Foundation Grant, Canada

    IDG is a recipient of a CIHR Foundation Grant (FRN# 143237)

Declarations of interest

Janet Jull: none known

Sascha Köpke (SKo): Co‐authorship of one included study

Maureen Smith: receives honoraria from the Ontario Ministry of Health to attend meetings, has received travel scholarships to attend conferences as a consumer, and receives an honorarium for roles as a co‐investigator and a knowledge user on two Canadian Institutes of Health Research grants.

Meg Carley: none known

Jeanette Finderup: none known

Anne C Rahn: Co‐authorship of one included study

Laura Boland: none known

Sandra Dunn: none known

Andrew Dwyer: is an Assistant Professor of Nursing at Boston College whose research focusses on developing more person‐centered approaches to care. He receives funding from Boston College and the U.S. National Institutes of Health (U.S.A.) and receives funding to cover travel expenses for his faculty participation in a Swiss rare diseases summer school. Dr. Dwyer has no competing interests to declare.

Jürgen Kasper: Co‐authorship of one included study

Simone Maria Kienlin (SKi): none known

France Légaré: none known

Krystina B Lewis: none known

Anne Lyddiatt: none known

Claudia Rutherford: none known

Jungqiang Zhao: none known

Tamara Rader: none known

Ian D Graham: none known

Dawn Stacey: is a Professor in the School of Nursing at the University of Ottawa and Senior Scientist at the Ottawa Hospital Research Institute where she conducts funded studies to evaluate the effectiveness of patient decision aids and decision coaching. The institution where she is employed, the University of Ottawa, has received funding to support her research studies from national granting agencies and cancer programmes. She has received funding for consultation with the Washington State Health Care Authority for the development and implementation of criteria for certifying patient decision aids. Finally, she received funding to travel for the Shared Decision Making Advisory Board Meeting in Vejle, Denmark, working with Safer Care Victoria in Melbourne, Australia, meetings and training for the Joint Commission of Taiwan.

New

References

References to studies included in this review

Adam 2019 {published data only}

  1. Adam S, Birch PH,  Coe RR,  Bansback N, Jones AL, Connolly MB, et al. Assessing an interactive online tool to support parents' genomic testing decisions. Journal of Genetic Counseling 2019;28(1):10-17. [DOI: 10.1007/s10897-018-0281-1] [DOI] [PubMed] [Google Scholar]

Aoki 2019 {published data only}

  1. Aoki Y,  Takaesu Y, Inoue M,  Furuno T, Kobayashi Y, Chiba H,  et al. Seven-day shared decision making for outpatients with first episode of mood disorders among university students: a randomized controlled trial. Psychiatry Research 2019;281:112531. [DOI: 10.1016/j.psychres.2019.112531] [DOI] [PubMed] [Google Scholar]

Berger‐Höger 2019 {published data only}

  1. Berger-Höger B,  Liethmann K,  Muhlhauser I,  Haastert B,  Steckelberg A. Nurse-led coaching of shared decision-making for women with ductal carcinoma in situ in breast care centers: a cluster randomized controlled trial. International Journal of Nursing Studies 2019;93:141-52. [DOI: 10.1016/j.ijnurstu.2019.01.013] [DOI] [PubMed] [Google Scholar]

Bozic 2013 {published data only}

  1. Bozic KJ,  Belkora J, Chan V,  Youm J,  Zhou T,  Dupaix J, et al. Shared decision making in patients with osteoarthritis of the hip and knee: results of a randomized controlled trial. Journal of Bone and Joint Surgery. American Volume 2013;95(18):1633-9. [DOI: 10.2106/JBJS.M.00004] [DOI] [PubMed] [Google Scholar]

Brown 2019 {published data only}

  1. Brown L, Gardner G, Bonner A. A randomized controlled trial testing a decision support intervention for older patients with advanced kidney disease. Journal of Advanced Nursing 2019;75(11):3032-44. [DOI: 10.1111/jan.14112] [DOI] [PubMed] [Google Scholar]

Col 2007 {published data only}

  1. Col NF,  Ngo L,  Fortin JM, Goldberg RJ, O'Connor AM. Can computerized decision support help patients make complex treatment decisions? A randomized controlled trial of an individualized menopause decision aid. Medical Decision Making 2007;27(5):585-98. [DOI: 10.1177/0272989X07306781] [DOI] [PubMed] [Google Scholar]

Davison 1997 {published data only}

  1. Davison BJ,  Degner LF. Empowerment of men newly diagnosed with prostate cancer. Cancer Nursing 1997;20(3):187-96. [DOI: 10.1097/00002820-199706000-00004] [DOI] [PubMed] [Google Scholar]

Deschamps 2004 {published data only}

  1. Deschamps MA, Taylor JG,  Neubauer SL, Whiting S, Green K. Impact of pharmacist consultation versus a decision aid on decision making regarding hormone replacement therapy. International Journal of Pharmacy Practice 2004;12(1):21-8. [DOI: 10.1211/0022357022999] [DOI] [Google Scholar]

Green 2001 {published data only}

  1. Green MJ,  Biesecker BB, McInerney AM,  Mauger D,  Fost N. An interactive computer program can effectively educate patients about genetic testing for breast cancer susceptibility. American Journal of Medical Genetics 2001;103(1):16-23. [DOI: 10.1002/ajmg.1500] [DOI] [PubMed] [Google Scholar]
  2. Green MJ, McInerney AM,  Biesecker BB, Fost N. Education about genetic testing for breast cancer susceptibility: patient preferences for a computer program or genetic counselor. American Journal of Medical Genetics 2001;103(1):24-31. [DOI: 10.1002/ajmg.1501] [DOI] [PubMed] [Google Scholar]

Hacking 2013 {published data only}

  1. Hacking B, Wallace L, Scott S, Kosmala-Anderson J, Belkora J,  McNeill A. Testing the feasibility, acceptability and effectiveness of a ‘decision navigation’ intervention for early stage prostate cancer patients in Scotland – a randomised controlled trial. Psycho-Oncology 2013;22(5):1017– 24. [DOI: 10.1002/pon.3093] [DOI] [PubMed] [Google Scholar]

Hamann 2006 {published data only}

  1. Hamann J, Langer B, Winkler V, Busch R, Cohen R,  Leucht S,  et al. Shared decision making for in-patients with schizophrenia. Acta Psychiatrica Scandinavica 2006;114(4):265-73. [DOI: 10.1111/j.1600-0447.2006.00798.x] [DOI] [PubMed] [Google Scholar]

Hunter 2005 {published data only}

  1. Hunter AG,  Cappelli M, Humphreys L,  Allanson JE, Chiu TT,  Peeters C,  et al. A randomized trial comparing alternative approaches to prenatal diagnosis counseling in advanced maternal age patients. Clinical Genetics 2005;67(4):303-13. [DOI: 10.1111/j.1399-0004.2004.00405.x] [DOI] [PubMed] [Google Scholar]

Kearing 2016 {published data only}

  1. Kearing S, Berg SZ,  Lurie JD. Can decision support help patients with spinal stenosis make a treatment choice?: a prospective study assessing the impact of a patient decision aid and health coaching. Spine 2016;41(7):563-7. [DOI: 10.1097/BRS.0000000000001272] [DOI] [PMC free article] [PubMed] [Google Scholar]

Kennedy 2002 {published data only}

  1. Kennedy AD,  Sculpher MJ, Coulter A, Dwyer N, Rees M, Abrams KR,  et al. Effects of decision aids for menorrhagia on treatment choices, health outcomes, and costs: a randomized controlled trial. Journal of the American Medical Association 2002;288(21):2701-8. [DOI: 10.1001/jama.288.21.2701] [DOI] [PubMed] [Google Scholar]
  2. Kennedy AD, Sculpher MJ, Coulter A, Dwyer N, Rees M, Horsley S, et al. A multicentre randomised controlled trial assessing the costs and benefits of using structured information and analysis of women’s preferences in the management of menorrhagia. Health Technology Assessment 2003;7(8):1-76. [DOI: 10.3310/hta7080] [DOI] [PubMed]

Langston 2010 {published data only}

  1. Langston AM, Rosario L,  Westhoff CL. Structured contraceptive counseling - a randomized controlled trial. Patient Education and Counseling 2010;81(3):362-7. [DOI: 10.1016/j.pec.2010.08.006] [DOI] [PubMed] [Google Scholar]

Lepore 2012 {published data only}

  1. Lepore SJ, Wolf RL,  Basch CE, Godfrey M, McGinty E,  Shmukler C,  et al. Informed decision making about prostate cancer testing in predominantly immigrant black men: a randomized controlled trial. Annals of Behavioral Medicine 2012;44(3):320-30. [DOI: 10.1007/s12160-012-9392-3] [DOI] [PMC free article] [PubMed] [Google Scholar]

Lerman 1997 {published data only}

  1. Lerman C,  Biesecker B,  Benkendorf JL, Kerner J, Gomez-Caminero A, Hughes C, et al. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. Journal of the National Cancer Institute 1997;89(2):148-57. [DOI: 10.1093/jnci/89.2.148] [DOI] [PubMed] [Google Scholar]

Matloff 2006 {published data only}

  1. Matloff ET, Moyer A, Shannon KM,  Niendorf KB, Col NF. Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making. Journal of Women's Health 2006;15(7):843-56. [DOI: 10.1089/jwh.2006.15.843] [DOI] [PubMed] [Google Scholar]

McBride 2016 {published data only}

  1. McBride E, Hacking B, O'Carroll R, Young M,  Jahr J,  Borthwick C,  et al. Increasing patient involvement in the diabetic foot pathway: a pilot randomized controlled trial. Diabetic Medicine 2016;33(11):1483-92. [DOI: 10.1111/dme.13158] [DOI] [PubMed] [Google Scholar]

Miller 2005a {published data only}

  1. Miller SM,  Fleisher L, Roussi P, Buzaglo JS,  Schnoll R, Slater  E, et al. Facilitating informed decision making about breast cancer risk and genetic counseling among women calling the NCI's Cancer Information Service. Journal of Health Communication 2005;10 Suppl 1:119–36. [DOI: 10.1080/07366290500265335] [DOI] [PubMed] [Google Scholar]

Mishel 2009 {published data only}

  1. Mishel MH,  Germino BB, Lin L,  Pruthi RS, Wallen EM,  Crandell J,  et al. Managing uncertainty about treatment decision making in early stage prostate cancer: a randomized clinical trial. Patient Education and Counseling 2009;77(3):349-59. [DOI: 10.1016/j.pec.2009.09.009] [DOI] [PubMed] [Google Scholar]

Myers 2005 {published data only}

  1. Myers RE,  Daskalakis C,  Cocroft J,  Kunkel EJ,  Delmoor E,  Liberatore M,  et al. Preparing African-American men in community primary care practices to decide whether or not to have prostate cancer screening. Journal of the National Medical Association 2005;97(8):1143-54. [PMID: ] [PMC free article] [PubMed] [Google Scholar]

Myers 2011 {published data only}

  1. Myers RE,  Daskalakis C,  Kunkel EJ,  Cocroft JR,  Riggio JM,  Capkin M,  et al. Mediated decision support in prostate cancer screening: a randomized controlled trial of decision counseling. Patient Education and Counseling 2011;83(2):240-6. [DOI: 10.1016/j.pec.2010.06.011] [DOI] [PubMed] [Google Scholar]

Rahn 2018 {published data only}

  1. Rahn AC,  Köpke S,  Backhus I,  Kasper J, Anger K,  Untiedt B,  et al. Nurse-led immunotreatment DEcision Coaching In people with Multiple Sclerosis (DECIMS) - feasibility testing, pilot randomised controlled trial and mixed methods process evaluation. International Journal of Nursing Studies 2018;78:26-36. [DOI: 10.1016/j.ijnurstu.2017.08.011] [DOI] [PubMed] [Google Scholar]

Shepherd 2019 {published data only}

  1. Shepherd SC, Hacking B, Wallace LM, Murdoch SE,  Belkora J. Randomised controlled trial of a repeated consultation support intervention for patients with colorectal cancer. Psycho-Oncology 2019;28(4):702–9. [DOI: 10.1002/pon.4965] [DOI] [PubMed] [Google Scholar]

Sheridan 2012 {published data only}

  1. Sheridan SL,  Golin C,  Bunton A,  Lykes JB, Schwartz B, McCormack L,  et al. Shared decision making for prostate cancer screening: the results of a combined analysis of two practice-based randomized controlled trials. BMC Medical Informatics and Decision Making 2012;12:130. [DOI: 10.1186/1472-6947-12-130] [DOI] [PMC free article] [PubMed] [Google Scholar]

Van Peperstraten 2010 {published data only}

  1. Brabers AEM,  Van Dijk L, Groenewegen PP,  Van Peperstraten AM, De Jong JD. Does a strategy to promote shared decision-making reduce medical practice variation in the choice of either single or double embryo transfer after in vitro fertilisation? A secondary analysis of a randomised controlled trial. BMJ Open 2016;6(5):e010894. [DOI: 10.1136/bmjopen-2015-010894] [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Van Peperstraten A, Nelen W, Grol R, Zielhuis G, Adang E, Stalmeier P,  et al. The effect of a multifaceted empowerment strategy on decision making about the number of embryos transferred in invitro fertilisation: randomised controlled trial. BMJ 2010;341:c2501. [DOI: 10.1136/bmj.c2501] [DOI] [PMC free article] [PubMed] [Google Scholar]

Vodermaier 2009 {published data only}

  1. Vodermaier A,  Caspari C,  Koehm J,  Kahlert S,  Ditsch N,  Untch M. Contextual factors in shared decision making: a randomised controlled trial in women with a strong suspicion of breast cancer. British Journal of Cancer 2009;100(4):590-7. [DOI: 10.1038/sj.bjc.6604916] [DOI] [PMC free article] [PubMed] [Google Scholar]

References to studies excluded from this review

Aboumatar 2013 {published data only}

  1. Aboumatar HJ, Carson KA, Beach MC, Roter DL, Cooper LA. The impact of health literacy on desire for participation in healthcare, medical visit communication, and patient reported outcomes among patients with hypertension. Journal of General Internal Medicine 2013;28(11):1469-76. [DOI] [PMC free article] [PubMed] [Google Scholar]

Adanikin 2013 {published data only}

  1. Adanikin AI, Onwudiegwu U, Loto OM. Influence of multiple antenatal counselling sessions on modern contraceptive uptake in Nigeria. European Journal of Contraception and Reproductive Health Care 2013;18(5):381-7. [DOI] [PubMed] [Google Scholar]

Adarkwah 2017 {published data only}

  1. Adarkwah CC, Kuss K, Donner-Banzhoff N, Semjonow A, Hense HW, Simbrich A. Boon or bane? ArribaVR PSA: a new decision aid to support PSA-screening counselling. European Journal of General Practice 2017;23(1):148. [Google Scholar]

Adekpedjou 2020 {published data only}

  1. Adekpedjou R, Stacey D, Brière N, Freitas A, Garvelink MM, Dogba MJ, et al. Engaging caregivers in health-related housing decisions for older adults with cognitive impairment: a cluster randomized trial. Gerontologist 2020;60(5):947-57. [DOI] [PMC free article] [PubMed] [Google Scholar]

Akman 2010 {published data only}

  1. Akman M, Tuzun S, Uzuner A, Basgul A, Kavak Z. The influence of prenatal counselling on postpartum contraceptive choice. Journal of International Medical Research 2010;38(4):1243-9. [DOI] [PubMed] [Google Scholar]

Aktan‐Collan 2000 {published data only}

  1. Aktan-Collan K, Mecklin JP, De la Chapelle A, Peltomaki P, Uutela A, Kaariainen H. Evaluation of a counselling protocol for predictive genetic testing for hereditary non-polyposis colorectal cancer. Journal of Medical Genetics 2000;37(2):108-13. [DOI] [PMC free article] [PubMed] [Google Scholar]

Alegria 2018 {published data only}

  1. Alegria M, Nakash O, Johnson K, Ault-Brutus A, Carson N, Fillbrunn M, et al. Effectiveness of the DECIDE interventions on shared decision making and perceived quality of care in behavioral health with multicultural patients: a randomized clinical trial. JAMA Psychiatry 2018;75(4):325-35. [DOI] [PMC free article] [PubMed] [Google Scholar]

Allen 2018 {published data only}

  1. Allen LA, McIlvennan CK, Thompson JS, Dunlay SM, LaRue SJ, Lewis EF, et al. Effectiveness of an intervention supporting shared decision making for destination therapy left ventricular assist device: the DECIDE-LVAD randomized clinical trial. JAMA Internal Medicine 2018;178(4):520-9. [DOI] [PMC free article] [PubMed] [Google Scholar]

AlSagheir 2020 {published data only}

  1. AlSagheir AI, Alrowais NA, Alkhudhair BK, AlYousefi NA, Al Sagheir AI, Ali AM, et al. Comparing the use of Arabic decision aid to usual care. A multicenter randomized controlled trial for Arabic speaking metastatic colorectal cancer patients in Saudi Arabia. Saudi Medical Journal 2020;41(5):499-507. [DOI] [PMC free article] [PubMed] [Google Scholar]

Andaroon 2020 {published data only}

  1. Andaroon N, Kordi M, Kimiaee SA, Esmaeili H. The effect of individual counseling on attitudes and decisional conflict in the choice of delivery among nulliparous women. Journal of Education & Health Promotion 2020;9:35. [DOI] [PMC free article] [PubMed] [Google Scholar]

Arimori 2006 {published data only}

  1. Arimori N. Randomized controlled trial of decision aids for women considering prenatal testing: the effect of the Ottawa Personal Decision Guide on decisional conflict. Japan Journal of Nursing Science 2006;3(2):119-30. [Google Scholar]

Athens 2017 {published data only}

  1. Athens BA, Caldwell SL, Umstead KL, Connors PD, Brenna E, Biesecker BB. A systematic review of randomized controlled trials to assess outcomes of genetic counseling. Journal of Genetic Counseling 2017;26(5):902-33. [DOI] [PMC free article] [PubMed] [Google Scholar]

Augstein 2007 {published data only}

  1. Augstein P, Vogt L, Kohnert KD, Freyse EJ, Heinke P, Salzsieder E. Outpatient assessment of Karlsburg Diabetes Management System-based decision support. Diabetes Care 2007;30(7):1704-8. [DOI] [PubMed] [Google Scholar]

Bailey 2021 {published data only}

  1. Bailey SC, Andrews EN, Halton CC, Wolf MS. Evaluation of a discussion guide to promote patient understanding of menopause and informed treatment decision-making. Journal of Women's Health 2021;30(3):445-51. [DOI] [PubMed] [Google Scholar]

Barnieh 2011 {published data only}

  1. Barnieh L, McLaughlin K, Manns BJ, Klarenbach S, Yilmaz S, Taub K, et al. Evaluation of an education intervention to increase the pursuit of living kidney donation: a randomized controlled trial. Progress in Transplantation (Aliso Viejo, Calif.) 2011;21(1):36-42. [DOI] [PubMed] [Google Scholar]

Barry 1997 {published data only}

  1. Barry MJ, Cherkin DC, Chang Y, Fowler FJ Jr, Skates S. A randomized trial of a multimedia shared decision-making program for men facing a treatment decision for benign prostatic hyperplasia. Disease Management and Clinical Outcomes 1997;1(1):5-14. [Google Scholar]

Basu 2015 {published data only}

  1. Basu M, Pastan SO, Mohan S, Friedewald JJ, Ladna DP, Patzer RE. Knowledge of treatment options in patients evaluated for kidney transplantation: iChoose kidney randomized trial. Journal of the American Society of Nephrology  2015;26:864a. [Google Scholar]

Becker 2009 {published data only}

  1. Becker H, Stuifbergen AK, Dormire SL. The effects of hormone therapy decision support for women with mobility impairments. Health Care for Women International 2009;30(9):845-54. [DOI] [PMC free article] [PubMed] [Google Scholar]

Belkora 2012 {published data only}

  1. Belkora J, Stupar L, O'Donnell S, Loucks A, Moore D, Jupiter C, et al. Decision support by telephone: randomized controlled trial in a rural community setting. Patient Education and Counseling 2012;89(1):134-42. [DOI] [PubMed] [Google Scholar]

Belkora 2015 {published data only}

  1. Belkora J, Volz S, Loth M, Teng A, Zarin-Pass M, Moore D, et al. Coaching patients in the use of decision and communication aids: RE-AIM evaluation of a patient support program. BMC Health Services Research 2015;15:209. [DOI] [PMC free article] [PubMed] [Google Scholar]

Benoit 2020 {published data only}

  1. Benoit AC, Moutel G, Morello R, Grandazzi G, Mayeur A, Grynberg M. Assessment of a French web-based patient decision aid (ptDA) of fertility preservation (FP) for women with breast cancer. Human Reproduction 2020 ;35 Suppl 1:i96‐i7. [Google Scholar]

Bergeron 2019 {published data only}

  1. Bergeron M, Duggins A, Chini B, Ishman SL. Clinical outcomes after shared decision-making tools with families of children with obstructive sleep apnea without tonsillar hypertrophy. Laryngoscope 2019;129(11):2646-51. [DOI] [PubMed] [Google Scholar]

Berry 2013 {published data only}

  1. Berry DL, Halpenny B, Hong F, Wolpin S, Lober WB, Russell KJ, et al. The Personal Patient Profile-Prostate decision support for men with localized prostate cancer: a multi-center randomized trial. Urologic Oncology 2013;31(7):1012-21. [DOI] [PMC free article] [PubMed] [Google Scholar]

Berry 2018 {published data only}

  1. Berry DL, Hong F, Blonquist TM, Halpenny B, Filson CP, Master VA, et al. Decision support with the Personal Patient Profile-Prostate: a multicenter randomized trial. Journal of Urology 2018;199(1):89-97. [DOI] [PMC free article] [PubMed] [Google Scholar]

Biesecker 2018 {published data only}

  1. Biesecker BB, Lewis KL, Umstead KL, Johnston JJ, Turbitt E, Fishler KP, et al. Web platform vs in-person genetic counselor for return of carrier results from exome sequencing a randomized clinical trial. JAMA Internal Medicine 2018;178(3):338-46. [DOI] [PMC free article] [PubMed] [Google Scholar]

Bjorklund 2012 {published data only}

  1. Bjorklund U, Marsk A, Levin C, Ohman SG. Audiovisual information affects informed choice and experience of information in antenatal Down Syndrome screening - a randomized controlled trial. Patient Education and Counseling 2012;86(3):390-5. [DOI] [PubMed] [Google Scholar]

Boulware 2018 {published data only}

  1. Boulware LE, Ephraim PL, Ameling J, Lewis-Boyer L, Rabb H, Greer RC, et al. Effectiveness of informational decision aids and a live donor financial assistance program on pursuit of live kidney transplants in African American hemodialysis patients. BMC Nephrology 2018;19(1):107. [DOI] [PMC free article] [PubMed] [Google Scholar]

Bowen 2002 {published data only}

  1. Bowen DJ, Burke W, Yasui Y, McTiernan A, McLeran D. Effects of risk counseling on interest in breast cancer genetic testing for lower risk women. Genetics in Medicine 2002;4(5):359‐65. [DOI] [PubMed] [Google Scholar]

Bowen 2017 {published data only}

  1. Bowen DJ, Robbins R, Bush N, Meischke H, Ludwig A, Wooldridge J. Effects of a web-based intervention on women's breast health behaviors. Translational Behavioral Medicine 2017;7(2):309-19. [DOI] [PMC free article] [PubMed] [Google Scholar]

Briggs 2004 {published data only}

  1. Briggs LA, Kirchhoff KT, Hammes BJ, Song MK, Colvin ER. Patient-centered advance care planning in special patient populations: a pilot study. Journal of Professional Nursing 2004;20(1):47‐58. [DOI] [PubMed] [Google Scholar]

Brown 1999 {published data only}

  1. Brown R, Butow PN, Boyer MJ, Tattersall MH. Promoting patient participation in the cancer consultation: evaluation of a prompt sheet and coaching in question-asking. British Journal of Cancer 1999;80(1-2):242-8. [DOI] [PMC free article] [PubMed] [Google Scholar]

Buhse 2015 {published data only}

  1. Buhse S, Muhlhauser I, Heller T, Kuniss N, Muller UA, Kasper J, et al. Informed shared decision-making programme on the prevention of myocardial infarction in type 2 diabetes: a randomised controlled trial. BMJ Open 2015;5(11):e009116. [DOI] [PMC free article] [PubMed] [Google Scholar]

Buhse 2017 {published data only}

  1. Buhse S, Kuniss N, Liethmann K, Muller UA, Lehmann T, Muhlhauser I. An informed shared decision making programme for patients with type 2 diabetes in primary care: cluster randomised controlled trial. Diabetologia 2017;60(1 Suppl 1):S347. [DOI] [PMC free article] [PubMed] [Google Scholar]

Buhse 2018 {published data only}

  1. Buhse S,  Kuniss N,  Liethmann K, Muller UA,  Lehmann T,  Muhlhauser I. Informed shared decision-making programme for patients with type 2 diabetes in primary care: cluster randomised controlled trial. BMJ Open 2018;8(12):1-10. [DOI] [PMC free article] [PubMed] [Google Scholar]

Calzone 2005 {published data only}

  1. Calzone KA, Prindiville SA, Jourkiv O, Jenkins J, DeCarvalho M, Wallerstedt DB, et al. Randomized comparison of group versus individual genetic education and counseling for familial breast and/or ovarian cancer. Journal of Clinical Oncology 2005;23(15):3455-64. [DOI] [PubMed] [Google Scholar]

Carlson 2021 {published data only}

  1. Carlson DS, Grivas P, Wei W, Dhillon PK, Abraksia S. The effectiveness of shared compared to informed decision making for prostate cancer screening in a high-risk African American population: a randomized control trial. Cancer Investigation 2021;39(2):124-32. [DOI] [PubMed] [Google Scholar]

Causarano 2015 {published data only}

  1. Causarano N, Platt J, Baxter NN, Bagher S, Jones JM, Metcalfe KA, et al. Pre-consultation educational group intervention to improve shared decision-making for postmastectomy breast reconstruction: a pilot randomized controlled trial. Supportive Care in Cancer 2015;23(5):1365-75. [DOI] [PubMed] [Google Scholar]

Cervantes 2007 {published data only}

  1. Cervantes A, Rodriguez-Braun E, Navarro S, Hernandez A, Campos S, Garcia-Granero E. Integrative decisions in rectal cancer. Annals of Oncology 2007;18 Suppl 9:ix127-31. [DOI] [PubMed] [Google Scholar]

Cha 2018 {published data only}

  1. Cha S, Levi E, Findley M, Leung W, Tarrash M, Benfield N. Effectiveness of a patient decision aid in postpartum contraceptive counseling. Obstetrics and Gynecology 2018;131 Suppl 1:52S. [Google Scholar]

Chambers 2015 {published data only}

  1. Chambers SK, Occhipinti S, Schover L, Nielsen L, Zajdlewicz L, Clutton S, et al. A randomised controlled trial of a couples-based sexuality intervention for men with localised prostate cancer and their female partners. Psycho-Oncology 2015;24(7):748-56. [DOI] [PubMed] [Google Scholar]

Chan 2011 {published data only}

  1. Chan EC, McFall SL, Byrd TL, Mullen PD, Volk RJ, Ureda J, et al. A community-based intervention to promote informed decision making for prostate cancer screening among Hispanic American men changed knowledge and role preferences: a cluster RCT. Patient Education and Counseling 2011;84(2):e44-e51. [DOI] [PubMed] [Google Scholar]

Chan 2018 {published data only}

  1. Chan HY, Ng JS, Chan KS, Ko PS, Leung DY, Chan CW, et al. Effects of a nurse-led post-discharge advance care planning programme for community-dwelling patients nearing the end of life and their family members: a randomised controlled trial. International Journal of Nursing Studies 2018;87:26-33. [DOI] [PubMed] [Google Scholar]

Chaney 2011 {published data only}

  1. Chaney D, Coates V, Shevlin M, Carson D, McDougall A, Long A, et al. Evaluation of the Carbohydrate, Insulin Collaborative Education (CHOICE) programme for young people with type 1 diabetes. Diabetic Medicine 2011;28:25. [Google Scholar]

Charles 2006 {published data only}

  1. Charles S, Kessler L, Stopfer JE, Domchek S, Halbert CH. Satisfaction with genetic counseling for BRCA1 and BRCA2 mutations among African American women. Patient Education and Counseling 2006;63(1-2):196-204. [DOI] [PubMed] [Google Scholar]

Chhatriwalla 2019 {published data only}

  1. Chhatriwalla AK, Decker C, Gialde E, Catley D, Goggin K, Jaschke K, et al. Developing and testing a personalized, evidence-based, shared decision-making tool for stent selection in percutaneous coronary intervention using a pre-post study design. Circulation. Cardiovascular Quality and Outcomes 2019;12(2):e005139. [DOI] [PMC free article] [PubMed] [Google Scholar]

Choi 2014 {published data only}

  1. Choi J,  Kim H. Effectiveness of the interventions utilized in genetic counseling. Advances in Nursing 2014;2014:725968. [Google Scholar]

Clark 2003 {published data only}

  1. Clark HD, O'Connor AM, Graham ID, Wells GA. What factors are associated with a woman's decision to take hormone replacement therapy? Evaluated in the context of a decision aid. Health Expectations 2003;6(2):110-7. [DOI] [PMC free article] [PubMed] [Google Scholar]

Clarke‐Pounder 2015 {published data only}

  1. Clarke-Pounder JP, Boss RD, Roter DL, Hutton N, Larson S, Donohue PK. Communication intervention in the neonatal intensive care unit: can it backfire? Journal of Palliative Medicine 2015;18(2):157-61. [DOI] [PubMed] [Google Scholar]

Cohan 2009 {published data only}

  1. Cohan D, Gomez E, Greenberg M, Washington S, Charlebois ED. Patient perspectives with abbreviated versus standard pre-test HIV counseling in the prenatal setting: a randomized-controlled, non-inferiority trial. PLOS One 2009;4(4):e5166. [DOI] [PMC free article] [PubMed] [Google Scholar]

Cohen 2004 {published data only}

  1. Cohen D, Longo MF, Hood K, Edwards A, Elwyn G. Resource effects of training general practitioners in risk communication skills and shared decision making competences. Journal of Evaluation in Clinical Practice 2004;10(3):439-45. [DOI] [PubMed] [Google Scholar]

Cooper 2014 {published data only}

  1. Cooper Z, Corso K, Bernacki R, Bader A, Gawande A, Block S. Conversations about treatment preferences before high-risk surgery: a pilot study in the preoperative testing center. Journal of Palliative Medicine 2014;17(6):701-7. [DOI] [PubMed] [Google Scholar]

Cooper 2018 {published data only}

  1. Cooper M, Messow CM, McConnachie A, Freire E, Elliott R, Heard D, et al. Patient preference as a predictor of outcomes in a pilot trial of person-centred counselling versus low-intensity cognitive behavioural therapy for persistent sub-threshold and mild depression. Counselling Psychology Quarterly 2018;31:460-76. [Google Scholar]

Costanza 2011 {published data only}

  1. Costanza ME, Luckmann RS, Rosal M, White MJ, LaPelle N, Partin M, et al. Helping men make an informed decision about prostate cancer screening: a pilot study of telephone counseling. Patient Education and Counseling 2011;82(2):193-200. [DOI] [PMC free article] [PubMed] [Google Scholar]

Coulter 2007 {published data only}

  1. Coulter A, Ellins J. Effectiveness of strategies for informing, educating, and involving patients. BMJ 2007;335:24-7. [DOI] [PMC free article] [PubMed] [Google Scholar]

Cuypers 2018 {published data only}

  1. Cuypers M, Lamers RED, Kil PJM, Van de Poll-Franse LV, De Vries M. Impact of a web-based prostate cancer treatment decision aid on patient-reported decision process parameters: results from the Prostate Cancer Patient Centered Care trial. Supportive Care in Cancer 2018;26(11):3739‐48. [DOI] [PMC free article] [PubMed] [Google Scholar]

Cuypers 2019 {published data only}

  1. Cuypers M, Lamers RED, Kil PJM, Van de Poll-Franse LV, De Vries M. Longitudinal regret and information satisfaction after deciding on treatment for localized prostate cancer with or without a decision aid. Results at one-year follow-up in the PCPCC trial. Patient Education and Counseling 2019;102(3):424-8. [DOI] [PubMed] [Google Scholar]

Damir 2011 {published data only}

  1. Damir F. Counseling the perimenopausal women in post WHI era. Climacteric 2011;1:23. [Google Scholar]

Davison 1997a {published data only}

  1. Davison BJ. Empowerment of Men Newly Diagnosed with Prostate Cancer in Treatment Decision-Making [doctoral thesis]. Winnipeg (Canada): University of Manitoba Libraries MSpace, 1997. [Google Scholar]

Davison 2003 {published data only}

  1. Davison BJ, Goldenberg SL, Gleave ME, Degner LF. Provision of individualized information to men and their partners to facilitate treatment decision making in prostate cancer. Oncology Nursing Forum 2003;30(1):107-14. [DOI] [PubMed] [Google Scholar]

Davison 2007 {published data only}

  1. Davison BJ, Goldenberg SL, Wiens KP, Gleave ME. Comparing a generic and individualized information decision support intervention for men newly diagnosed with localized prostate cancer. Cancer Nursing 2007;30(5):E7-15. [DOI] [PubMed] [Google Scholar]

Deen 2012 {published data only}

  1. Deen D, Lu WH, Weintraub MR, Maranda MJ, Elshafey S, Gold MR. The impact of different modalities for activating patients in a community health center setting. Patient Education and Counseling 2012;89(1):178-83. [DOI] [PubMed] [Google Scholar]

Dehlendorf 2019 {published data only}

  1. Dehlendorf C, Fitzpatrick J, Fox E, Holt K, Vittinghoff E, Reed R, et al. Cluster randomized trial of a patient-centered contraceptive decision support tool, My Birth Control. American Journal of Obstetrics and Gynecology 2019;220(6):565.e1-565.e12. [DOI] [PubMed] [Google Scholar]

Deinzer 2006 {published data only}

  1. Deinzer A, Babel H, Veelken R, Kohnen R, Schmieder RE. Shared decision-making with hypertensive patients. Results of an implementation in Germany. Deutsche Medizinische Wochenschrift (1946) 2006;131(46):2592-6. [DOI] [PubMed] [Google Scholar]

Deinzer 2009 {published data only}

  1. Deinzer A, Veelken R, Kohnen R, Schmieder RE. Is a shared decision-making approach effective in improving hypertension management? Journal of Clinical Hypertension (Greenwich, Conn.) 2009;11(5):266-70. [DOI] [PMC free article] [PubMed] [Google Scholar]

Di 2017 {published data only}

  1. Di M. A randomized controlled trial on impacts of individualized, evidence-based counseling on medication use in insured hypertensive patients in China. Dissertation Abstracts International: Section B: Sciences and Engineering 2017;78:No Pagination. [Google Scholar]

Dobke 2008 {published data only}

  1. Dobke MK,  Bhavsar D. Pilot trial of telemedicine as a decision aid for patients with chronic wounds. Telemedicine Journal and E-health 2008;14(3):245-9. [DOI] [PubMed] [Google Scholar]

Dobscha 2006 {published data only}

  1. Dobscha SK, Corson K, Hickam DH, Perrin NA, Kraemer DF, Gerrity MS. Depression decision support in primary care: a cluster randomized trial. Annals of Internal Medicine 2006;145(7):477-87. [DOI] [PubMed] [Google Scholar]

Duncan 2010 {published data only}

  1. Duncan E, Best C, Hagen S. Shared decision making interventions for people with mental health conditions. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI] [PMC free article] [PubMed] [Google Scholar]

Duru 2017 {published data only}

  1. Duru OK, Martin J, Grotts J, Moin T, Fu JY, Tseng CH, et al. Satisfaction, change in knowledge and adherence to diabetes prevention after a pharmacist led prediabetes shared decision making visit: the prediabetes informed decision and education (PRIDE) study. Journal of General Internal Medicine 2017;32 (2 Suppl 1):S312. [Google Scholar]

Dwamena 2012 {published data only}

  1. Dwamena F, Holmes‐Rovner M, Gaulden CM, Jorgenson S, Sadigh G, Sikorskii A, et al. Interventions for providers to promote a patient‐centred approach in clinical consultations. Cochrane Database of Systematic Reviews 2012, Issue 12. [DOI] [PMC free article] [PubMed] [Google Scholar]

Edbrooke‐Childs 2019 {published data only}

  1. Edbrooke-Childs J, Edridge C, Averill P, Delane L, Hollis C, Craven MP, et al. A feasibility trial of power up: smartphone app to support patient activation and shared decision making for mental health in young people. Journal of Medical Internet Research mHealth and uHealth 2019;7(6):e11677. [DOI] [PMC free article] [PubMed] [Google Scholar]

Edwards 2004 {published data only}

  1. Edwards A, Elwyn G, Hood K, Atwell C, Robling M, Houston H, et al. Patient-based outcome results from a cluster randomized trial of shared decision making skill development and use of risk communication aids in general practice. Family Practice 2004;21(4):347-54. [DOI] [PubMed] [Google Scholar]

El‐Jawahri 2015 {published data only}

  1. El-Jawahri A, Mitchell SL, Paasche-Orlow MK, Temel JS, Jackson VA, Rutledge RR, et al. A randomized controlled trial of a CPR and intubation video decision support tool for hospitalized patients. Journal of General Internal Medicine 2015;30(8):1071-80. [DOI] [PMC free article] [PubMed] [Google Scholar]

Epstein 2018 {published data only}

  1. Epstein AS, O'Reilly EM, Shuk E, Romano D, Li Y, Breitbart W, et al. A randomized trial of acceptability and effects of values-based advance care planning in outpatient oncology: person-centered oncologic care and choices. Journal of Pain and Symptom Management 2018;56(2):169-77.e1. [DOI] [PMC free article] [PubMed] [Google Scholar]

Fan 2018 {published data only}

  1. Fan CW, Castonguay L, Rummell S, Levesque S, Mitchell JJ, Sillon G. Online module for carrier screening in Ashkenazi Jewish individuals compared with in-person genetics education: a randomized controlled trial. Journal of Genetic Counseling 2018;27(2):426-38. [DOI] [PubMed] [Google Scholar]

Farmer 2012 {published data only}

  1. Farmer A, Hardeman W, Hughes D, Prevost AT, Kim Y, Craven A, et al. An explanatory randomised controlled trial of a nurse-led, consultation-based intervention to support patients with adherence to taking glucose lowering medication for type 2 diabetes. BMC Family Practice 2012;13:30. [DOI] [PMC free article] [PubMed] [Google Scholar]

Ferguson 2017 {published data only}

  1. Ferguson C, Hendriks J. Partnering with patients in shared decision-making for stroke prevention in atrial fibrillation. European Journal of Cardiovascular Nursing 2017;16(3):178-80. [DOI] [PubMed] [Google Scholar]

Finucane 1988 {published data only}

  1. Finucane TE, Shumway JM, Powers RL, D'Alessandri RM. Planning with elderly outpatients for contingencies of severe illness: a survey and clinical trial. Journal of General Internal Medicine 1988;3(4):322‐5. [DOI] [PubMed] [Google Scholar]

Fischer 2006 {published data only}

  1. Fischer M, Visser A, Voerman B, Garssen B, Van Andel G, Bensing J. Treatment decision making in prostate cancer: patients' participation in complex decisions. Patient Education and Counseling 2006;63(3):308-13. [DOI] [PubMed] [Google Scholar]

Fischl 2010 {published data only}

  1. Fischl AF, Herman WH, Sereika SM, Hannan M, Becker D, Mansfield MJ, et al. Impact of a preconception counseling program for teens with type 1 diabetes (READY-Girls) on patient-provider interaction, resource utilization, and cost. Diabetes Care 2010;33(4):701-5. [DOI] [PMC free article] [PubMed] [Google Scholar]

Fitzpatrick 2016 {published data only}

  1. Fitzpatrick SL, Golden SH, Stewart K, Sutherland J, DeGross S, Brown T, et al. Effect of DECIDE (decision-making education for choices in diabetes everyday) program delivery modalities on clinical and behavioral outcomes in urban African Americans with type 2 diabetes: a randomized trial. Diabetes Care 2016;39(12):2149-57. [DOI] [PMC free article] [PubMed] [Google Scholar]

Fooladi 2018 {published data only}

  1. Fooladi E, Weller C, Salehi M, Abhari FR, Stern J. Using reproductive life plan-based information in a primary health care center increased Iranian women's knowledge of fertility, but not their future fertility plan: a randomized, controlled trial. Midwifery 2018;67:77-86. [DOI] [PubMed] [Google Scholar]

Foy 2019 {published data only}

  1. Foy AJ, Levi BH, Van Scoy LJ, Bucher A, Dimmock A, Green MJ. Patient preference to accept medical treatment is associated with spokesperson agreement. Annals of the American Thoracic Society 2019;16(4):518-21. [DOI] [PMC free article] [PubMed] [Google Scholar]

Frijling 2003 {published data only}

  1. Frijling BD, Lobo CM, Hulscher ME, Akkermans RP, Van Drenth BB, Prins A, et al. Intensive support to improve clinical decision making in cardiovascular care: a randomised controlled trial in general practice. Quality & Safety in Health Care 2003;12(3):181-7. [DOI] [PMC free article] [PubMed] [Google Scholar]

Frosch 2001 {published data only}

  1. Frosch DL, Kaplan RM, Felitti V. The evaluation of two methods to facilitate shared decision making for men considering the prostate-specific antigen test. Journal of General Internal Medicine 2001;16(6):391-8. [DOI] [PMC free article] [PubMed] [Google Scholar]

Fujimoto 2017 {published data only}

  1. Fujimoto K. Effectiveness of coaching for enhancing the health of menopausal Japanese women. Journal of Women & Aging 2017;29(3):216-29. [DOI] [PubMed] [Google Scholar]

Gagne 2017 {published data only}

  1. Gagne ME, Legare F, Moisan J, Boulet LP. Impact of adding a decision aid to patient education in adults with asthma: a randomized clinical trial. PLOS One 2017;12(1):e0170055. [DOI] [PMC free article] [PubMed] [Google Scholar]

Gammon 2018 {published data only}

  1. Gammon BL, Otto L, Wick M, Borowski K, Allyse M. Implementing group prenatal counseling for expanded noninvasive screening options. Journal of Genetic Counseling 2018;27:894-901. [DOI] [PubMed] [Google Scholar]

Garbers 2012 {published data only}

  1. Garbers S, Meserve A, Kottke M, Hatcher R, Ventura A, Chiasson MA. Randomized controlled trial of a computer-based module to improve contraceptive method choice. Contraception 2012;86(4):383-90. [DOI] [PubMed] [Google Scholar]

Ghasemi 2018 {published data only}

  1. Ghasemi F, Bolbol-Haghighi N, Mottaghi Z, Hosseini SR, Khosravi A. The effect of group counseling with cognitive-behavioral approach on self-efficacy of pregnant women's choice of vaginal delivery. Iranian Journal of Psychiatry and Behavioral Sciences 2018;12(3):e7632. [Google Scholar]

Giordano 2012 {published data only}

  1. Giordano L, Stefanini V, Senore C, Frigerio A, Castagno R, Marra V, et al. The impact of different communication and organizational strategies on mammography screening uptake in women aged 40-45 years. European Journal of Public Health 2012;22(3):413-8. [DOI] [PubMed] [Google Scholar]

Green 1997 {published data only}

  1. Green MJ, Fost N. An interactive computer program for educating and counseling patients about genetic susceptibility to breast cancer. Journal of Cancer Education 1997;12(4):204-8. [DOI] [PubMed] [Google Scholar]

Green 2004 {published data only}

  1. Green MJ, Peterson SK, Baker MW, Harper GR, Friedman LC, Rubinstein WS, et al. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial. JAMA 2004;292(4):442-52. [DOI] [PMC free article] [PubMed] [Google Scholar]

Green 2005 {published data only}

  1. Green MJ, Peterson SK, Baker MW, Friedman LC, Harper GR, Rubinstein WS, et al. Use of an educational computer program before genetic counseling for breast cancer susceptibility: effects on duration and content of counseling sessions. Genetics in Medicine 2005;7(4):221-9. [DOI] [PMC free article] [PubMed] [Google Scholar]

Green 2015 {published data only}

  1. Green MJ, Schubart JR, Whitehead MM, Farace E, Lehman E, Levi BH. Advance care planning does not adversely affect hope or anxiety among patients with advanced cancer. Journal of Pain and Symptom Management 2015;49(6):1088-96. [DOI] [PubMed] [Google Scholar]

Green 2018 {published data only}

  1. Green MJ, Van Scoy LJ, Foy AJ, Stewart RR, Sampath R, Schubart JR, et al. A randomized controlled trial of strategies to improve family members' preparedness for surrogate decision-making. American Journal of Hospice and Palliative Medicine 2018;35(6):866-74. [DOI] [PMC free article] [PubMed] [Google Scholar]

Green 2020 {published data only}

  1. Green MJ, Van Scoy LJ, Foy AJ, Dimmock AEF, Lehman E, Levi BH. Patients with advanced cancer choose less aggressive medical treatment on vignettes after using a computer-based decision aid. American Journal of Hospice and Palliative Medicine 2020;37(7):537-41. [DOI] [PubMed] [Google Scholar]

Greenfield 1985 {published data only}

  1. Greenfield S, Kaplan S, Ware JE. Expanding patient involvement in care. Effects on patient outcomes. Annals of Internal Medicine 1985;102(4):520-8. [DOI] [PubMed] [Google Scholar]

Greenfield 1988 {published data only}

  1. Greenfield S, Kaplan SH, Ware JE Jr, Yano EM, Frank HJ. Patients' participation in medical care: effects on blood sugar control and quality of life in diabetes. Journal of General Internal Medicine 1988;3(5):448-57. [DOI] [PubMed] [Google Scholar]

Guillen 2019 {published data only}

  1. Guillen U, Mackley A, Laventhal N, Kukora S, Christ L, Derrick M, et al. Evaluating the use of a decision aid for parents facing extremely premature delivery: a randomized trial. Journal of Pediatrics 2019;209:52-60.e1. [DOI] [PMC free article] [PubMed] [Google Scholar]

Hamann 2011 {published data only}

  1. Hamann J, Mendel R, Meier A, Asani F, Pausch E, Leucht S, et al. "How to speak to your psychiatrist": shared decision-making training for inpatients with schizophrenia. Psychiatric Services (Washington, D.C.) 2011;62(10):1218-21. [DOI] [PubMed] [Google Scholar]

Hamann 2013 {published data only}

  1. Hamann J, Maris N, Iosifidou P, Mendel R, Cohen R, Wolf P, et al. Effects of a question prompt sheet on active patient behaviour: a randomized controlled trial with depressed outpatients. International Journal of Social Psychiatry 2014;60(3):227-35. [DOI] [PubMed] [Google Scholar]

Hamann 2020 {published data only}

  1. Hamann J, Holzhüter F, Blakaj S, Becher S, Haller B, Landgrebe M, et al. Implementing shared decision-making on acute psychiatric wards: a cluster-randomized trial with inpatients suffering from schizophrenia (SDM-PLUS). Epidemiology and Psychiatric Sciences 2020;29:e137. [DOI] [PMC free article] [PubMed] [Google Scholar]

Harmsen 2013 {published data only}

  1. Harmsen CG, Jarbøl DE, Nexøe J, Støvring H, Gyrd-Hansen D, Nielsen JB, et al. Impact of effectiveness information format on patient choice of therapy and satisfaction with decisions about chronic disease medication: the "Influence of intervention Methodologies on Patient Choice of Therapy (IMPACT)" cluster-randomised trial in general practice. BMC Health Services Research 2013;13:76. [DOI] [PMC free article] [PubMed] [Google Scholar]

Harter 2016 {published data only}

  1. Harter M, Dirmaier J, Dwinger S, Kriston L, Herbarth L, Siegmund-Schultze E, et al. Effectiveness of telephone-based health coaching for patients with chronic conditions: a randomised controlled trial. PLOS One 2016;11(9):e0161269. [DOI] [PMC free article] [PubMed] [Google Scholar]

Heisler 2014 {published data only}

  1. Heisler M, Choi H, Palmisano G, Mase R, Richardson C, Fagerlin A, et al. Comparison of community health worker-led diabetes medication decision-making support for low-income Latino and African American adults with diabetes using e-health tools versus print materials: a randomized, controlled trial. Annals of Internal Medicine 2014;161(10 Suppl):S13-22. [DOI] [PMC free article] [PubMed] [Google Scholar]

Helden 2012 {published data only}

  1. Helden L, Morrison K, Levinson A, Ng S, Colizza L. Randomized trial of e-learning vs face-to-face education on patient knowledge and treatment choices for cholesterol lowering interventions. Canadian Journal of Cardiology 2012;28(5 Suppl 1):S450. [Google Scholar]

Helmes 2006 {published data only}

  1. Helmes AW, Culver JO, Bowen DJ. Results of a randomized study of telephone versus in-person breast cancer risk counseling. Patient Education and Counseling 2006;64(1-3):96-103. [DOI] [PubMed] [Google Scholar]

Henteleff 2006 {published data only}

  1. Henteleff H, McCready D, Giuliano A. Canadian Association of General Surgeons and American College of Surgeons Evidence Based Reviews in Surgery. 19. The effect of a decision aid on knowledge and treatment decision making for breast cancer. Canadian Journal of Surgery 2006;49(6):431-3. [PMC free article] [PubMed] [Google Scholar]

Hess 2011a {published data only}

  1. Hess E, Knoedler MA, Kline JA, Shah ND, Breslin M, Branda ME, et al. Effect of a decision aid on patient knowledge, patient satisfaction, safety, and resource use in emergency department patients presenting with chest pain: a randomized trial. Circulation: Cardiovascular Quality and Outcomes 2011;4:A2. [Google Scholar]

Hess 2011b {published data only}

  1. Hess EP, Knoedler MA, Kline J, Shah ND, Breslin MA, Branda ME, et al. Effect of a decision aid on patient knowledge, patient satisfaction, safety, and resource use in low-risk emergency department patients with chest pain: a randomized trial. Academic Emergency Medicine 2011;1:S17. [Google Scholar]

Hippman 2016 {published data only}

  1. Hippman C, Ringrose A, Inglis A, Cheek J, Albert AK, Remick R, et al. A pilot randomized clinical trial evaluating the impact of genetic counseling for serious mental illnesses. Journal of Clinical Psychiatry 2016;77:E190-8. [DOI] [PMC free article] [PubMed] [Google Scholar]

Holt 2009 {published data only}

  1. Holt CL, Wynn TA, Litaker MS, Southward P, Jeames S, Schulz E. A comparison of a spiritually based and non-spiritually based educational intervention for informed decision making for prostate cancer screening among church-attending African-American men. Urologic Nursing 2009;29(4):249-58. [PMC free article] [PubMed] [Google Scholar]

Hooker 2011 {published data only}

  1. Hooker GW, Leventhal KG, DeMarco T, Peshkin BN, Finch C, Wahl E, et al. Longitudinal changes in patient distress following interactive decision aid use among BRCA1/2 carriers: a randomized trial. Medical Decision Making 2011;31(3):412-21. [DOI] [PMC free article] [PubMed] [Google Scholar]

Hoseini Haji 2020 {published data only}

  1. Hoseini Haji SZ,  Mahboobeh F,  Asgharipour Pour N, Shakeri MT. Impact of motivational interviewing on women's knowledge, attitude and intention to choose vaginal birth after caesarean section: a randomized clinical trial. Journal of Midwifery & Reproductive Health 2020;8(1):2114-25. [Google Scholar]

Hsu 2003 {published data only}

  1. Hsu J, Schmittdiel J, Krupat E, Stein T, Thom D, Fireman B, et al. Patient choice: a randomised controlled trial of provider selection. Journal of General Internal Medicine 2003;18(5):319-25. [DOI] [PMC free article] [PubMed] [Google Scholar]

Hu 2021 {published data only}

  1. Hu X, Deng H, Zhang Y, Guo X, Cai M, Ling C, et al. Efficacy and safety of a decision support intervention for basal insulin self-titration assisted by the nurse in outpatients with T2DM: a randomized controlled trial. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021;14:1315-27. [DOI] [PMC free article] [PubMed] [Google Scholar]

Hulin 2017 {published data only}

  1. Hulin J, Baker SR, Marshman Z, Albadri S, Rodd HD. Development of a decision aid for children faced with the decision to undergo dental treatment with sedation or general anaesthesia. International Journal of Paediatric Dentistry 2017;27(5):344-55. [DOI] [PubMed] [Google Scholar]

Jacobsen 2012 {published data only}

  1. Jacobsen PB, Wells KJ, Meade CD, Quinn GP, Lee JH, Fulp WJ, et al. Effects of a brief multimedia psychoeducational intervention on the attitudes and interest of patients with cancer regarding clinical trial participation: a multicenter randomized controlled trial. Journal of Clinical Oncology 2012;30(20):2516-21. [DOI] [PMC free article] [PubMed] [Google Scholar]

Jalil 2020 {published data only}

  1. Jalil NB, Lee PY, Nor Afiah MZ, Abdullah KL, Azizi FM, Rassip NA, et al. Effectiveness of decision aid in men with localized prostate cancer: a multicenter randomized controlled trial at tertiary referral hospitals in an Asia Pacific country. Journal of Cancer Education 2020 [Online ahead of print]:No pagination. [DOI] [PubMed] [Google Scholar]

Jayadevappa 2019 {published data only}

  1. Jayadevappa R, Chhatre S, Gallo JJ, Wittink M, Morales KH, Lee DI, et al. Patient-centered preference assessment to improve satisfaction with care among patients with localized prostate cancer: a randomized controlled trial. Journal of Clinical Oncology 2019;37(12):964-73. [DOI] [PubMed] [Google Scholar]

Kaplan 1989 {published data only}

  1. Kaplan SH, Greenfield S, Ware JE Jr. Assessing the effects of physician-patient interactions on the outcomes of chronic disease. Medical Care 1989;27 Suppl 3:S110-27. [DOI] [PubMed] [Google Scholar]

Katz 2005 {published data only}

  1. Katz SJ, Lantz PM, Janz NK, Fagerlin A, Schwartz K, Liu L, et al. Patient involvement in surgery treatment decisions for breast cancer. Journal of Clinical Oncology 2005;23(24):5526-33. [DOI] [PubMed] [Google Scholar]

Keyserling 2014 {published data only}

  1. Keyserling TC, Sheridan SL, Draeger LB, Finkelstein EA, Gizlice Z, Kruger E, et al. A comparison of live counseling with a web-based lifestyle and medication intervention to reduce coronary heart disease risk: a randomized clinical trial. JAMA Internal Medicine 2014;174(7):1144-57. [DOI] [PMC free article] [PubMed] [Google Scholar]

Kim 2005 {published data only}

  1. Kim YM, Kols A, Martin A, Silva D, Rinehart W, Prammawat S, et al. Promoting informed choice: evaluating a decision-making tool for family planning clients and providers in Mexico. International Family Planning Perspectives 2005;31(4):162-71. [DOI] [PubMed] [Google Scholar]

Kim 2007 {published data only}

  1. Kim YM, Davila C, Tellez C, Kols A. Evaluation of the World Health Organization's family planning decision-making tool: improving health communication in Nicaragua. Patient Education and Counseling 2007;66(2):235-42. [DOI] [PubMed] [Google Scholar]

Kinney 2014 {published data only}

  1. Kinney AY, Butler KM, Schwartz MD, Mandelblatt JS, Boucher KM, Pappas LM, et al. Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial. Journal of the National Cancer Institute 2014;106(12):dju328. [DOI] [PMC free article] [PubMed] [Google Scholar]

Kinney 2016 {published data only}

  1. Kinney AY, Steffen LE, Brumbach BH, Kohlmann W, Du R, Lee JH, et al. Randomized noninferiority trial of telephone delivery of BRCA1/2 genetic counseling compared with in-person counseling: 1-year follow-up. Journal of Clinical Oncology 2016;34(24):2914-24. [DOI] [PMC free article] [PubMed] [Google Scholar]

Kirk 2016 {published data only}

  1. Kirk J, Quinn VF, Meiser B, Tucker KM, Watts KJ, Rahman B, et al. Streamlined genetic education is effective in preparing women newly diagnosed with breast cancer for decision-making about treatment-focused genetic testing: a randomized controlled noninferiority trial. Asia-Pacific Journal of Clinical Oncology 2016;12 Suppl 5:76-7. [DOI] [PubMed] [Google Scholar]

Knerr 2017 {published data only}

  1. Knerr S, Wernli KJ, Leppig K, Ehrlich K, Graham AL, Farrell D, et al. A web-based personalized risk communication and decision-making tool for women with dense breasts: design and methods of a randomized controlled trial within an integrated health care system. Contemporary Clinical Trials 2017;56:25-33. [DOI] [PMC free article] [PubMed] [Google Scholar]

Kosaka 2017 {published data only}

  1. Kosaka S, Hoshino J, Yamanouchi M, Sekine A. Assessment of efficacy of a CKD support decision making application and home blood pressure measurement system in patients with CKD: study protocol of a randomized, controlled trial. Journal of the American Society of Nephrology  2017;28(Abstract Suppl):1013. [Google Scholar]

Labrias 2020 {published data only}

  1. Labrias PR, Feinn R, Johnson S, McLeod KM. Investigating the impact of a theory-based education intervention on patients' osteoporosis knowledge, health beliefs, and self-efficacy after DXA. Osteoporosis International 2020;31 Suppl 1:S341. [Google Scholar]

Larsson 2017 {published data only}

  1. Larsson B, Karlstrom A, Rubertsson C, Ternstrom E, Ekdahl J, Segebladh B, et al. Birth preference in women undergoing treatment for childbirth fear: a randomised controlled trial. Women and Birth 2017;30(6):460-7. [DOI] [PubMed] [Google Scholar]

Lauffenburger 2019 {published data only}

  1. Lauffenburger JC, Roya G, Saira J, Sagar M, Ferro CA, Lewey J, et al. Impact of a novel pharmacist-delivered behavioral intervention for patients with poorly-controlled diabetes: the ENhancing outcomes through Goal Assessment and Generating Engagement in Diabetes Mellitus (ENGAGE-DM) pragmatic randomized trial. PLOS One 2019;14(4):e0214754. [DOI] [PMC free article] [PubMed] [Google Scholar]

Lazcano 2000 {published data only}

  1. Lazcano Ponce EC, Sloan NL, Winikoff B, Langer A, Coggins C, Heimburger A, et al. The power of information and contraceptive choice in a family planning setting in Mexico. Sexually Transmitted Infections 2000;76(4):277-81. [DOI] [PMC free article] [PubMed] [Google Scholar]

Le 2015 {published data only}

  1. Le TK, Chang M, Nelson C, Sortais JA, Chand P, Tallman K. Upstream discussion provided in the ambulatory setting to assist patients with chronic kidney disease considering dialysis. Permanente Journal 2015;19(1):30‐3. [DOI] [PMC free article] [PubMed] [Google Scholar]

LeBlanc 2015 {published data only}

  1. LeBlanc A, Wang AT, Wyatt K, Branda ME, Shah ND, Van Houten H, et al. Encounter decision aid vs. clinical decision support or usual care to support patient-centered treatment decisions in osteoporosis: the Osteoporosis Choice randomized trial II. PLOS One 2015;10(5):e0128063. [DOI] [PMC free article] [PubMed] [Google Scholar]

Legare 2003 {published data only}

  1. Legare F, Tremblay S, O'Connor AM, Graham ID, Wells GA, Jacobsen MJ. Factors associated with the difference in score between women's and doctors' decisional conflict about hormone therapy: a multilevel regression analysis. Health Expectations 2003;6(3):208-21. [DOI] [PMC free article] [PubMed] [Google Scholar]

Levi 2017 {published data only}

  1. Levi BH, Simmons Z, Hanna C, Brothers A, Lehman E, Farace E, et al. Advance care planning for patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2017;18(5-6):388-96. [DOI] [PMC free article] [PubMed] [Google Scholar]

Lewis 2018 {published data only}

  1. Lewis KL, Umstead KL, Johnston JJ, Miller IM, Thompson LJ, Fishler KP, et al. Outcomes of counseling after education about carrier results: a randomized controlled trial. American Journal of Human Genetics 2018;102(4):540-6. [DOI] [PMC free article] [PubMed] [Google Scholar]

Liao 2016 {published data only}

  1. Liao C, Navas JJ, Amaya S, Yazdany T. Randomized trial of an enhanced visual consulation and standard consultation for prolapse: impact on patient satisfaction, knowledge and treatment decision. Female Pelvic Medicine & Reconstructive Surgery 2016;22 (5 Suppl 1):S65-6. [Google Scholar]

Liberatore 2003 {published data only}

  1. Liberatore MJ, Myers RE, Nydick RL, Steinberg M, Brown ER, Gay R, et al. Decision counseling for men considering prostate cancer screening. Computers & Operations Research 2003;30(10):1421-34. [Google Scholar]

Lurie 2011 {published data only}

  1. Lurie JD, Spratt KF, Blood EA , Tosteson TD, Tosteson AN, Weinstein JN. Effects of viewing an evidence-based video decision aid on patients' treatment preferences for spine surgery. Spine (Phila Pa 1976) 2011;36(18):1501-4. [DOI] [PMC free article] [PubMed] [Google Scholar]

Manchanda 2016 {published data only}

  1. Manchanda R, Burnell M, Loggenberg K, Desai R, Wardle J, Sanderson SC, et al. Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutations. Journal of Medical Genetics 2016;53(7):472-80. [DOI] [PubMed] [Google Scholar]

Manne 2010 {published data only}

  1. Manne SL, Meropol NJ, Weinberg DS, Vig H, Ali-Khan Catts Z, Manning C, et al. Facilitating informed decisions regarding microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer. Journal of Clinical Oncology 2010;28(8):1366-72. [DOI] [PMC free article] [PubMed] [Google Scholar]

Martin 1999 {published data only}

  1. Martin CD. Psychological aspects of genetic counseling and testing for melanoma predisposition (expectancy value). Dissertation Abstracts International: Section B: the Sciences and Engineering 1999;60:2380. [Google Scholar]

Maslin 1998a {published data only}

  1. Maslin AM, Baum M, Walker JS, A'Hern R, Prouse A. Using an interactive video disk in breast cancer patient support. Nursing Times 1998;94(44):52-5. [PubMed] [Google Scholar]

Maslin 1998b {published data only}

  1. Maslin AM, Baum M, Walker JS, A'Hern R, Prouse A. Shared decision-making using an interactive video disk system for women with early breast cancer. NT Research 1998;3(6):444-55. [Google Scholar]

Massey 2016 {published data only}

  1. Massey EK, Gregoor PJ, Nette RW, Van den Dorpel  A, Van Kooij A, Zietse R, et al. Early home-based group education to support informed decision-making among patients with end-stage renal disease: a multi-centre randomized controlled trial. Nephrology, Dialysis, Transplantation 2016;31(5):823-30. [DOI] [PubMed] [Google Scholar]

McIlvennan 2018 {published data only}

  1. McIlvennan CK, Matlock DD, Thompson JS, Dunlay SM, Blue L, LaRue SJ, et al. Caregivers of patients considering a destination therapy left ventricular assist device and a shared decision-making intervention: the DECIDE-LVAD Trial. JACC Heart Failure 2018;6(11):904-13. [DOI] [PubMed] [Google Scholar]

Metz 2019 {published data only}

  1. Metz MJ, Veerbeek MA, Twisk JWR, Van der Feltz-Cornelis CM, De Beurs E, Beekman ATF. Shared decision-making in mental health care using routine outcome monitoring: results of a cluster randomised-controlled trial. Social Psychiatry and Psychiatric Epidemiology 2019;54(2):209-19. [DOI] [PubMed] [Google Scholar]

Miller 2005b {published data only}

  1. Miller SM, Roussi P, Daly MB, Buzaglo JS, Sherman K, Godwin AK, et al. Enhanced counseling for women undergoing BRCA1/2 testing: impact on subsequent decision making about risk reduction behaviors. Health Education & Behavior 2005;32(5):654-67. [DOI] [PubMed] [Google Scholar]

Minneci 2019 {published data only}

  1. Minneci PC, Cooper JN, Leonhart K, Nacion K, Sulkowski J, Porter K, et al. Effects of a patient activation tool on decision making between surgery and nonoperative management for pediatric appendicitis: a randomized clinical trial. JAMA Network Open 2019;2(6):e195009. [DOI] [PMC free article] [PubMed] [Google Scholar]

Mino 2020 {published data only}

  1. Mino MF, Paz Y, Martinez-Portilla RJ, Pauta M, Borrell A. OC11.03: a randomised controlled trial on the influence of extensive prenatal counselling on the attitudes and preferences towards first-line prenatal testing for fetal aneuploidy detection (INVASIVE). Ultrasound in Obstetrics & Gynecology 2020;56:32. [Google Scholar]

Mohamed 2018 {published data only}

  1. Mohamed N, Leung TM, Mehrazin R, Sfakianos J, Knauer C. An intervention to improve bladder cancer knowledge and treatment decision making in patients with muscle invasive bladder cancer: a pilot study. Journal of Urology 2018;199 (4 Suppl 1):e310-11. [Google Scholar]

Moudi 2020 {published data only}

  1. Moudi Z, Ansari H, Umarzeh M. Effect of the REDI counselling approach on the use of modern postpartum contraceptive methods among adolescent mothers in Iran. Africa Journal of Nursing and Midwifery 2020;22(2):1-19. [Google Scholar]

Murray 2004 {published data only}

  1. Murray S, Shetty A, Rattray A, Taylor V, Bhattacharya S. A randomized comparison of alternative methods of information provision on the acceptability of elective single embryo transfer. Human Reproduction (Oxford, England) 2004;19(4):911-6. [DOI] [PubMed] [Google Scholar]

Myers 2012 {published data only}

  1. Myers RE, Manne S, Ruth K, Cocroft J, Sifri R, Ziring B, et al. Predictors of change in colorectal cancer screening decision stage among participants in a randomized, controlled trial of genetic and environmental risk assessment. Cancer Prevention Research 2012;5(11 Suppl 1):No pagination. [Google Scholar]

Myers 2019 {published data only}

  1. Myers RE, Stello B, Daskalakis C, Sifri R, González ET, DiCarlo M, et al. Decision support and navigation to increase colorectal cancer screening among Hispanic patients. Cancer Epidemiology, Biomarkers & Prevention 2019;28(2):384-91. [DOI] [PubMed] [Google Scholar]

NCT00262899 {published data only}

  1. NCT00262899. Genetic counseling or usual care in helping women with newly diagnosed ductal carcinoma in situ or stage I, stage II, or stage IIIA breast cancer make treatment decisions. clinicaltrials.gov/show/NCT00262899 (first received December 6, 2005).

Nichol 1992 {published data only}

  1. Nichol MB, McCombs JS, Johnson KA, Spacapan S, Sclar DA. The effects of consultation on over-the-counter medication purchasing decisions. Medical Care 1992;30(11):989-1003. [DOI] [PubMed] [Google Scholar]

Nosratabadi 2018 {published data only}

  1. Nosratabadi M, Hekmat K, Dencker A, Abbaspoor Z. Individual and group psycho-educational counseling on knowledge, attitude and preference for birth method in nulliparous women: a randomized controlled trial. Journal of Family and Reproductive Health 2018;12(2):103-10. [PMC free article] [PubMed] [Google Scholar]

O'Cathain 2002 {published data only}

  1. O'Cathain A, Walters S, Thomas K, Kirkham M. Use of evidence based leaflets to promote informed choice in maternity care: randomized controlled trial in everyday practice. BMJ (Clinical Research Edition) 2002;324:643. [DOI] [PMC free article] [PubMed] [Google Scholar]

Oduncu 2002 {published data only}

  1. Oduncu FS. The role of non-directiveness in genetic counseling. Medicine, Health care, and Philosophy 2002;5(1):53-63. [DOI] [PubMed] [Google Scholar]

Omer 2007 {published data only}

  1. Omer R, Dar R. Comparing decision counseling to strategic counseling for individuals with personal dilemmas. Psychotherapy Research 2007;17:600-12. [Google Scholar]

Parapiboon 2020 {published data only}

  1. Parapiboon W, Pitsawong W, Wongluechai L, Thammavaranucupt K, Raegasint L. Customized versus conventional video counseling for peritoneal dialysis decision-making in patients with stage 5 chronic kidney disease under a PD-first policy: a randomized controlled study. Kidney Research and Clinical Practice 2020;39(4):451-9. [DOI] [PMC free article] [PubMed] [Google Scholar]

Park 2005 {published data only}

  1. Park S, Chang S, Chung C. Effects of a cognition-emotion focused program to increase public participation in Papanicolaou smear screening. Public Health Nursing 2005;22(4):289‐98. [DOI] [PubMed] [Google Scholar]

Paz 2020 {published data only}

  1. Paz Y Miño F, Martinez-Portilla RJ, Pauta M, Borrell A. A randomized controlled trial on the influence of prenatal counseling on the attitudes and preferences toward invasive prenatal testing among women in their first trimester of pregnancy (INVASIVE). Frontiers in Genetics 2020;11:561283. [DOI] [PMC free article] [PubMed] [Google Scholar]

Pearson 2020 {published data only}

  1. Pearson E, Senderowicz L, Pradhan E, Francis J, Muganyizi P, Shah I, et al. Effect of a postpartum family planning intervention on postpartum intrauterine device counseling and choice: evidence from a cluster-randomized trial in Tanzania. BMC Women's Health 2020;20(1):102. [DOI] [PMC free article] [PubMed] [Google Scholar]

Pendley 2018 {published data only}

  1. Pendley SL, Lusk L, Kaplan ET, Hunt WR Stecenko A, Bellcross C,  et al. Comparison of a self-directed educational module on genetics to in-person counseling for cystic fibrosis adolescents. Pediatric Pulmonology 2018;53 Suppl 2:447. [Google Scholar]

Penson 2011 {published data only}

  1. Penson DF. Supporting informed decision making for prostate specific antigen (PSA) testing on the web: an online randomized controlled trial. Journal of Urology 2011;185(6):2158-9. [DOI] [PMC free article] [PubMed] [Google Scholar]

Peralta 2019 {published data only}

  1. Peralta CA, Robinson AD, Livaudais-Toman J, Stebbins M, Scherzer R, Lo LJ, et al. Pragmatic cluster-randomized trial of an electronic clinical decision support system (ECDSS) to improve CKD management in primary care. Journal of the American Society of Nephrology  2019;30:13-4. [Google Scholar]

Peralta 2020 {published data only}

  1. Peralta CA, Livaudais-Toman J, Stebbins M, Lo L, Robinson A, Pathak S, et al. Electronic decision support for management of CKD in primary care: a pragmatic randomized trial. American Journal of Kidney Diseases 2020;76(5):636-44. [DOI] [PMC free article] [PubMed] [Google Scholar]

Perestelo‐Perez 2017 {published data only}

  1. Perestelo-Perez L, Rivero-Santana A, Sanchez-Afonso JA, Perez-Ramos J, Castellano-Fuentes CL, Sepucha K, et al. Effectiveness of a decision aid for patients with depression: a randomized controlled trial. Health Expectations 2017;20(5):1096-105. [DOI] [PMC free article] [PubMed] [Google Scholar]

Pieterse 2005 {published data only}

  1. Pieterse AH, Ausems MG, Van Dulmen AM, Beemer FA, Bensing JM. Initial cancer genetic counseling consultation: change in counselees' cognitions and anxiety, and association with addressing their needs and preferences. American Journal of Medical Genetics - Part A 2005;137(1):27-35. [DOI] [PubMed] [Google Scholar]

Rahn 2014 {published data only}

  1. Rahn A, Kopke S, Kasper J, Backhus I, Muhlhauser I, Heesen C. Nurse-led immunotherapy DEcision Coaching In Multiple Sclerosis (DECIMS) - design and feasibility study for a cluster randomised controlled trial. Multiple Sclerosis (Houndmills, Basingstoke, England) 2014;20(7):1007. [Google Scholar]

Rahn 2016 {published data only}

  1. Rahn AC, Kopke S, Backhus I, Kasper J, Krutzelmann A, Kleiter I, et al. Decision coaching in multiple sclerosis (DECIMS) - pilot randomised controlled trial and process evaluation. Multiple Sclerosis 2016;22 Suppl 3:681-2. [Google Scholar]

Rahn 2019 {published data only}

  1. Rahn AC, Kopke S, Barabasch A, Heesen C. Nurse-led immunotreatment decision coaching in people with multiple sclerosis (DECIMS) - cluster randomised controlled trial and process evaluation (ISRCTN37929939). Multiple Sclerosis Journal 2019;25 Suppl 2:575-6. [Google Scholar]

Raphaelis 2018 {published data only}

  1. Raphaelis S, Mayer H, Ott S, Hornung R, Senn B. Effects of written information and counseling on illness-related uncertainty in women with vulvar neoplasia. Oncology Nursing Forum 2018;45(6):748-60. [DOI] [PubMed] [Google Scholar]

Redfern 2009 {published data only}

  1. Redfern J, Briffa T, Ellis E, Freedman SB. Choice of secondary prevention improves risk factors after acute coronary syndrome: 1-year follow-up of the CHOICE (Choice of Health Options In prevention of Cardiovascular Events) randomised controlled trial. Heart (British Cardiac Society) 2009;95(6):468-75. [DOI] [PubMed] [Google Scholar]

Reinhardt 2014 {published data only}

  1. Reinhardt JP, Chichin E, Posner L, Kassabian S. Vital conversations with family in the nursing home: preparation for end-stage dementia care. Journal of Social Work in End-of-Life & Palliative Care 2014;10(2):112-26. [DOI] [PubMed] [Google Scholar]

Rimer 2001 {published data only}

  1. Rimer BK, Halabi S, Sugg Skinner C, Kaplan EB, Crawford Y, Samsa GP, et al. The short-term impact of tailored mammography decision-making interventions. Patient Education and Counseling 2001;43(3):269-85. [DOI] [PubMed] [Google Scholar]

Rimer 2002 {published data only}

  1. Rimer BK, Halabi S, Sugg Skinner C, Lipkus IM, Strigo TS, Kaplan EB, et al. Effects of a mammography decision-making intervention at 12 and 24 months. American Journal of Preventive Medicine 2002;22(4):247-57. [DOI] [PubMed] [Google Scholar]

Rothert 1997 {published data only}

  1. Rothert ML, Holmes-Rovner M,  Rovner D,  Kroll J,  Breer L,  Talarczyk G, et al. An educational intervention as decision support for menopausal women. Research in Nursing & Health 1997;20(5):377-87. [DOI] [PubMed] [Google Scholar]

Roussi 2010 {published data only}

  1. Roussi P, Sherman KA, Miller S, Buzaglo J, Daly M, Taylor A, et al. Enhanced counselling for women undergoing BRCA1/2 testing: impact on knowledge and psychological distress - results from a randomised clinical trial. Psychology & Health 2010;25(4):401-15. [DOI] [PMC free article] [PubMed] [Google Scholar]

Schroy 2012 {published data only}

  1. Schroy PC, Emmons KM, Peters E, Glick JT, Robinson PA, Lydotes MA, et al. Aid-assisted decision making and colorectal cancer screening: a randomized controlled trial. American Journal of Preventive Medicine 2012;43(6):573-83. [DOI] [PMC free article] [PubMed] [Google Scholar]

Schubart 2019 {published data only}

  1. Schubart JR, Levi BH, Bain MM, Farace E, Green MJ. Advance care planning among patients with advanced cancer. Journal of Oncology Practice 2019;15(1):e65-e73. [DOI] [PubMed] [Google Scholar]

Schwartz 2014 {published data only}

  1. Schwartz MD, Valdimarsdottir HB, Peshkin BN, Mandelblatt J, Nusbaum R, Huang AT, et al. Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer. Journal of Clinical Oncology 2014;32(7):618-26. [DOI] [PMC free article] [PubMed] [Google Scholar]

Schwartz 2018 {published data only}

  1. Schwartz MD, Peshkin BN, Isaacs C, Willey S, Valdimarsdottir HB, Nusbaum R, et al. Randomized trial of proactive rapid genetic counseling versus usual care for newly diagnosed breast cancer patients. Breast Cancer Research and Treatment 2018;170(3):517‐24. [DOI] [PMC free article] [PubMed] [Google Scholar]

Sepucha 2002 {published data only}

  1. Sepucha KR, Belkora JK, Mutchnick S, Esserman LJ. Consultation planning to help breast cancer patients prepare for medical consultations: effect on communication and satisfaction for patients and physicians. Journal of Clinical Oncology 2002;20(11):2695-700. [DOI] [PubMed] [Google Scholar]

Sepuchra 2000 {published data only}

  1. Sepuchra KR, Belkora JK, Tripathy D, Esserman LJ. Building bridges between physicians and patients: results of a pilot study examining new tools for collaborative decision making in breast cancer. Journal of Clinical Oncology 2000;18(6):1230-8. [DOI] [PubMed] [Google Scholar]

Shelin 2019 {published data only}

  1. Shelin A, Birch PH, Coe RR, Bansback N, Jones AL, Connolly MB, et al. Assessing an interactive online tool to support parents' genomic testing decisions. Journal of Genetic Counseling 2019;28(1):10-17. [DOI] [PubMed] [Google Scholar]

Sheridan 2011 {published data only}

  1. Sheridan SL, Draeger LB, Pignone MP, Keyserling TC, Simpson RJ Jr, Rimer B, et al. A randomized trial of an intervention to improve use and adherence to effective coronary heart disease prevention strategies. BMC Health Services Research 2011;11:331. [DOI] [PMC free article] [PubMed] [Google Scholar]

Sheridan 2014 {published data only}

  1. Sheridan SL, Draeger LB, Pignone MP, Rimer B, Bangdiwala SI, Cai J, et al. The effect of a decision aid intervention on decision making about coronary heart disease risk reduction: secondary analyses of a randomized trial. BMC Medical Informatics and Decision Making 2014;14:14. [DOI] [PMC free article] [PubMed] [Google Scholar]

Simoni 2015 {published data only}

  1. Simoni JM, Yang JP, Shiu CS, Chen WT, Udell W, Bao M, et al. Nurse-delivered counselling intervention for parental HIV disclosure: results from a pilot randomized controlled trial in China. AIDS (London, England) 2015;29 Suppl 1:S99‐S107. [DOI] [PMC free article] [PubMed] [Google Scholar]

Simons 2017 {published data only}

  1. Simons HR, Leon-Atkins J, Spector H, Fager G, Kantor L, Kohn JE. Associations between contraceptive counseling practices and patient satisfaction. Contraception 2017;96(4):285-6. [DOI] [PubMed] [Google Scholar]

Skinner 2002 {published data only}

  1. Skinner CS, Schildkraut JM, Berry D, Calingaert B, Marcom PK, Sugarman J, et al. Pre-counseling education materials for BRCA testing: does tailoring make a difference? Genetic Testing 2002;6(2):93-105. [DOI] [PubMed] [Google Scholar]

Street 2010 {published data only}

  1. Street R, Slee C, Kalauokalani D, Evans Dean D, Tancredi D, Kravitz R. Improving physician-patient communication about cancer pain with a tailored education-coaching intervention. Patient Education and Counseling 2010;80(1):42-7. [DOI] [PMC free article] [PubMed] [Google Scholar]

SUPPORT 1996 {published data only}

  1. SUPPORT Principal Investigators. A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). JAMA 1995;274(20):1591-8. Erratum in: JAMA 1996 Apr 24;275(16):1232. [PubMed] [Google Scholar]

Sweet 2014 {published data only}

  1. Sweet K, Gordon ES, Sturm AC, Schmidlen TJ, Manickam K, Toland AE, et al. Design and implementation of a randomized controlled trial of genomic counseling for patients with chronic disease. Journal of Personalized Medicine 2014;4(1):1-19. [DOI] [PMC free article] [PubMed] [Google Scholar]

Swoboda 2016 {published data only}

  1. Swoboda CM. Multiple Behavior Change using Goal Setting, Decision Support, and Motivational Interviewing for Type 2 Diabetes [PhD thesis]. Ohio (USA): OhioLINK Electronic Theses and Dissertations Center, 2016 . [Google Scholar]

Swoboda 2017 {published data only}

  1. Swoboda CM, Miller CK, Wills CE. Impact of a goal setting and decision support telephone coaching intervention on diet, psychosocial, and decision outcomes among people with type 2 diabetes. Patient Education and Counseling 2017;100(7):1367-73. [DOI] [PubMed] [Google Scholar]

Talen 2011 {published data only}

  1. Talen MR, Muller-Held CF, Eshleman KG, Stephens L. Patients' communication with doctors: a randomized controlled study of a brief patient communication intervention. Families, Systems & Health 2011;29(3):171-83. [DOI] [PubMed] [Google Scholar]

Tea 2018 {published data only}

  1. Tea MM, Tan YY, Staudigl C, Eibl B, Renz R, Asseryanis E, et al. Improving comprehension of genetic counseling for hereditary breast and ovarian cancer clients with a visual tool. PLOS One 2018;13(7):e0200559. [DOI] [PMC free article] [PubMed] [Google Scholar]

Thomas 2013 {published data only}

  1. Thomas KL, Zimmer LO, Dai D, Al-Khatib SM, Allen LaPointe NM, Peterson ED. Educational videos to reduce racial disparities in ICD therapy via innovative designs (VIVID): a randomized clinical trial. American Heart Journal 2013;166(1):157-63. [DOI] [PubMed] [Google Scholar]

Thomson 2007 {published data only}

  1. Thomson RG, Eccles MP, Steen IN, Greenaway J, Stobbart L, Murtagh MJ, et al. A patient decision aid to support shared decision-making on anti-thrombotic treatment of patients with atrial fibrillation: randomised controlled trial. Quality & Safety in Health Care 2007;16(3):216-23. [DOI] [PMC free article] [PubMed] [Google Scholar]

Tingey 2015 {published data only}

  1. Tingey L, Mullany B, Chambers R, Hastings R, Lee A, Parker A, et al. Respecting the circle of life: one year outcomes from a randomized controlled comparison of an HIV risk reduction intervention for American Indian adolescents. AIDS Care 2015;27:1087-97. [DOI] [PubMed] [Google Scholar]

Toohill 2014 {published data only}

  1. Toohill J, Fenwick J, Gamble J, Creedy DK, Buist A, Turkstra E, et al. A randomized controlled trial of a psycho-education intervention by midwives in reducing childbirth fear in pregnant women. Birth (Berkeley, Calif.) 2014;41(4):384-94. [DOI] [PMC free article] [PubMed] [Google Scholar]

Van Peperstraten 2011 {published data only}

  1. Van Peperstraten AM, Kreuwel IM, Hulscher ME, Kremer JM, Grol RM, Nelen WM, et al. The value of different means of support in shared decision making for single or double embryo transfer. Human Reproduction (Oxford, England) 2011;1:i96-7. [Google Scholar]

Van Roosmalen 2004 {published data only}

  1. Van Roosmalen MS, Stalmeier PF, Verhoef LC, Hoekstra-Weebers JE, Oosterwijk JC, Hoogerbrugge N, et al. Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers. Journal of Clinical Oncology 2004;22(16):3293-3301. [DOI] [PubMed] [Google Scholar]

Van Tol‐Geerdink 2013 {published data only}

  1. Van Tol-Geerdink JJ, Willem Leer J, Weijerman PC, Van Oort IM, Vergunst H, Van Lin EN, et al. Choice between prostatectomy and radiotherapy when men are eligible for both: a randomized controlled trial of usual care vs decision aid. BJU International 2013;111(4):564‐73. [DOI] [PubMed] [Google Scholar]

Veroff 2013 {published data only}

  1. Veroff D, Marr A, Wennberg DE. Enhanced support for shared decision making reduced costs of care for patients with preference-sensitive conditions. Health Affairs (Project Hope) 2013;32(2):285-93. [DOI] [PubMed] [Google Scholar]

Vitinius 2019 {published data only}

  1. Vitinius F, Koberlein-Neu J, Steckelberg A, Berger-Hoger B, Isselhard A, Rhiem K, et al. Evaluation of a decision coaching program for structured decision support in preference sensitive decisions of risk-adapted prevention for BRCA1/2 (BReast CAncer)gene carriers: study of a German multicentre study. Journal of Psychosomatic Research 2019;121:133-4. [Google Scholar]

Vitinius 2020 {published data only}

  1. Vitinius F,  Koberlein-Neu J,  Steckelberg A, Berger-Hoger B,  Beifus K,  Fischer H, et al. Study protocol of the German multicentre study "evaluation of a decision coaching program for structured decision support of preference sensitive decisions within the context of risk-adapted prevention for BRCA1/2 (breast cancer) gene carriers" (EDCP-BRCA). Oncology Research and Treatment 2020;43 Suppl 1:229. [Google Scholar]

Voepel‐Lewis 2020 {published data only}

  1. Voepel-Lewis T, Malviya S, Grant JA, Dwyer S, Becher A, Schwartz JH, et al. Effect of a brief scenario-tailored educational program on parents' risk knowledge, perceptions, and decisions to administer prescribed opioids: a randomized controlled trial. Pain 2020;162(3):976-85. [DOI] [PMC free article] [PubMed] [Google Scholar]

Volk 1999 {published data only}

  1. Volk RJ, Cass AR, Spann SJ. A randomized controlled trial of shared decision making for prostate cancer screening. Archives of Family Medicine 1999;8(4):333-40. [DOI] [PubMed] [Google Scholar]

Wakefield 2008 {published data only}

  1. Wakefield CE, Meiser B, Homewood J, Taylor A, Gleeson M, Williams R, et al. A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling. Psycho-Oncology 2008;17(8):844-54. [DOI] [PubMed] [Google Scholar]

Walczak 2017 {published data only}

  1. Walczak A, Butow PN, Tattersall MHN, Davidson PM, Young J, Epstein RM, et al. Encouraging early discussion of life expectancy and end-of-life care: a randomised controlled trial of a nurse-led communication support program for patients and caregivers. International Journal of Nursing Studies 2017;67:31-40. [DOI] [PubMed] [Google Scholar]

Wang 2005 {published data only}

  1. Wang C, Gonzalez R, Milliron KJ, Strecher VJ, Merajver SD. Genetic counseling for BRCA1/2: a randomized controlled trial of two strategies to facilitate the education and counseling process. American Journal of Medical Genetics. Part A 2005;134A(1):66-73. [DOI] [PubMed] [Google Scholar]

Waterman 2015 {published data only}

  1. Waterman AD, McSorley AM, Peipert JD, Goalby CJ, Peace LJ, Lutz PA, et al. Explore transplant at home: a randomized control trial of an educational intervention to increase transplant knowledge for black and white socioeconomically disadvantaged dialysis patients. BMC Nephrology 2015;16:150. [DOI] [PMC free article] [PubMed] [Google Scholar]

Waterman 2017 {published data only}

  1. Waterman A, Peipert J, McSorley AM, Goalby C, Peace L. At-home transplant education increases black and low-income dialysis patients' transplant knowledge, attitudes, informed decision-making, and pursuit: an explore transplant @ home randomized controlled trial. American Journal of Transplantation 2017;13 Suppl 3:381. [Google Scholar]

Waterman 2018a {published data only}

  1. Waterman A, Peipert J, Beaumont J. Efficacy of at-home transplant education on transplant knowledge and pursuit in low-income and black dialysis patients with varying educational characteristics. American Journal of Transplantation 2018;18 Suppl 4:338. [Google Scholar]

Waterman 2018b {published data only}

  1. Waterman AD, Peipert JD. An explore transplant group randomized controlled education trial to increase dialysis patients' decision-making and pursuit of transplantation. Progress in Transplantation (Aliso Viejo, Calif.) 2018;28(2):174-83. [DOI] [PubMed] [Google Scholar]

Waterman 2019 {published data only}

  1. Waterman AD, Cui Y, Peipert JD, Beaumont JL, Anderson CS, Paiva AL, et al. Your path to transplant education increases patients' transplant knowledge, attitudes, informed decision-making, and pursuit: an randomized controlled trial. American Journal of Transplantation 2019;19 Suppl 3:420. [Google Scholar]

Wensaas 2014 {published data only}

  1. Wensaas L, Ruland CM, Moore SM. Effects of a decision aid and additional decisional counselling on cardiac risk reduction behaviour and health outcomes: randomised controlled trial. European Heart Journal 2014;35:347. [Google Scholar]

Wenzel 2019 {published data only}

  1. Wenzel LA, Peper J, Scheiderbauer J, Meyer B, Haas J, Focke K, et al. Development of an interactive web-based educational programme on relapse management for people with multiple sclerosis (Power@MS2). Multiple Sclerosis Journal 2019;25(7):1066. [Google Scholar]

Westermann 2013 {published data only}

  1. Westermann GM, Verheij F, Winkens B, Verhulst FC, Van Oort FV. Structured shared decision-making using dialogue and visualization: a randomized controlled trial. Patient Education and Counseling 2013;90(1):74-81. [DOI] [PubMed] [Google Scholar]

Wevers 2013 {published data only}

  1. Wevers M, Ausems M, Bleiker E, Rutgers E, Witkamp A, Hahn D, et al. Psychosocial impact of rapid genetic counseling and testing in breast cancer patients: findings from a RCT. Psycho-Oncology 2013;3:25-6. [Google Scholar]

Wevers 2014 {published data only}

  1. Wevers MR, Aaronson NK, Verhoef S, Bleiker EM, Hahn DE, Kuenen MA, et al. Impact of rapid genetic counselling and testing on the decision to undergo immediate or delayed prophylactic mastectomy in newly diagnosed breast cancer patients: findings from a randomised controlled trial. British Journal of Cancer 2014;110(4):1081-7. [DOI] [PMC free article] [PubMed] [Google Scholar]

Wevers 2017 {published data only}

  1. Wevers MR, Aaronson NK, Bleiker EA, Hahn DE, Brouwer T, Van Dalen T, et al. Rapid genetic counseling and testing in newly diagnosed breast cancer: patients' and health professionals' attitudes, experiences, and evaluation of effects on treatment decision making. Journal of Surgical Oncology 2017;116(8):1029-39. [DOI] [PubMed] [Google Scholar]

Wilkie 2020 {published data only}

  1. Wilkie DJ, Yao Y, Ezenwa MO, Suarez ML, Dyal BW, Gill A, et al. A stepped-wedge randomized controlled trial: effects of eHealth interventions for pain control among adults with cancer in hospice. Journal of Pain and Symptom Management 2020;59(3):626-36. [DOI] [PubMed] [Google Scholar]

Wolf 1996 {published data only}

  1. Wolf AM, Nasser JF, Schorling JB. The impact of informed consent on patient interest in prostate-specific antigen screening. Archives of Internal Medicine 1996;156(12):1333‐6. [PubMed] [Google Scholar]

Wolf 2000 {published data only}

  1. Wolf AM, Schorling JB. Does informed consent alter elderly patients' preferences for colorectal cancer screening? Results of a randomized trial. Journal of General Internal Medicine 2000;15(1):24-30. [DOI] [PMC free article] [PubMed] [Google Scholar]

Yee 2014 {published data only}

  1. Yee LM, Wolf M, Mullen R, Bergeron AR, Cooper Bailey S, Levine R, et al. A randomized trial of a prenatal genetic testing interactive computerized information aid. Prenatal Diagnosis 2014;34(6):552-7. [DOI] [PMC free article] [PubMed] [Google Scholar]

References to studies awaiting assessment

Hadizadeh‐Talasaz 2021 {published data only}

  1. Hadizadeh-Talasaz F, Ghoreyshi F, Mohammadzadeh F, Rahmani R. Effect of shared decision making on mode of delivery and decisional conflict and regret in pregnant women with previous cesarean section: a randomized clinical trial. BMC Pregnancy and Childbirth 2021;21(1):144. [DOI: 10.1186/s12884-021-03615-w] [DOI] [PMC free article] [PubMed] [Google Scholar]

Perfors 2021 {published data only}

  1. Perfors IAA, Noteboom EA, De Wit NJ, Van der Wall E, Visserman EA, Van Dalen T, et al. Effects of a time out consultation with the general practitioner on cancer treatment decision-making: a randomised controlled trial: time out with the general practitioner and cancer treatment decision. Psycho-Oncology 2021;30(4):571-80. [DOI: 10.1002/pon.5604] [DOI] [PMC free article] [PubMed] [Google Scholar]

Wagner 2021 {published data only}

  1. Wagner GJ, Wanyenze RK, Beyeza-Kashesya J, Gwokyalya V, Hurley E, Mindry D, et al. "Our Choice" improves use of safer conception methods among HIV serodiscordant couples in Uganda: a cluster randomized controlled trial evaluating two implementation approaches. Implementation Science 2021;16(1):41. [DOI: 10.1186/s13012-021-01109-z] [DOI] [PMC free article] [PubMed] [Google Scholar]

Wang 2021 {published data only}

  1. Wang TJ, Chiu PP, Chen KK, Hung LP. Efficacy of a decision support intervention for reducing decisional conflict in patients with elevated serum prostate-specific antigen: a randomized controlled trial. European Journal of Oncology Nursing  2021;50:101865. [DOI: 10.1016/j.ejon.2020.101865] [DOI] [PubMed] [Google Scholar]

References to ongoing studies

Chambers 2008 {published data only}

  1. Chambers SK, Ferguson M, Gardiner RA, Nicol D, Gordon L,  Occhipinti S, et al. ProsCan for men: randomised controlled trial of a decision support intervention for men with localised prostate cancer. BMC Cancer 2008;8:207. [DOI: 10.1186/1471-2407-8-207] [DOI] [PMC free article] [PubMed] [Google Scholar]

DRKS00015527 {published data only}

  1. DRKS00015527. Evaluation of a decision coaching program for structured decision support in preference sensitive decisions of risk-adapted prevention for BRCA1/2 gene mutation carriers (EDCP-BRCA). www.who.int/trialsearch/Trial2.aspx?TrialID=DRKS00015527 (first received October 30, 2019).

IRCT2017100231117N5 {published data only}

  1. IRCT2017100231117N5. Effect of crisis counseling on anxiety, decision-making style and strategies in women with unplanned pregnancy. www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2017100231117N5 (first received November 11, 2017).

IRCT20200105046014N1 {published data only}

  1. IRCT20200105046014N1. The effect of individual counseling on the intention to choose. www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT20200105046014N1 (first received February 22, 2020).

Karra 2021 {published data only}

  1. Karra M, Zhang K. User-centered counseling and male involvement in contraceptive decision making: protocol for a randomized controlled trial. Journal of Medical Internet Research, Research Protocols 2021;10(4):e24884. [DOI: 10.2196/24884] [DOI] [PMC free article] [PubMed] [Google Scholar]

Makarov 2021 {published data only}

  1. Makarov DV, Feuer Z, Ciprut S, Lopez NM, Fagerlin A, Shedlin M, et al. Randomized trial of community health worker-led decision coaching to promote shared decision-making for prostate cancer screening among Black male patients and their providers. Trials 2021;22(1):128. [DOI: 10.1186/s13063-021-05064-4] [DOI] [PMC free article] [PubMed] [Google Scholar]

NCT00685256 {published data only}

  1. NCT00685256. Standard genetic counseling with or without a decision guide in improving communication between mothers undergoing BRCA1/2 testing and their minor-age children. clinicaltrials.gov/ct2/show/record/NCT00685256 (first received May 24, 2008).

NCT01263678 {published data only}

  1. NCT01263678. Helping patients with spinal stenosis make a treatment decision: a randomized study assessing the benefits of health coaching. clinicaltrials.gov/show/NCT01263678 (first received December 20, 2010).

NCT03956004 {published data only}

  1. NCT03956004. The impact of a technology-enabled decision aid, for patients with hip and knee osteoarthritis on decision quality, level of shared decision-making, patient satisfaction and magnitude of limitations. clinicaltrials.gov/ct2/show/record/NCT03956004 (first received May 17, 2019).

NCT04659005 {published data only}

  1. NCT04659005. Nurse-led decision counseling on hepatocellular carcinoma screening. clinicaltrials.gov/ct2/show/NCT04659005 (first received October 31, 2020).

Nelson 2020 {published data only}

  1. Nelson LE, Ajiboye W, Djiadeu P, Odhiambo AJ, Pedersen C, Ramos SR, et al. A web-based intervention to reduce decision conflict regarding HIV pre-exposure prophylaxis: protocol for a clinical trial. Journal of Medical Internet Research, Research Protocols 2020;9(6):e15080. [DOI: 10.2196/15080] [DOI] [PMC free article] [PubMed] [Google Scholar]

Ockhuysen‐Vermey 2008 {published data only}

  1. Ockhuysen-Vermey CF, Henneman L, Van Asperen CJ, Oosterwijk JC, Menko FH, Timmermans DRM. Design of the BRISC study: a multicentre controlled clinical trial to optimize the communication of breast cancer risks in genetic counselling. BMC Cancer 2008;8:283. [DOI: 10.1186/1471-2407-8-283] [DOI] [PMC free article] [PubMed] [Google Scholar]

Scalia 2019 {published data only}

  1. Scalia P, Durand MA, Forcino RC, Schubbe D, Barr PJ, O'Brien N, et al. Implementation of the uterine fibroids Option Grid patient decision aids across five organizational settings: a randomized stepped-wedge study protocol. Implementation Science 2019;14(1):88. [DOI: 10.1186/s13012-019-0933-z] [DOI] [PMC free article] [PubMed] [Google Scholar]

Shirzad 2020 {published data only}

  1. Shirzad M, Shakibazadeh E, Rahimi Foroushani A, Abedini M, Poursharifi H, Babaei S. Effect of "motivational interviewing" and "information, motivation, and behavioral skills" counseling interventions on choosing the mode of delivery in pregnant women: a study protocol for a randomized controlled trial. Trials 2020;21(1):970. [DOI: 10.1186/s13063-020-04865-3] [DOI] [PMC free article] [PubMed] [Google Scholar]

TCTR20191226001 {published data only}

  1. TCTR20191226001. The effect of empowerment education on decisional conflict and attitude towards fertility and childbearing of women with a history of failed pregnancy. www.who.int/trialsearch/Trial2.aspx?TrialID=TCTR20191226001 (first received October 3, 2019).

TCTR20200320002 {published data only}

  1. TCTR20200320002. Decisions of adolescent mothers toward using etonogestrel implant: comparison between the people that knowledge from Print Media in individual counseling and counseling from video-based group counseling. http://www.thaiclinicaltrials.org/show/TCTR20200320002 (first received March 7, 2020).

Additional references

ACSQHC 2021

  1. Australian Commission on Safety and Quality in Healthcare (ACSQHC). Shared decision making. www.safetyandquality.gov.au/our-work/shared-decision-making/ (accessed 30 August 2021).

Agbadjé 2020

  1. Agbadjé TT, Elidor H, Perin MS,  Adekpedjou R,  Légaré F. Towards a taxonomy of behavior change techniques for promoting shared decision making. Implementation Science 2020;15(1):67. [DOI: 10.1186/s13012-020-01015-w] [DOI] [PMC free article] [PubMed] [Google Scholar]

Alders 2017

  1. Alders I, Smits C, Brand P, Van Dulmen S. Does patient coaching make a difference in patient-physician communication during specialist consultations? A systematic review. Patient Education and Counseling 2017;100(5):882-96. [DOI: 10.1016/j.pec.2016.12.029] [PMID: ] [DOI] [PubMed] [Google Scholar]

Bekker 2003

  1. Bekker HL, Legare F, Stacey D, O'Connor A, Lemyre L. Is anxiety a suitable measure of decision aid effectiveness: a systematic review? Patient Education and Counseling 2003;50(3):255-62. [DOI: 10.1016/s0738-3991(03)00045-4] [PMID: ] [DOI] [PubMed] [Google Scholar]

Belkora 2015

  1. Belkora J, Volz S, Loth M, Teng A, Zarin-Pass M, Moore D, et al. Coaching patients in the use of decision and communication aids: RE-AIM evaluation of a patient support program. BMC Health Services Research 2015;15:209. [DOI: 10.1186/s12913-015-0872-6] [DOI] [PMC free article] [PubMed] [Google Scholar]

Belkora 2021

  1. Belkora J. SCOPED. www.scoped.org (accessed 13 January 2021).

Bennett 2010

  1. Bennett C, Graham ID, Kristjansson E, Kearing SA, Clay KF, O'Connor AM. Validation of a preparation for decision making scale. Patient Education and Counseling 2010;78:130-3. [DOI: 10.1016/j.pec.2009.05.012] [DOI] [PubMed] [Google Scholar]

Bowen 2013

  1. Bowen S, Graham I. Integrated knowledge translation. In: Straus SE, Tetroe J, Graham ID, editors(s). Knowledge Translation in Healthcare: Moving Evidence to Practice. West Sussex: Wiley, 2013:14-23. [Google Scholar]

Brazier 1992

  1. Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Usherwood T, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992;305(6846):160-4. [DOI: 10.1136/bmj.305.6846.160] [DOI] [PMC free article] [PubMed] [Google Scholar]

Brehaut 2003

  1. Brehaut JC, O'Connor AM, Wood TJ, Hack TF, Siminoff L, Gordon E, et al. Validation of a decision regret scale. Medical Decision Making 2003;23(4):281-92. [DOI: 10.1177/0272989X03256005] [DOI] [PubMed] [Google Scholar]

Brooks 1996

  1. Brooks R. EuroQol: the current state of play. Health Policy 1996;37(1):53-72. [DOI: 10.1016/0168-8510(96)00822-6] [DOI] [PubMed] [Google Scholar]

CCCG 2021

  1. Cochrane Consumers and Communication. Standard protocol text and additional guidance for review authors. cccrg.cochrane.org/author-resources (accessed 30 August 2021).

Chow 2009

  1. Chow S, Teare G, Basky G. Shared decision making: helping the system and patients to make quality health care decisions. hqc.sk.ca/Portals/0/documents/Shared_Decision_Making_Report_April_08_2010.pdf (accessed prior to 6 August 2018).

CIHR 2015

  1. Canadian Institutes of Health Research (CIHR). Guide to knowledge translation planning at CIHR: integrated and end-of-grant approaches. www.cihr-irsc.gc.ca/e/45321.html (accessed prior to 4 October 2021).

Clark 1997

  1. Clark JA, Wray N, Brody B, Ashton C, Giesler B, Watkins H. Dimensions of quality of life expressed by men treated for metastatic prostate cancer. Social Science & Medicine 1997;45(8):1299-309. [DOI: 10.1016/s0277-9536(97)00058-0] [DOI] [PubMed] [Google Scholar]

Cochrane Training 2021

  1. Pollock A, Morley R, Watts C. Involving people: a learning resource for systematic review authors. training.cochrane.org/involving-people (accessed 30 August 2021).

Conger 1988

  1. Conger JA, Kanungo RN. The empowerment process: integrating theory and practice. Academy of Management Review 1988;13(3):471-82. [Google Scholar]

Couet 2013

  1. Couët N, Desroches S, Robitaille A, Vallaincourt H, Leblanc A, Turcotte S, et al. Assessments of the extent which healthcare providers involve patients in decison-making: a systematic review of studies using the OPTION instrument. Health Expectations 2013;18(4):542-61. [DOI: 10.1111/hex.12054] [DOI] [PMC free article] [PubMed] [Google Scholar]

Coulter 2011

  1. Coulter A, Collins A. Making Shared Decision-Making a Reality: No Decision About Me Without Me. London: The King’s Fund, 2011. [Google Scholar]

Coulter 2018

  1. Coulter A. National Strategies for Implementing Shared Decision Making. Gütersloh: Bertelsmann Stiftung, 2018. [Google Scholar]

Covidence 2021 [Computer program]

  1. Veritas Health Innovation Covidence. Version accessed 30 August 2021. Melbourne, Australia: Veritas Health Innovation. Available at covidence.org.

Danko 2018

  1. Danko KJ, Dahabreh IJ, Ivers NM, Trikalinos TA, Grimshaw JM. Seeing the forest and the trees – getting more value out of systematic reviews of complex interventions. training.cochrane.org/resource/making-sense-systematic-reviews-complex-interventions (accessed prior to 4 October 2021).

Deeks 2017

  1. Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S, editors(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 . Chichester (UK): John Wiley & Sons, 2011. [Google Scholar]

Degner 1997

  1. Degner LF, Sloan JA, Venkatesh P. The control preferences scale. Canadian Journal of Nursing Research 1997;29(3):21-43. [PubMed] [Google Scholar]

Diefenbach 1999

  1. Diefenbach MA, Miller SM, Daly MB. Specific worry about breast cancer predicts mammography use in women at risk for breast and ovarian cancer. Health Psychology 1999;18(5):532-6. [DOI: 10.1037//0278-6133.18.5.532] [DOI] [PubMed] [Google Scholar]

Edwards 2003

  1. Edwards A, Elwyn G, Hood K, Robling M, Atwell C, Holmes-Rovner M, et al. The development of COMRADE - a patient-based outcome measure to evaluate the effectiveness of risk communication and treatment decision making in consultations. Patient Education and Counseling 2003;50(3):311-22. [DOI: 10.1016/s0738-3991(03)00055-7] [DOI] [PubMed] [Google Scholar]

Elwyn 2001

  1. Elwyn G, Edwards A, Wensing M, Hibbs R, Wilkinson C, Grol R. Shared decision making observed in clinical practice: visual displays of communication sequence and patterns. Journal of Evaluation in Clinical Practice 2001;7(2):211-21. [DOI: 10.1046/j.1365-2753.2001.00286.x] [DOI] [PubMed] [Google Scholar]

Elwyn 2006

  1. Elwyn G, O'Connor A, Stacey D, Volk R, Edwards A, Coulter A, et al. International Patient Decision Aids Standards (IPDAS) Collaboration. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ 2006;333(7565):417. [DOI: 10.1136/bmj.38926.629329.AE] [PMID: ] [DOI] [PMC free article] [PubMed] [Google Scholar]

Engel 1995

  1. Engel JF, Blackwell RD, Miniard PW. Consumer Behavior. 8th edition. FortWorth (TX): Dryden Press, 1995. [Google Scholar]

Evans 2003

  1. Evans T, Brown H. Road traffic crashes: operationalizing equity in the context of health sector reform. Injury Control and Safety Promotion 2003;10(1-2):11-2. [DOI: 10.1076/icsp.10.1.11.14117] [DOI] [PubMed] [Google Scholar]

Frosch 2011

  1. Frosch DL, Moulton BW, Wexler RM, Holmes-Rovner M, Volk RJ, Levin CA. Shared decision making in the United States: policy and implementation activity on multiple fronts [Partizipative entscheidungsfindung in den Vereinigten Staaten: politische maßnahmen und implementierungsaktivitäten an vielen fronten]. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen 2011;105(4):305-12. [DOI] [PubMed] [Google Scholar]

Gentles 2013

  1. Gentles SJ, Stacey D, Bennett C, Alshurafa M, Walter SD. Factors explaining the heterogeneity of effects of patient decision aids on knowledge of outcome probabilities: a systematic review sub-analysis. Systematic Reviews 2013;2:95. [DOI: 10.1186/2046-4053-2-95] [DOI] [PMC free article] [PubMed] [Google Scholar]

GRADEpro GDT 2021 [Computer program]

  1. McMaster University (developed by Evidence Prime) GRADEpro GDT. Version accessed 30 August 2021. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.

Graham 1995

  1. Graham ID, O'Connor A, Ottawa Hospital Research Institute. User manual - Preparation for decision making scale. decisionaid.ohri.ca/docs/develop/user_manuals/UM_prepdm.pdf (accessed prior to 4 October 2021).

Härter 2011

  1. Härter M, Müller H, Dirmaier J, Donner-Banzhoff N, Bieber C, Eich W. Patient participation and shared decision making in Germany - history, agents and current transfer to practice [Patientenbeteiligung und partizipative entscheidungsfindung in Deutschland: historische entwicklung, träger und praxistransfer]. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen 2011;105(4):263-70. [DOI] [PubMed] [Google Scholar]

Hatala 2005

  1. Hatala R, Keitz S, Wyer P, Guyatt G. Tips for learners of evidence-based medicine: 4. Assessing heterogeneity of primary studies in systematic reviews and whether to combine their results. Canadian Medical Association Journal 2005;172(5):661-5. [DOI: 10.1503/cmaj.1031920] [DOI] [PMC free article] [PubMed] [Google Scholar]

Higgins 2011

  1. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011.. Available from training.cochrane.org/handbook/archive/v5.1.

Hoefel 2020

  1. Hoefel L, O'Connor AM, Lewis KB, Boland L, Sikora L, Hu J, et al. 20th anniversary update of the Ottawa Decision Support Framework part 1: a systematic review of the decisional needs of people making health or social decisions. Medical Decision Making 2020;40:555-81. [DOI: 10.1177/0272989X20936209] [DOI] [PubMed] [Google Scholar]

Hoffmann 2014

  1. Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ 2014;348:g1687. [DOI: 10.1136/bmj.g1687] [DOI] [PubMed] [Google Scholar]

Janis  1977

  1. Janis IL, Mann L. Decision Making: a Psychological Analysis of Conflict, Choice, and Commitment. New York: Free Press, 1977. [Google Scholar]

Joseph‐Williams 2014

  1. Joseph-Williams N, Elwyn G, Edwards A. Knowledge is not power for patients: a systematic review and thematic synthesis of patient-reported barriers and facilitators to shared decision making. Patient Education and Counseling 2014;94(3):291-309. [DOI: 10.1016/j.pec.2013.10.031] [DOI] [PubMed] [Google Scholar]

Jull 2019

  1. Jull J, Köpke S, Boland L, Coulter A, Dunn S, Graham ID, et al. Decision coaching for people making healthcare decisions. Cochrane Database of Systematic Reviews 2019, Issue 7. Art. No: CD013385. [DOI: 10.1002/14651858.CD013385] [DOI] [PMC free article] [PubMed] [Google Scholar]

Kasper 2012

  1. Kasper J, Hoffmann F, Heesen C, Köpke S, Geiger F. MAPPIN'SDM - the multifocal approach to sharing in shared decision making. PLOS One 2012;7(6):e34849. [DOI: 10.1371/journal.pone.0034849] [DOI] [PMC free article] [PubMed] [Google Scholar]

Kessler 1979

  1. Kessler S. Genetic Counseling: Psychological Dimensions. New York: AcademicPress, 1979. [Google Scholar]

Légaré 2012

  1. Légaré F, Turcotte S, Stacey D, Ratté S, Kryworuchko J, Graham ID. Patients' perceptions of sharing in decisions: a systematic review of interventions to enhance shared decision making in routine clinical practice. Patient 2012;5(1):1-19. [DOI: 10.2165/11592180-000000000-00000] [DOI] [PubMed] [Google Scholar]

Légaré 2014

  1. Légaré F, Thompson-Leduc P. Twelve myths about shared decision making. Patient Education and Counseling 2014;96(3):281-6. [DOI: 10.1016/j.pec.2014.06.014] [DOI] [PubMed] [Google Scholar]

Légaré 2018

  1. Légaré F, Adepkpedjou R, Stacey D, Turcotte S, Kryworuchko J, Graham ID, et al. Interventions for increasing the use of shared decision making by healthcare professionals. Cochrane Database of Systematic Reviews 2018, Issue 7. Art. No: CD006732. [DOI: 10.1002/14651858.CD006732.pub4] [DOI] [PMC free article] [PubMed] [Google Scholar]

Liberati 2009

  1. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009;339:b2700. [DOI: 10.1136/bmj.b2700] [DOI] [PMC free article] [PubMed] [Google Scholar]

Luszczynska 2005

  1. Luszczynska A, Scholz U, Schwarzer R. The general self-efficacy scale: multicultural validation studies. Journal of Psychology 2005;139(5):439-57. [DOI: 10.3200/JRLP.139.5.439-457] [DOI] [PubMed] [Google Scholar]

Makoul 2006

  1. Makoul G, Clayman ML. An integrative model of shared decision making in medical encounters. Patient Education and Counseling 2006;60(3):301-12. [DOI: 10.1016/j.pec.2005.06.010] [DOI] [PubMed] [Google Scholar]

Man‐Son‐Hing 1999

  1. Man-Son-Hing M, Laupacis A, O'Connor AM, Biggs J, Drake E, Yetisir E, et al. A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled trial. Journal of the American Medical Association 1999;282(8):737-43. [DOI: 10.1001/jama.282.8.737] [DOI] [PubMed] [Google Scholar]

Marteau 1992

  1. Marteau TM, Bekker H. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). British Journal of Clinical Psychology 1992;31(3):301-6. [DOI: 10.1111/j.2044-8260.1992.tb00997.x] [DOI] [PubMed] [Google Scholar]

Marteau 2001

  1. Marteau TM, Dormandy E, Michie S. A measure of informed choice. Health Expectations 2001;4(2):99-108. [DOI: 10.1046/j.1369-6513.2001.00140.x] [DOI] [PMC free article] [PubMed] [Google Scholar]

McAllister 2011

  1. McAllister M, Wood AM, Dunn G, Shiloh S, Todd C. The Genetic Counseling Outcome Scale: a new patient-reported outcome measure for clinical genetics services. Clinical Genetics 2011;79(5):413-24. [DOI: 10.1111/j.1399-0004.2011.01636.x] [DOI] [PubMed] [Google Scholar]

McGowan 2016

  1. McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS Peer Review of Electronic Search Strategies: 2015 guideline statement. Journal of Clinical Epidemiology 2016;75:40-6. [DOI: 10.1016/j.jclinepi.2016.01.021] [DOI] [PubMed] [Google Scholar]

Moher 2012

  1. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. International Journal of Surgery 2012;10(1):28-55. [DOI: 10.1016/j.ijsu.2011.10.001] [DOI] [PubMed] [Google Scholar]

NICE 2021

  1. National Institute for Health and Care Excellence (NICE). Shared decision making. www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-guidelines/shared-decision-making (accessed 30 August 2021). [PubMed]

O'Connor 1995

  1. O'Connor AM. Decision self-efficacy scale. www.ohri.ca/decisionaid (accessed prior to 4 October 2021).

O'Connor 1995b

  1. O'Connor AM. Validation of a decisional conflict scale. Medical Decision Making 1995;15(1):25-30. [DOI: 10.1177/0272989X9501500105] [DOI] [PubMed] [Google Scholar]

O'Connor 1996

  1. O'Connor AM. Decision regret scale. decisionaid.ohri.ca/docs/develop/User_manuals/UM_Regret_Scale.pdf (accessed prior to 4 October 2021).

O'Connor 1998

  1. O'Connor AM, Tugwell P, Wells GA, Elmslie T, Jolly E, Hollingworth G, et al. A decision aid for women considering hormone therapy after menopause: decision support framework and evaluation. Patient Education and Counseling 1998;33(3):267-79. [DOI: 10.1016/s0738-3991(98)00026-3] [DOI] [PubMed] [Google Scholar]

O'Neill 2013

  1. O'Neill J, Tabish H, Welch V, Petticrew M, Pottie K, Clarke M, et al. Applying an equity lens to interventions: using PROGRESS ensures consideration of socially stratifying factors to illuminate inequities in health. Journal Clinical Epidemiology 2014;67(1):56-64. [DOI: 10.1016/j.jclinepi.2013.08.005] [DOI] [PubMed] [Google Scholar]

Oliver 2008

  1. Oliver S, Kavanagh J, Caird J, Lorenc T, Oliver K, Harden A, et al. Health promotion, inequalities and young people's health: a systematic review of research. EPPI Centre report no. 1611 (2008). eppi.ioe.ac.uk/cms/Portals/0/PDF%20reviews%20and%20summaries/Inequalities%20Young%20People%20R2008Oliver.pdf?ver=2010-12-22-123934-167 (accessed prior to 6 August 2018).

Oliver 2012

  1. Oliver S, Dickson K, Newman M. Getting started with a review. In: Gough D, Oliver S, Thomas J, editors(s). An Introduction to Systematic Reviews. London: SAGE Publications, 2012. [Google Scholar]

Oslo University Hospital 2021

  1. Oslo University Hospital. Centre for Shared Decision Making and Collaborative Care Research. www.ous-research.no/sps/ (accessed 30 August 2021).

Politi 2013

  1. Politi MC, Dizon DS, Frosch DL, Kuzemchak MD, Stiggelbout AM. Importance of clarifying patients' desired role in shared decision making to match their level of engagement with their preferences. BMJ 2013;347:f7066. [DOI: 10.1136/bmj.f7066] [DOI] [PubMed] [Google Scholar]

Pollock 2019

  1. Pollock A, Campbell P, Struthers C, Synnot A, Nunn J, Hill S, et al. Development of the ACTIVE framework to describe stakeholder involvement in systematic reviews. Journal of Health Services Research and Policy 2019;24(4):245-255. [DOI: doi: 10.1177/1355819619841647] [PMID: ] [DOI] [PubMed] [Google Scholar]

Rahn 2021

  1. Rahn AC, Jull J, Boland L, Finderup J, Loiselle MC, Smith M, et al. Guidance and/or decision coaching with patient decision aids: scoping reviews to inform the International Patient Decision Aid Standards (IPDAS). Medical Decision Making 2021 (online ahead of print):272989X21997330. [DOI: 10.1177/0272989X21997330] [DOI] [PubMed] [Google Scholar]

RevMan Web 2021 [Computer program]

  1. The Cochrane Collaboration Review Manager Web (RevMan Web). Version 1.22.0. The Cochrane Collaboration, 2021. Available at revman.cochrane.org.

Ryan 2013

  1. Ryan R, Hill S, Prictor M, McKenzie J, Cochrane Consumers and Communication Group. Study quality guide. cccrg.cochrane.org/authorresources (accessed 2 March 2018).

Ryan 2016

  1. Ryan R, Santesso N, Hill S. Preparing summary of findings (SoF) tables. Version 2.0 (2016). cccrg.cochrane.org/author-resources (accessed prior to July 23 2018).

Scalia 2020

  1. Scalia P, Barr PJ, O'Neill C, Crealey GE, Bagley PJ, Blunt HB, et al. Does the use of patient decision aids lead to cost savings? A systematic review. BMJ Open 2020;10(11):e036834. [DOI: 10.1136/bmjopen-2020-036834] [PMID: ] [DOI] [PMC free article] [PubMed] [Google Scholar]

Schünemann 2011

  1. Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1.

Schünemann 2013

  1. Schünemann H, Brożek J, Guyatt G, Oxman A, editors. Handbook for grading the quality of evidence and the strengthof recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html.

SCPOR 2019

  1. Saskatchewan Centre for Patient Oriented Research. Who is a patient? www.scpor.ca/who-is-a-patient (accessed 30 August 2021).

Sepucha 2011

  1. Sepucha KR, Stacey D, Clay CF, Chang Y, Cosenza C, Dervin G, et al. Decision quality instrument for treatment of hip and knee osteoarthritis: a psychometric evaluation. BMC Musculoskeletal Disorders 2011;12:149. [DOI: 10.1186/1471-2474-12-149] [DOI] [PMC free article] [PubMed] [Google Scholar]

Shea 2017

  1. Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ 2017;358:j4008. [DOI: 10.1136/bmj.j4008] [PMID: ] [DOI] [PMC free article] [PubMed] [Google Scholar]

Simmons 2017

  1. Simmons MB, Batchelor S, Dimopoulos-Bick T, Howe D. The choice project: peer workers promoting shared decision making at a youth mental health service. Psychiatric Services : a Journal of the American Psychiatric Association 2017;68(8):764-70. [DOI: 10.1176/appi.ps.201600388] [DOI] [PubMed] [Google Scholar]

Spielberger 1983

  1. Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press, 1983. [Google Scholar]

Stacey 2006

  1. Stacey D, Menard P, Higuchi K, Davies B, O'Connor A. Integrating evidence-based patient decision support in nursing curriculum. www.ohri.ca/decisionaid (accessed prior to 4 October 2021).

Stacey 2009

  1. Stacey D, Higuchi KA, Menard P, Davies B, Graham ID, O'Connor AM. Integrating patient decision support in an undergraduate nursing curriculum: an implementation project. International Journal Nursing Education Scholarship 2009;6:Article 10. [DOI: 10.2202/1548-923X.1741] [DOI] [PubMed] [Google Scholar]

Stacey 2012

  1. Stacey D, Kryworuchko J, Bennett C, Murray MA, Mullan S, Légaré F. Decision coaching to prepare patients for making health decisions: a systematic review of decision coaching in trials of patient decision AIDS. Medical Decision Making 2012;32(3):E22-33. [DOI: 10.1177/0272989X12443311] [DOI] [PubMed] [Google Scholar]

Stacey 2013

  1. Stacey D, Kryworuchko J, Belkora J, Davison BJ, Durand MA, Eden KB, et al. Coaching and guidance with patient decision aids: a review of theoretical and empirical evidence. BMC Medical Informatics and Decision Making 2013;13(Suppl 2):S11. [DOI: 10.1186/1472-6947-13-S2-S11] [DOI] [PMC free article] [PubMed] [Google Scholar]

Stacey 2017a

  1. Stacey D,  Hill S, McCaffery K, Boland L, Lewis KB, Horvat L. Shared decision making interventions: theoretical and empirical evidence with implications for health literacy. In: R Logan, editors(s). Health Literacy: New Directions in Research, Theory, and Practice. IOS Press, 2017:263-83. [DOI: 10.3233/978-1-61499-790-0-263] [DOI] [PubMed] [Google Scholar]

Stacey 2017b

  1. Stacey D, Légaré F, Lewis K, Barry MJ, Bennett CL, Eden KB, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database of Systematic Reviews 2017, Issue 4. Art. No: CD001431. [DOI: 10.1002/14651858.CD001431.pub5] [DOI] [PMC free article] [PubMed] [Google Scholar]

Stacey 2020

  1. Stacey D, Légaré F, Boland L, Lewis KB, Loiselle MC, Hoefel L, et al. 20th anniversary Ottawa Decision Support Framework: part 3 overview of systematic reviews and updated framework. Medical Decision Making 2020;40(3):379-98. [DOI: 10.1177/0272989X20911870] [DOI] [PubMed] [Google Scholar]

Staniszewska 2017

  1. Staniszewska S,  Brett J,  Simera I,  Seers K,  Mockford C,  Goodlad S,  et al. GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research. BMJ 2017;358:j3453. [DOI: 10.1136/bmj.j3453] [DOI] [PMC free article] [PubMed] [Google Scholar]

Thomas 2020

  1. Thomas J, Petticrew M, Noyes J, Chandler J, Rehfuess E, Tugwell P, et al. Chapter 17: Intervention complexity. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.1. Chichester (UK): John Wiley & Sons, 2020:451-78. [Google Scholar]

Trenaman 2014

  1. Trenaman L, Bryan S, Bansback N. The cost-effectiveness of patient decision aids: a systematic review. Healthcare 2014;2(4):251-7. [DOI: 10.1016/j.hjdsi.2014.09.002] [PMID: ] [DOI] [PubMed] [Google Scholar]

Van der Bij 2003

  1. Van der Bij AK, De Weerd S, Cikot RJ, Steegers EA, Braspenning JC. Validation of the Dutch short form of the state scale of the Spielberger State-Trait Anxiety Inventory: considerations for usage in screening outcomes. Community Genetics 2003;6(2):84-7. [DOI: 10.1159/000073003] [DOI] [PubMed] [Google Scholar]

Van de Ven 2006

  1. Van de Ven D, Johnson P. Knowledge for theory and practice. Academy of Management Review 2006;31(4):802-21. [DOI: 10.2307/20159252] [DOI] [Google Scholar]

Ware 2007

  1. Ware J, Kosinski M, Bjorner J, Turner-Bowker D, Gandek B, Maruish M. User's Manual for the SF-36v2® Health Survey. Lincoln (RI); QualityMetric Incorporated, 2007. [Google Scholar]

Welch 2015

  1. Welch V, Petticrew M, Petkovic J, Moher D, Waters E, White H, et al, PRISMA-Equity Bellagio group. Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration. International Journal for Equity in Health 2015;14:92. [DOI: 10.1186/s12939-015-0219-2] [DOI] [PMC free article] [PubMed] [Google Scholar]

WHO 2007

  1. World Health Organization. Everybody business : strengthening health systems to improve health outcomes: WHO’s frameworkfor action. www.who.int/healthsystems/strategy/everybodys_business.pdf (accessed prior to 4 October 2021).

WHO 2010

  1. World Health Organization. Health workforce. www.who.int/healthinfo/systems/WHO_MBHSS_2010_section2_web.pdf?ua=1 (accessed prior to 4 October 2021).

Zigmond 1983

  1. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression scale. Acta Psychiatrica Scandinavica 1983;67(6):361-70. [DOI: 10.1111/j.1600-0447.1983.tb09716.x] [PMID: ] [DOI] [PubMed] [Google Scholar]

Articles from The Cochrane Database of Systematic Reviews are provided here courtesy of Wiley

RESOURCES